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1 Proteotoxic stress
Proteins make up a substantial proportion of the cell mass, and are involved 
in most regulated aspects of the activity in a cell. Multiple physiological or 
pathological conditions can affect proper protein folding, leading to accu-
mulation of misfolded proteins which in turn leads to perturbation of the cell 
function, a process also known as proteotoxicity. Cells have developed vari-
ous ways to cope with the diverse conditions that are encountered during 
a normal life span. These conditions vary from normal cellular growth and 
differentation to stressful pathophysiological states such as fever and infl am-
mation [1]. The mechanism of the reaction to stress has been a continuous 
subject of research since the observations described by Ritossa in 1962 [2]. 
In this work a transient increase in temperature activated the expression of 
a small group of Drosophila genes encoding a set of proteins which became 
known as heat shock proteins (hsp’s) [3]. Perhaps the name ‘stress proteins’ 
would have been more suitable since their synthesis is not only induced by 
heat but also by a wide range of other stressors, such as  oxidative stress 
[4], hypoxia [5], viral infection [6], heavy metal contamination [7], ischemia 
[8], exercise [4] and metabolic stress [9]. The hsp encoding genes are highly 
conserved among species and their protein products can be assigned to 
families on the basis of conserved domains. In eukaryotic cells, these sub-
families comprise multiple members. These members differ in intracellular 
localization and function [10]. The products of stress-responsive genes are 
known to function in the protection and resistance to stress [11, 12]. During 
stress, the hsp’s act as molecular chaperones to refold denatured proteins 
and to inhibit the accumulation of misfolded proteins, thereby helping the cell 
to endure the stress and survive. Also under normal conditions, hsp’s serve 
to maintain proteostasis. 
From the moment that the hsp’s were discovered, the stress response 
leading to the synthesis of hsp’s has been studied extensively and became 
known as the heat shock response (HSR). The HSR is a response designed 
to combat proteotoxic stress in the cytosol [13-15]. Now it is known that dif-
ferent intracellular compartments handle proteotoxic stress in a distinct way. 
The understanding of endoplasmic reticulum (ER) proteotoxicity has grown 
by characterization of the unfolded protein response (UPR) [16]. However, 
relatively less is known about protein homeostasis in other cellular compart-
ments. Recently, the mitochondrial unfolded protein response has been 
described [17, 18]. 
2 Molecular Chaperones
Molecular chaperones can be classifi ed into six major highly conserved fam-
ilies: Hsp100s (HSPH), Hsp90s (HSPC), Hsp70s (HSPA), Hsp60s (HSPD), 
Hsp40s (DNAJ), and small heat shock proteins (sHsp’s, HSPB) [19]. In 
cells, a constant need for chaperone assistance is present. During de novo 
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protein folding and refolding of nonnative polypeptide chains chaperones are 
needed, since in the in vivo high protein concentration environment aggre-
gation competes with productive folding. This is not only a problem during 
stress but even at physiological temperatures [19-21]. The three main cel-
lular compartments, cytoplasm, mitochondria and ER have their own general 
chaperoning network. These networks are similar because they all contain 
related chaperones and associated factors which promote protein fold-
ing (Hsp90 and Hsp70 machines), chaperones which are known to deliver 
substrates to the folding machines (DNAJ/Hsp40 proteins) and chaperones 
which can store unfolded protein for later refolding or degradation (sHsp’s). 
The main characteristics of the Hsp90, Hsp70, Hsp40 and sHsp family will 
be briefl y discussed in this introduction because these families are, for the 
content of this thesis, the most relevant. 
     2.1 Hsp90 (HSPC)
Hsp90 proteins have three functional domains: the N-terminal, the middle 
domain involved in ATP hydrolysis and client and co-chaperone binding and 
a C-terminal dimerization domain [19]. The activity of Hsp90 is regulated by 
ATP binding and hydrolysis. Hsp90 family members have constitutive and 
stress related functions [22]. Hsp90 has many different client proteins such 
as steroid receptors, protein kinases, calmodulin, calcineurin, nitric oxide 
synthase (NOS), chloride channel CFTR, telomerase and transcription fac-
tors such as HSF-1, reviewed in [23, 24]. Over a dozen co-chaperones of 
Hsp90 are known in eukaryotes [25]. HSPC1 (HSP90AA1) is present in high 
amounts in the cytosol and it is further upregulated under stress conditions 
[26]. HSPC4 (HSP90B1, Grp94) is the ER Hsp90 paralog [27], while HSPC5 
(TRAP1) is the mitochondrial Hsp90 paralog [28]. Hsp90 was shown to 
prevent the aggregation of the enzyme citrate synthase, yet the refolding of 
this enzyme requires the Hsp70 machinery as well, suggesting that there is 
cross-talk between both systems [29]. A similar co-operation between Hsp70 
and Hsp90 has been described for maturation of steroid hormone recep-
tors, reviewed in [30]. Co-chaperone STIP1 is unique because it interacts 
with both Hsp70 and Hsp90, providing a connection between the Hsp70 and 
Hsp90 chaperone machinery [31]. Hsp90 bound by ATP is stabilized by p23 
[32], which replaces STIP1. CHIP modulates the balance between the fold-
ing of proteins and degradation of chaperone substrates [33].
     2.2 Hsp70 (HSPA)
Hsp70 recognizes hydrophobic segments of unfolded polypeptides and 
binds them in an ATP dependent way. Hsp70 binds tightly to its substrates in 
the ADP-bound state allowing folding, whereas it associates and dissociates 
rapidly when ATP is bound. Hsp70 proteins contain an N-terminal ATPase 
domain and a C-terminal domain where the substrates bind. Between the 
ATPase domain and the C-terminal domain exists a small linker domain, 
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which couples the nucleotide hydrolysis to the ability of the C-terminal 
domain to bind substrate [34, 35]. Hsp70 family members are involved in de 
novo folding of newly synthesized proteins. During stress they are known to 
prevent the aggregation of unfolded proteins and they can refold unfolded or 
misfolded proteins in an ATP dependent way [36]. HSPA1A and HSPA1B are 
stress inducible members of the Hsp70 family located in the cytosolic com-
partment, whereas HSPA8 (Hsc70) is known to be constitutively expressed 
in the cytosol. HSPA6 is highly stress inducible, but lacks refolding capacities 
of heat-unfolded luciferase as well as the capacity to inhibit (polyQ) aggre-
gation [37]. Nevertheless, HSPA6 is thought to be involved in cell survival 
after severe stress [38]. HSPA5 (also known as Grp78, BiP) is the ER Hsp70 
paralog [27], while HSPA9 is located in the mitochondria [39]. The activ-
ity of Hsp70s is regulated by co-chaperones. Hsp40 proteins presents the 
substrate to the Hsp70 machine [40] and they accelerate ATP hydrolysis 
by Hsp70, which mediates strong binding of the substrate [41]. Additionally 
Hsp40 was shown to facilitate binding of the next component of the Hsp70 
complex, the co-chaperone STIP1 (for review see [42]). STIP1 interacts 
with Hsp70 and Hsp90 simultaneously and transfers the substrate from the 
Hsp70 machine to the Hsp90 machine [43]. Bag-1 increases the ATPase 
activity of Hsp70 just like Hsp40 but Bag-1 inhibits release of the substrate, 
which results in ineffi cient folding [44], while ST13 prevents the dissociation 
of ADP and thus enhances refolding [45]. ST13 and Bag-1 compete directly 
for binding Hsp70. Interaction of CHIP with Hsp70 directs Hsp70 bound 
client proteins to the proteolytic pathway. However, the function of CHIP is 
thought to be more specifi c for the degradation of Hsp90 client proteins [33].
     2.3 Hsp40 (DNAJ)
The largest class of Hsp70 co-chaperones are the Hsp40/ J-domain-con-
taining proteins [35]. DNAJ family members are identifi ed by the presence 
of a conserved J-domain. DNAJ family members are known to bind nonna-
tive proteins and deliver these to Hsp70.  The J-domains interact with the 
ATPase domain of Hsp70 and stimulate the hydrolysis of ATP. DNAJ fam-
ily members can be subdivided in a type A, B and a type C. Type A and B 
contain an N-terminal J-domain, a glycine/phenylalanine-rich region, and 
a variable C-terminal domain. Type A proteins also contain a cysteine-rich 
region. Type C proteins only contain the J-domain which is not necessarily 
located at the N-terminus [46]. Only a few members of the DNAJ family are 
stress inducible, amongst which DNAJB1 and DNAJB9. The DNAJB family, 
in particular DNAJB1, is by far the most extensively studied DNAJ group. 
DNAJB1 cooperates with HSPA1A and HSPA8 in the cytosol and nucleus. 
DNAJA3 (Tid-1) isoforms exhibit a conserved mitochondrial DNAJ-like func-
tion [47]. DNAJB9 (ERdj4) [48] and DNAJB11 (ERdj3) [49] are ER specifi c 
and cooperate with HSPA5. 
11
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     2.4 Small heat shock protein’s (HSPB)
Ten sHsp family members have been described [50]. All of them share a 
protein sequence, which is generally referred to as the α-crystallin domain 
[51]. The sHsp family shows high heterogeneity in sequence but also in size 
[52]. Although sHsp’s lack the refolding capacities of the large Hsp’s, they 
can form large dynamic complexes composed of homo- or hetero-dimers. 
These homogeneous or heterogeneous oligomeric complexes are thought 
to be acting in an ATP-independent manner by interacting with large num-
bers of partially folded proteins to prevent interactions between hydrophobic 
domains of unfolded proteins [53, 54]. In this manner, aggregation of mis-
folded proteins is prevented. The substrate is kept in a folding competent 
state and can be transferred to the large Hsp’s to be refolded [55] or to the 
proteasome which degrades the substrate [56]. The α-crystallin domain 
plays an important role in oligomerization as site-directed mutagenesis on 
HSP16.3 from Mycobacterium tuberculosis showed that particular residues 
on the α-crystallin domain are involved in the formation of β-sheets which 
are needed in oligomer formation [57]. 
A few HSPB’s, e.g. HSPB1 and HSPB5, are induced by stress conditions. 
Human HSPB1 (hsp27) has three known phosphorylation sites (serines 15, 
78 and 82) and becomes phosphorylated upon different stress stimuli like 
arsenite and heat. HSPB5 (αB- crystallin) can also be phosphorylated at 
Ser19, Ser45 and Ser59 upon different stress stimuli. Phosphorylation of 
HSPB1 monomers infl uences their oligomeric state [46]. Upon phosphoryla-
tion HSPB1 dissociates from large oligomers into small oligomers, presum-
ably tetramers and dimers, to bind unfolded proteins [58, 59]. The dissocia-
tion into smaller oligomers leads to decreased in vitro chaperone activity of 
HSPB1 [60]. In vivo a HSPB1 mutant mimicking phosphorylation can pro-
tect the cells from the deleterious effect of a heat shock but not from other 
stresses, as oxidative stress [60-63]. Overexpressed pseudophosphorylated 
HSPB1 might also form mixed oligomers with endogenous HSPB proteins. 
HSPB4 and HSPB5 (αA- and αB- crystallin) are highly expressed in the eye 
lens were they provide a compact network of water-soluble proteins which is 
needed for the transparency of the lens. HSPB8 was shown to be involved in 
autophagy [64]. HSPB2 is located in the cytosol and mitochondria, no sHsp 
was found in the ER.
3 Transcriptional stress response cytosol
     3.1 HSF family
The constitutively synthesized hsp’s are expressed at a basal level and func-
tion under normal growth conditions. The stress-inducible forms of the hsp 
family are signifi cantly induced following stress [65]. Expression of hsp’s is 
under the control of a family of transcription factors which consists of seven 
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members: heat shock factor 1-5 (HSF1-5) [66, 67], HSFY1 [68] and HSFX1 
[67]. The HSF family shows around 40% sequence homology within a spe-
cies which is for the greater part limited to the oligomerization [69] and DNA-
binding [70] domains. 
HSF1 knock out models have unveiled that HSF1 is needed for the stress 
induced upregulation of hsp genes, and to gain thermotolerance (discussed 
below) [71-74]. HSF2 is required for oogenesis, spermatogenesis and brain 
development [75]. During development HSF2 becomes highly expressed 
leading to spontaneous activation of HSF2 [76]. HSF3 has been found in avi-
an species, were it regulates cellular development and the stress response 
[77, 78]. Recently a murine HSF3 was found. This protein translocates to the 
nucleus upon heat shock but was not able to activate classical hsp genes 
[79]. HSF3 is absent in human. The fourth family member, HSF4, has two 
isoforms namely HSF4a and HSF4b, as a result of alternative splicing [80]. 
Both isoforms lack the heptad repeat (HR)-C which is needed to suppress 
HSF trimer formation. HSF4a has been thought to be a negative regulator 
of the heat shock response and the stress-induced gene expression [81], 
while HSF4b acts as a transcriptional activator [80]. Furthermore, HSF4 was 
shown to be needed for the development of the lens and lens fi ber cell dif-
ferentiation [82]. HSF5 and HSFX1 are not predicted to bind the heat shock 
element and are of unknown function [67]. HSFY1 has been mapped on the 
Y chromosome [68] and altered expression of HSFY1 in the testis results in  
deteriorated spermatogenesis [83].
     3.2 HSF1 structure
A model of the functional domains of HSF1 is shown in fi gure 1. HSF1 con-
tains a DNA-binding domain, hydrophobic repeats which are necessary for 
trimerization, a regulatory domain and an activation domain located at the 
C-terminal part of the protein. The DNA binding domain, located near the N-
terminus of HSF1 is composed of a helix-turn-helix motif [84]. Trimerization 
of HSF1 occurs via a classical helical coiled-coil interaction of HR-A/B and 
HR-C domains [85]. HR-C associates with the HR-A/B in unstressed cells 
to form an intramolecular coiled coil. In this particular conformation, trimer 
formation becomes repressed [85, 86]. When HSF1 becomes activated, the 
intramolecular interactions become disrupted and intermolecular interactions 
are formed through HR-A/B to form an HSF1 trimer [69, 87]. The trimeric 
form of HSF1 possesses an increased affi nity for the heat shock element 
(HSE) [88]. The HSE is located upstream of hsp genes and is composed of 
multiple elements containing three or more pentameric nucleotide repeats 
of 5’-nGAAn-3’ that vary in orientation. Each DNA domain of the HSF trimer 
binds a GAA [89-91]. The transactivation domain of human HSF1 is located 
at the C-terminal part [66] and can be dissected into two distinct activation 
domains AD1 and AD2 which together ensure a fast and prolonged response 
upon stress [92]. A negative regulatory domain is located between the HR-
A/B and HR-C domains. This domain causes repression of the transcription-
13
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al activation domain of HSF1 in unstressed cells [92, 93].
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Figure 1  Organization of HSF1 protein. 
Schematic representation of human HSF1. DNA binding domain (DBD), hydrophobic repeats 
(HR-A/B), the regulatory domain, hydrophobic repeat (HR-C), and the AD1 and AD2 transacti-
vation domains are shown. This scheme has been adapted from [66, 92-95]. 
     3.3 Regulation of HSF1 and kinetics of HSR
Under non stress conditions, HSF1 is found in a multichaperone complex 
located in the cytoplasm. The signal triggering activation of the HSR is the 
accumulation of nonnative proteins in the cytosol, as a result of chemical or 
physical denaturation [96-102]. The total concentration of client proteins for 
chaperones increases and competes with HSF1 for binding, as a result the 
concentration of chaperone bound HSF1 will decrease. Free HSF1 homo-
trimerizes, subsequently, trimeric HSF1 translocates to the nucleus bind-
ing DNA at the highly conserved HSE sequences located in the promoter 
regions of hsp genes [103] (Fig. 2).  When transcriptionally competent HSF1 
transactivates chaperone genes, the concentration of chaperones increases. 
The newly synthesized chaperones accelerate removal of denatured pro-
teins and promote refolding, thus the concentration of client proteins for 
chaperones decreases as the amount of chaperones increases and the 
amount of nonnative proteins decreases [104]. Finally HSF1 adopts its unac-
tive state and reassembles with the chaperone complex. The reassembly 
of the chaperone complex with HSF1 monomers is one of the last HSF1 
inactivation steps. Early reports suggested that HSF1 is regulated by the 
amount of free Hsp70 [105, 106]. Others showed a role for Hsp90 as being 
a key regulator of HSF1 activity. Here, HSF1 is maintained in a monomeric 
form in the cytoplasm via a heterocomplex that involves Hsp90 [107, 108], 
p23 [109], as well as immunophilin [110] but other chaperones are probably 
also involved. 
Compounds as such salicylates and hydrogen peroxide induce HSE DNA-
binding activity but are not able to induce expression of the inducible hsp 
genes [111, 112]. In addition, heat exposure of an erythroleukemia cell line 
results in HSE DNA-binding activity but no increase in chaperone expres-
sion was seen [113]. These results imply that HSF1 activity is regulated 
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at multiple levels, DNA binding of HSF1 is not suffi cient for transcriptional 
activation, HSF1 also needs to be activated in another way. Therefore HSF1 
must be targeted by other regulatory mechanisms as well. HSF1 is post-
translationally modifi ed (see below) and associates with other transcription 
factors such as HSF2, STAT-1 and NF-IL6. Although HSF1 is known as the 
master regulator of the transcriptional response upon stress, HSF2 was also 
shown to bind promoters of hsp genes during stress. This binding activity of 
HSF2 is dependent on the presence of HSF1 [114]. During stress transcrip-
tional competent HSF1-HSF2 heterotrimers are formed. Prolonged stress 
decreases the HSF2 levels, thereby limiting heterotrimerization. It has been 
postulated that HSF1 mediated transactivation might be modulated by HSF2 
levels [115]. HSF1 and HSF2 heterotrimerization might provide a switch 
between transcriptional activation in response to diverse stimuli. HSF1 was 
also shown to associate with regulatory factors like DAXX, splicing factors, 
chromatin remodeling factors and components of the transcriptional machin-
ery (reviewed in [116]). 
HSF1 is a constitutively phosphorylated protein which under stress condi-
tions is inducibly hyperphosphorylated [86, 117, 118]. Phosphorylation 
induced by stress results in modifi cation of 12, and maybe more, serine 
residues [119]. Phosphorylation of Serine -303, -307, and -363 were shown 
to have negative regulatory effects [117, 120, 121]. Under normal conditions, 
these serine residues are constitutively phosphorylated; the phosphorylation 
state is mediated by multiple kinases [117, 122]. ERK was shown to phos-
phorylate HSF1 at serine 303 and serine 307 was shown to be phosphor-
ylated by GSK3β [120, 123]. Serine 363, which is located adjacent to AD1, 
was found to be phosphorylated by JNK and PKC [120, 124]. Two positive 
regulatory sites have been found within the HSF1 protein. Serine 230 is 
phosphorylated under normal conditions, but undergoes enhanced phos-
phorylation under stress conditions by the calcium dependent protein kinase 
II (CaMKII) [125]. Furthermore, phosphorylation of HSF1 at Serine 326 was 
shown to induce transcriptional enhancement [119]. Phosphorylation of none 
of the known sites is absolutely required for activation of HSFl in response 
to a stress or subsequent inactivation after stress. Phosphorylation of Serine 
303 is needed for SUMOylation of HSF1 at Lys298 [126, 127]. SUMOylation 
does not affect the DNA binding ability of HSF1 [128], but the transactiva-
tional capacity of HSF1 becomes impaired when HSF1 is SUMOylated [128, 
129]. 
Figure 2  Activation of HSF1. 
Under normal conditions, HSF1 is a monomer which is kept inactive by binding of chaperones. 
During stress, the chaperone complex dissociates from HSF1, allowing HSF1 to from trimers 
and to bind heat shock elements located in the promoter regions of heat shock protein genes. 
Then the phosphorylation events start with transcription enhancing phosphorylation at HSF1 
residues S230 and S326 and they end with repressive phosphorylation at S303, S307 and 
S363, followed by SUMOylation and acetylation, which also suppress HSF1 activity. Finally 
HSF1 reassembles with the chaperone complex.
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Phosphorylation of serine sites which repress stress induced transcriptional 
activation of HSF1, and SUMOylation, which also represses transcrip-
tional activity of HSF1, are relatively early events in the stress response. 
HSF1 is suggested to be acetylated by histone acetyltransferase p300, and 
acetylation triggers the dissociation of HSF1 from its target genes. HSF1 
is acetylated on at least nine lysine residues. Acetylation of Lys80 controls 
HSF1 binding to DNA [130]. SIRT1 directly deacetylates HSF1 and thereby 
regulates the heat shock response. Decreasing HSF1 acetylation has been 
implicated to prolong HSF1 binding to target promoters, and to enhance the 
heat shock response. 
In summary, the present model is not complete enough to explain all (HSF1 
dependent) events during and after stress. The time that HSF1 is bound to 
the DNA is cell type dependent and depends on the dose of stress [130, 
131]. The transient nature of HSF1 binding makes explaining the HSF1 
dependent induction of chaperones at a later time point after stress diffi cult. 
For example, HSPA1A protein levels increase relatively early during the 
HSR, while HSPB1 protein levels increase at a later time point, when HSF1 
is not thought to be bound or transcriptionally active anymore. The HSPA1A 
promoter is the most wide spread model used to monitor transcriptional 
activation of HSF1. This model might be, to some extent, limited because 
the stress response appears to have more phases and this is also not be-
ing monitored. Furthermore, the interplay between the different HSFs is not 
included. This suggests that using the HSPA1A promoter as a model system 
is not enough to unveil the complete picture regarding the transcriptional 
activation of HSF1.
Figure 3  HSF1 becomes post-translationally modified upon proteotoxic 
stress.
The transactivational activity of HSF1 is regulated by several post translational modifi ca-
tions, such as phosphorylation and SUMOyaltion. During the attenuation phase of the stress 
response, Hsp’s represses the transactivation activity of DNA bound HSF1 and DNA binding is 
inhibited by acetylation of Lysine 80 located in the DBD of HSF1 [132].
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4 Translational control during stress 
     4.1 Stress induced leaky scanning
Translation initiation involves the assembly of the ribosomal 40S subunit, 
several initiation factors and a ternary complex (eIF2 bound to GTP and the 
initiator tRNAi 
Met) at the 5’ cap of the mRNA (reviewed in [133]). This as-
sembly, together called the 43S complex, scans the mRNA for the initiation 
codon. Before the 60S subunit can bind, eIF2-GTP is hydrolyzed to eIF2-
GDP. eIF2 is recycled to an eIF2-GTP bound form in a reaction catalyzed by 
eIF2B. eIF2 is a complex of three polypeptide chains, α-, β- and γ-. eIF2α 
is the major target for translation regulation under various stress conditions 
including heat shock, accumulation of unfolded or denatured proteins in 
cytosol or ER lumen, changes in intracellular calcium, nutrient deprivation, 
virus infection or the induction of apoptosis. Different kinases mediate the 
phosphorylation of eIF2α: GCN2 (amino acid starvation, UV), PKR (dsRNA 
or heat), HRI (low heme, arsenite, osmotic stress, heat stress), and PERK 
(ER stress). When phosphorylated on Serine 51, eIF2α binds to eIF2B and 
prevents the exchange of GDP to GTP, thus reducing the availability of the 
ternary complex which is needed for translation initiation. When the avail-
ability of the ternary complex is low, initiation of translation of messengers 
is largely inhibited. Phosphorylation of eIF2α upon stress thus results in the 
inhibition of general protein synthesis (Fig. 4a). Paradoxically, it can also 
result in the translation of downstream ORFs (Fig. 4b). Around 10% of the 
eukaryotic mRNAs contain upstream open reading frames (uORFs) [134]. 
Well known messengers containing a uORF are ATF4, ATF5, CHOP and 
GADD34 mRNAs. 
The uORFs normally inhibit translation of the downstream ORFs, but leaky 
scanning and reinitiation make the translation of the downstream ORF pos-
sible [135]. After translation of the fi srt uORF, ribosomes resume scanning 
in the 5’ to 3’ direction. Under non- stress conditions, eIF2/GTP/tRNAi
met is 
plenty available. The small ribosomal subunit will bind eIF2/GTP/tRNAi
met 
and couples with the 60S ribosome. Then reinitiation of translation occurs 
and the second ORF will be translated. In the case of ATF4 messenger, the 
second ORF overlaps the third ORF (which encodes ATF4) partially and is 
inhibitory because it is out of frame with the ATF4 ORF. After translation of 
uORF2, ribosomes will dissociate from the mRNA without translating ATF4 
ORF. When eIF2α is phosphorylated, the levels of eIF2/GTP/tRNAi
met  will 
be reduced. After translation of uORF1, the ribosomes have more scanning 
time before they will be recharged with eIF2/GTP/tRNAi
met. The chance that 
the ribosome skips the AUG of the second ORF and reinitiates at the ATF4 
ORF increases, which results in increased translation of the ATF4 ORF [136] 
(Fig. 4b). ATF4 was shown to be a strong transcriptional activator [137-141]. 
Some of the genes induced by ATF4 are CHOP (GADD153) [142], GADD34 
18
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[143] and asparagine synthetase [144, 145].
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Figure 4  Translational control stress response.
a) A wide spectrum of cell stress signals are transduced by four eIF2α kinases; GCN2, 
double-stranded RNA-activated protein kinase (PKR), double-stranded RNA activated protein 
kinase-like ER kinase (PERK), and heme regulated inhibitor kinase (HRI). All four kinases phos-
phorylate eIF2α on serine 51. eIF2α-P binds eIF2B in a non-functional complex which leads 
to suppression of global translation and a paradoxical increase in translation of some ORFs, 
such as that encoding ATF4. Dephosphorylation of eIF2α is mediated by protein phosphatase 
1 (PP1), which is targeted to eIF2α by growth arrest and DNA damage-inducible 34 (GADD34). 
Adapted from [146].
b) Synthesis of ATF4 is increased in response to cell stress induced eIF2α phosphorylation. 
The mRNA for ATF4 includes two short upstream open reading frames (uORF). In non stress 
conditions, ribosomal scanning leads to translation of uORF1 and re-initiation at uORF2, which 
is out-of-frame and has an overlap with the ATF4 coding sequence leading to a low rate of 
ATF4 synthesis. During stress, eIF2α becomes phosphorylated which causes a depletion of 
the available GDP-GTP exchange factor, eIF2B, by non-functional binding. The amount of 
active eIF2-GTP is reduced and results in a slower rate of re-initiation after uORF1 translation. 
Consequently, ribosome assembly occurs after the AUG in uORF2 with translation initiation at 
the ORF encoding ATF4 [136]. 
The ER is the site where secretory and membrane proteins are synthe-
sized. Proteins folded by chaperones inside the ER are transported to the 
Golgi apparatus. Unfolded or misfolded proteins are kept inside the ER and 
ultimately degraded by ER-associated degradation (ERAD). ERAD targets 
selected by a quality control system within the ER lumen are degraded by 
the cytoplasmic ubiquitin proteasome system [147, 148]. When unfolded 
proteins accumulate inside the ER, the UPR becomes activated. Just like 
the HSR, the UPR induces transient attenuation of protein synthesis and 
transcriptional induction of genes to expand the protein-folding and protein-
degradative capacities of the ER [16, 149]. The UPR is regulated by three 
ER-localized transmembrane proteins: inositol requiring 1α (IRE1 α), PKR-
like endoplasmic reticulum kinase (PERK), and activating transcription factor 
6 (ATF6). The ER chaperone protein HSPA5 (BiP) serves as a master UPR 
regulator. It associates with, and represses activity of IRE1α, PERK and 
ATF6. Upon accumulation of unfolded proteins in the ER, the unfolded pro-
teins bind HSPA5 and sequester it from interacting with IRE1α, PERK and 
ATF6 to elicit activation of these three ER membrane proteins [150]. 
5 The Unfolded Protein Response 
     5.1 IRE1α
Upon activation of the UPR, splicing initiated by IRE1α removes a 26-nu-
cleotide intron from unspliced mammalian X-box binding protein 1 (XBP1) 
mRNA, to induce a translational frameshift producing a fusion protein en-
coded from two evolutionarily conserved open reading frames [151]. XBP1 
is a basic leucine zipper type transcription factor involved in the UPR. It was 
reported that the unconventional splicing occurs in the cytoplasm without 
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nuclear processing when the catalytic domain of IRE1α is ectopically ex-
pressed in the cytoplasm [152, 153]. The catalytic domain of IRE1α contains 
a nuclear exclusion signal to prevent mislocalization of IRE1α to the nucleus 
which indicates that the splicing of XBP1 mRNA occurs predominantly in the 
cytoplasm [154]. 
XBP1s activates transcription of ER chaperone and ERAD genes as a 
homodimer or a heterodimer with ATF6, whereas XBP1u, encoded by un-
spliced XBP1 mRNA, enhances degradation of XBP1s [155, 156]. The pro-
moter of XBP1 carries an ERSE where ATF6 can bind to activate transcrip-
tion. The increase in XBP1 mRNA levels was greatly reduced in Chinese 
hamster ovary (M19) cells lacking Site-2 protease, which is important for the 
activation of ATF6. Cells lacking Site-2 protease were more sensitive to ER 
stress than wild type cells, but this effect could be reversed by overexpress-
ing XBP1 [157]. In some organs and cells, XBP1s is required for protein se-
cretion. In plasma cells XBP1s is necessary to produce immunoglobulin and 
in pancreatic exocrine cells it is needed to produce zymogens [158, 159]. 
In adult liver XBP1s does not affect protein secretory function but rather 
controls growth and survival of hepatocytes, thereby infl uencing processes 
such as lipogenesis [160, 161]. There are confl icting reports about the role of 
XBP1s in cellular integrity. XBP1s has been implicated to positively infl uence 
cell survival. XBP1s overexpression protected fi broblasts against cell death 
induced by ER stress [162]. Furthermore, the exogenous expression of 
XBP1s had protective effects against proteasome inhibitor induced dopamin-
ergic cell death [163]. In addition, more cell death occurred in hydrogen 
peroxide treated XBP1 defi cient cells compared with wild type cells. Recent-
ly, IL-3 signaling in murine pro-B-cells cells was shown to enhance XBP1 
promoter activity and to promote XBP1 splicing. Inhibition of IL-3 signaling 
or knockdown of XBP1 induces apoptosis, while constitutive expression of 
XBP1s protects BaF3 cells from apoptosis during IL-3 depletion [164].There 
are also reports suggesting a negative role for XBP1s in cell survival. Muta-
tions in SOD1 cause familial amyotropic lateral sclerosis. Mice harboring 
mutant SOD1 but lacking XBP1 were more resistant to developing disease 
compared with mice having mutant SOD1 and no XBP1 defi ciency, possibly 
because increased levels of autophagy in motor neurons [165]. Overexpres-
sion of XBP1s induced apoptosis in HUVECs by activating caspase and 
downregulation of VE-cadherin [166]. Furthermore, XBP1s overexpression 
impaired glucose stimulated insulin secretion in rat beta cells and increased 
levels of beta cell apoptosis were observed [162]. These reports stress that 
the role of XBP1s is condition and cell type dependent. Therefore expression 
of XBP1s is tightly regulated.
IRE1α targets several RNAs other than XBP1 mRNA. The function of the 
cleavage of these targets under stressed conditions is not clear [167]. IRE1α 
has also signaling functions beyond its nucleolytic property: phosphorylated 
IRE1α can also recruit tumor necrosis factor receptor associated factor 2 
(TRAF2). IRE1α and TRAF2 interact with apoptosis signal-regulating kinase 
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1 (ASK1), which phosphorylates and activates JNK [168, 169]. TRAF2 also 
interacts with procaspase-12 and promotes the clustering of procaspase-12 
and its activation by cleavage in response to ER stress [170]. JNK also 
phosphorylates the anti-apoptotic protein BCL-2 at the ER membrane. This 
could affect the initiation of macro-autophagy because phosphorylated BCL-
2 dissociates from Beclin-1 and this dissociation induces activation of Bec-
lin-1 [171], an essential component of the macro-autophagy machinery [172]. 
It has also been shown that knocking down UPR components in Drosophila 
melanogaster results in increased basal macro-autophagy levels, suggesting 
a link between the UPR and macro-autophagy [173].
     5.2 ATF6
ATF6 is an ER transmembrane transcription factor with the C-terminus locat-
ed in the ER lumen and its N-terminal DNA binding domain faces the cytosol 
[174, 175]. ATF6 is thought to be associated with HSPA5 and is released 
from HSPA5 upon ER stress. Two isoforms of ATF6 are known, ATF6α (90 
kDa) and ATF6β (110 kDa). The ATF6α homolog is thought to be responsi-
ble for transcriptional regulation of prosurvival genes during ER stress, but 
ATF6β may also play a role. Upon activation of the UPR, ATF6α and ATF6β 
translocate to the Golgi where they are cleaved by site-1 protease and site-
2 protease to generate 50-kDa cytosolic b-ZIP-containing fragments that 
migrate into the nucleus. In the nucleus transcription of UPR target genes 
is activated [176, 177]. ATF6 was shown to bind to the ER stress response 
element (ERSE). ERSE is a short consensus sequence found in the pro-
moter region of UPR target genes [178] such as CHOP (a gene implicated 
in apoptosis), and XBP1 [179]. ATF6 induces transcription of ER chaperone 
genes as well as ERAD genes.
     5.3 PERK
Activation of the eIF2α kinase PKR-like endoplasmic reticulum kinase 
(PERK) is part of the UPR [136]. As described earlier, eIF2α-P results in a 
decrease in the global rates of translation initiation and is one of the earliest 
events of the UPR. This will not only reduce the load of protein folding on 
the ER, but will also causes the release of ribosomes and translation factors 
from the mRNA. This resetting of the translational programme is proposed 
to help newly synthesized mRNAs that are transcribed by the UPR induced 
gene-expression programme to compete for limiting translation factors [136]. 
Furthermore, ATF4, GADD34, CHOP [180, 181] and ATF5 ORFs are trans-
lated [182, 183]. The induction of chaperone-encoding genes by the ATF6 
and IRE1α pathways seems to be at odds with the repression of mRNA 
translation. However, GADD34, a target of ATF4, mediates eIF2α dephos-
phorylation and serves as a feedback mechanism. GADD34 coordinates the 
recovery of eIF2B activity and thereby enhances translation initiation and 
with the transcriptional induction of UPR target genes, promotes the transla-
tion of their mRNAs [184, 185].
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     5.4 ERAD
The process Endoplasmic reticulum-associated degradation (ERAD) medi-
ates translocation of proteins from the ER to the cytosol. In the cytosol the 
proteins are degraded by the 26S proteasome, a multicatalytic protease 
which is enriched at the membrame of the ER and degrades ubiquitinated 
polypeptides [186-190]. ERAD removes potentially dangerous proteins from 
the secretory pathway when the concentration of misfolded proteins accu-
mulates to high levels [191, 192].  Proteins to be degraded are ubiquitinated. 
Different ubiquitin ligase complexes are used to tag each class of protein 
(misfolded lumenal, misfolded transmembrane and proteins with misfolded 
cytosolic domains), suggesting that the ERAD pathways differ for varying 
classes of proteins [193, 194].
     5.5 ER stress induced apoptosis
The UPR does not only include prosurvival pathways, but can also activate 
apoptosis cascades. The IRE1α pathway elicits apoptosis via activation 
of JNK. Activation of the PERK and ATF6 pathways lead to transcriptional 
induction of CHOP, which was shown to have pro-apoptotic properties [195]. 
Chop−/− cells are protected from ER stress-induced apoptosis [196]. The 
precise mechanism by which CHOP mediates apoptosis in unclear, CHOP 
activates the transcription of several genes that could trigger apoptosis. 
These include GADD34, ERO1, DR5 and TRB3 [149].
     5.6 Kinetics of UPR signaling
The IRE1α, ATF6 and PERK pathways of the UPR do not operate simul-
taneously [197]. The fi rst immediate response involves the PERK pathway 
to decrease the load of unfolded proteins in the ER by attenuating transla-
tion. Additionally the ATF4 ORF becomes translated. If unfolded proteins 
still accumulate, the ATF6 and IRE1α pathways increase the expression of 
ER chaperones to enhance the folding of unfolded proteins and to increase 
the clearance of misfolded or unfolded proteins by upregulating the capac-
ity of ERAD. Macro-autophagy is also activated by the IRE1α pathway, to 
remove aggregated proteins. ATF6 activation is accomplished by cleavage of 
a preexisting transmembrane protein, while XBP1 needs to be transcribed, 
spliced and translated before it is an active transcription factor. Therefore 
detection of active ATF6 precedes detection of XBP1s in ER stressed cells 
[151]. ATF6 prefers NF-Y-dependent ERSE binding to NF-Y-independent 
UPRE binding, while XBP1s binds both ERSE and UPRE [151]. Target 
genes under the control of ERSE are ER chaperones such as HSPA5 and 
GRP94, while the promoter regions of components of ERAD like EDEM con-
tain an UPRE. XBP1s is able to transactivate its own transcription, allowing 
the activity of XBP1 to continue as long as  IRE1α is activated [198]. These 
fi ndings suggest that cells activate ATF6 to induce transcription via ERSE 
directly in response to ER stress, prior to activation of XBP1s to induce not 
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only ERSE-mediated but also UPRE-mediated transcription. During pro-
longed ER stress, the IRE1α pathway and the ATF6 pathway are turned off, 
while the PERK pathway remains active. This shift results in a transition from 
adaptation/survival to pro-apoptotic conditions [199].
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Figure 5  Unfolded Protein Response.
Upon aggregation of unfolded proteins, HSPA5 dissociates from the three ER membrane recep-
tors, PKR-like ER kinase (PERK), inositol-requiring enzyme 1α (IRE1α) and activating transcrip-
tion factor 6 (ATF6). Dissociation from these receptors leads to activation of the three pathways. 
The three pathways co-operate to restore ER function by inhibiting the production of new client 
proteins, increasing the folding capacity and promoting degradation of protein aggregates.
24
Chapter 1
6 The physiological importance of 
  cellular proteostasis
     6.1 Role of HSF1 in the absence of stress
HSF1 is not only important during stress, various reports suggest a tran-
scription regulatory role for HSF1 in de absence of stress. HSF1 null mice 
show the expected stress-related phenotypes, such as a complete lack 
of the heat shock response and the inability to develop thermotolerance 
(discussed below). However, they also suffer from neuronal, developmental 
and germ cell defects [74, 200-203], which cannot be directly linked to the 
heat shock response and which strongly suggests that HSF1 also regulates 
gene expression under non-stress conditions. Microarray analysis resulted 
in the identifi cation of 49 genes (19 related to immune response) that are 
expressed at reduced levels in HSF1 null fi broblasts compared with wild 
type cells cultured under physiological conditions. The immune response 
of HSF1 null mice was shown to be severely impaired [204]. More recently, 
direct evidence for the stress independent regulation of genes by HSF1 was 
provided in the case of the multi-drug resistance gene 1 [205], and the IL-6 
gene [206]. Furthermore HSF1 inhibits heregulin induced transcription in 
breast carcinoma cells [207]. It has also been discovered that mice carrying 
a mutant HSF1 gene show altered circadian period lengths, suggesting that 
HSF1 is of functional importance for the circadian clock [208].
     6.2 Thermotolerance
Prior exposure to a single preconditioning stress allows cells [209], tissues 
[210], and animals [211] to survive an otherwise lethal stress dose. This 
phenomenom is called thermotolerance and was fi rst described by Gerner 
et.al. [212], who noticed that cellular sensitivity to a second hyperthermic 
dose was reduced after an initial thermal dose followed by a recovery period 
at 37 °C. Additionally, a stronger initial dose induces a longer transient state 
of thermotolerance and makes that a cell can survive stronger stresses. 
To acquire the state of thermotolerance, the recovery period at 37 °C was 
shown to be crucial. The upregulation of the synthesis of several chaperones 
closely correlated with the level of thermtolerance [213]. The synthesis of 
these chaperones is not only upregulated upon heat stress, but also upon 
other types of stresses. Furthermore, overexpression of various chaperones 
confers tolerance to a subsequent stress [214] and inhibition of the synthe-
sis of chaperones by using blocking antibodies decreases the survival rate 
[215]. Overexpression of HSPA1A increases ER stress-induced activation of 
the IRE1α axis and promotes survival during ER stress. HSPA1A was shown 
to bind and enhance the RNase activity of IRE1α. This provides a molecular 
link between the heat shock response and the ER stress response [216].
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     6.3 The critical node of the chaperone network    
    strongly depends on the substrate which is   
    used for measuring
Cells have an extensive chaperone network to maintain protein homeostasis. 
To identify the critical nodes in this network various approaches can be used. 
Polyglutamine (polyQ) diseases are caused by an expansion of a triplet re-
peat in the causative gene and misfolding and aggregation are both associ-
ated with the cytotoxicity in polyglutamine diseases. Molecular chaperones 
have been shown to ameliorate disease progression. Measuring aggregation 
of polyQ proteins gives an indication of the chaperone capacity of a cell. 
Depleting cells of chaperones by overexpressing a dominant negative HSF1 
mutant promotes aggregation of polyQ proteins. A subfamily of the DNAJB 
family was shown to be able to suppresses polyglutamine aggregation and 
associated toxicity both in mam¬malian cell-lines as well as in an in vivo 
Xenopus model [217]. The sHsp’s HSPB1 and HSPB8 are also able to inhibit 
the aggregation of polyQ proteins. 
Chaperone activity can also be monitored by measuring refolding of heat de-
natured luciferase ‘in vivo’. Cells are transfected with a luciferase expression 
construct. Heat shocking the cells causes luciferase to denature which leads 
to loss of activity. Endogenous chaperones are able to refold luciferase and 
thereby recovering the activity. Introducing an excess of chaperones protects 
luciferase from unfolding and also enhances refolding after denaturation; 
depleting cells of chaperones has the opposite effect. Refolding of luciferase 
can be increased by exogenous expression of HSPA1A and is mainly de-
pendent on the Hsp70 machinery.
Another tool to monitor chaperone activity is the glucocorticoid response. Ef-
fi cient maturation of the glucocorticoid receptor (GR) to a conformation which 
has a high affi nity for hormone binding requires the Hsp70 and the Hsp90 
machines (for review see in [218]). Whereas the Hsp70 mediates folding of 
the GR, the Hsp90 machine is needed for the maturation of the GR [219, 
220]. Members of the DNAJB family were able to rescue an impaired glu-
cocorticoid response as a result of chaperone depletion. Which node of the 
cytoplasmic chaperoning network is critical thus depends on the substrate 
tested.
Aging is a multifactorial and complex process that involves the gradual 
impairment of normal biological cellular functions and which results in in-
creased sensitivity to stress and a decreased ability to survive [221]. One of 
the hallmarks of aging is the increase in aberrant proteins which are prone to 
aggregation. Furthermore, a strong decline in degradation of proteins occurs 
[222], as the proteosomal function declines with age [223, 224]. In addition, 
lysosomes, where intra-cellular proteolysis can be achieved, become 
7 Aging 
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signifi cantly affected with age (due to accumulation of lipofuscin, a non-
degradable intralysosomal polymeric aggregate) [225]. Lysosomal degrada-
tion of dysfunctional intracellular components can occur via three different 
pathways; macroautophagy, microautophagy and chaperone-mediated 
autophagy (CMA). The activity of CMA was shown to decline with age [226]. 
Therefore, unfolded proteins tend to accumulate within the cell with age. 
     7.1 The HSR in aging
During aging, the DNA binding capacity of HSF1 becomes impaired which 
results in reduced expression of heat shock proteins [227, 228]. Further-
more, abnormal increases in GSK3β levels have been shown in Alzheimer’s 
disease, which leads to inhibition of HSF1 activity [229]. An age related 
reduction of the HSR was not only found in neuronal tissue but also in skel-
etal and cardiac muscle [230] and in liver tissue [231]. The loss of functional 
protein or the presence of misfolded proteins can result in a wide range of 
diseases involving deposition of aggregated proteins, which includes Alzhe-
imer disease, Parkinson disease, Huntington disease, and spongiformen-
cephalopathies (prion diseases). Dysfunction of the HSR plays an important 
role in these neurodegenerative diseases [232-234].
Other studies which implicate a role for HSF1 in the aging process have 
shown that increased HSF1 activity is positively related to the lifespan of 
nematodes and fl ies, whereas decreased expression of HSF1 decreases the 
lifespan of C.elegans [235, 236]. Hsp70 and shsp’s were shown to play a 
role in the lifespan of Drosophila [237, 238]. 
In C. elegans and Drosophila it has been demonstrated that decreased activ-
ity of the insulin/IGF1 pathway leads to an extended lifespan [239, 240]. This 
effect requires HSF1 and DAF-16/FOXO to stimulate directly the transcrip-
tion of genes which infl uence the stress resistance [241]. Increased lifespan 
by decreased activity of the insulin/IGF1 pathway was also shown to be 
ire-1 or xbp-1 dependent. Xbp-1 is predicted to synergize with one or more 
transcription factors (e.g. DAF-16) in C.elegans [242]. Mice with deletion of 
(IRS)1 also show an increased lifespan [243]. So the insulin/IGF-1pathway 
has been shown to affect lifespan of worms, fl ies and mice, which strength-
en the evidence for evolutionary conservation of mechanisms regulating 
lifespan. Recent studies in humans also suggest an association but the 
results are not yet conclusive; the strongest evidence to date is the FOXO3A 
gene. A variation in the gene of FOXO3A was shown to have a positive ef-
fect on the life expectancy of humans, and is found more often in centarians 
[244]. 
It is known that low levels of stressors like caloric restriction or thermal stress 
infl uence eukaryotic life span [245]. It has been reported that the benefi cial 
effects of caloric restriction are mediated by sirtuins. Overexpression of sir-
tuins would extend lifespan [246]. In yeast, worms and fl ies, the lack of Sir2 
(ortholog of mammalian SIRT1) inhibits the positive effect of caloric restric-
tion on life span [247]. Likewise mice do not have an increased life span 
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by caloric restriction without SIRT1 [248, 249]. Recently it was found that 
some of the reported effects could be due to inconsistencies in experimental 
design. The lifespan increase as a result of dietary restriction in fl y would be 
Sir2 independent, because two long lived strains as a result of sirtuin overex-
pression were not long lived when they were compared with another control 
strain. Furthermore, longevity and overexpression of sirtuins could be sepa-
rated in C.elegans using genetic backcrossing. These results emphasize the 
importance of controlling genetic backgrounds. However, Sir2 overexpress-
ing worms were more resistant to toxic protein aggregates, suggesting that 
sirtuins do have a positive effect on age-associated protein folding disease 
[250]. HSF1 is essential for longevity accomplished by dietary restriction in 
C.elegans [251]. Whereas HSF1 protein concentration increases with age, 
the amount of SIRT1 protein was shown to decrease with age [227, 252]. 
Together with a decrease in SIRT1 protein expression, HSF1 DNA binding 
and expression of heat shock proteins decrease [130]. 
HSF1 is important to protect cells from various stresses, to promote survival, 
and to extend life span. Yet, too much of HSF1 can also be deleterious. 
Higher resistance to stress could have a negative side effect by promoting 
development of cancer [253]. In addition, it is well known that human cancer 
cell lines show a greater dependence on HSF1 function than their normal 
counterparts [253].
     7.2 The endoplasmic reticulum and UPR in aging
To date, only a few reports have implicated ER stress in the aging process. A 
study using a human diploid fi broblast cellular senescence culture model of 
aging showed an age-related decline in the expression of the ER chaperone 
calnexin, which is an essential component of ER-dependent protein folding. 
A decrease in calnexin could contribute to decreased cytoprotection [254]. 
Furthermore, three ER resident proteins, namely HSPA5, protein disulfi de 
isomerase (PDI), and calreticulin show an age related increase in oxidative 
modifi cations. This implies a decline in protein folding, disulfi de crosslinking 
and glycosylation during aging [255]. Another fi nding showed that cultured 
hepatocytes isolated from old rats were more sensitive to cell death induced 
by ER stress than their younger counterparts; this effect was c-Jun N-
terminal protein kinase (JNK) dependent [256]. Activation of PERK and the 
inhibition of global protein synthesis by sleep deprivation is impaired in aged 
mice [257], which will result in more ER stress because new protein synthe-
sis will raise the burden the ER. Sustained ER stress causes CHOP levels to 
increase and CHOP mediates apoptosis under ER stress conditions. Others 
have shown that young rat tissues displayed higher background of eIF2α 
phosphorylation plus a higher level of eIF2B to cope with the negative effect 
of eIF2α-P on translation. The decline in endogenous eIF2α phosphoryla-
tion in tissues from old rats is associated with increased GADD34 levels, 
and pro-apoptotic proteins such as CHOP. These results suggest that young 
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tissues possess an effi cient ER stress adaptive mechanism that declines 
with aging [258]. The effect of proteasome inhibition on the UPR was studied 
in hippocampus from young and old rats. In hippocampus from young rats, 
IRE1α, ATF6 and PERK were active, while aged rats showed no activation of 
the IRE1α and ATF6 pathways. The PERK pathway was activated in young 
and old rats, which results in imbalanced pro-survival and pro-apoptotic 
protein concentrations [259]. 
The precise role of the ER and the UPR in the aging process is not fully 
identifi ed yet. The ER plays vital roles in regulating overall protein homeos-
tasis and cellular stress response pathways and the redox status is essential 
in regulating these functions, therefore the role of the ER in the normal aging 
process needs further investigation.
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Figure 6  Proteotoxic stress responses and aging.
The DNA damage response is not shown for simplicity. UPRmt has not been implicated in aging 
yet and a Golgi stress response pathway has also not been described. Only proteins with a role 
during aging are depicted (modifi ed from [260]).
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Cross-talk between the HSR and the UPR.
The HSR and the UPR are both activated by proteotoxic stress, although 
in different compartments, and share cellular resources. How these re-
sources are allocated when both responses are active is not known. Insight 
in possible crosstalk will help understanding the consequences of failure of 
these systems in (age-related) disease. eIF2α phosphorylation is a mutual 
response to different types of stress. Cytosolic proteotoxic stress, ER stress, 
but also lack amino acids, all result in eIF2α phosphorylation. In chapter 
2 we show that a heat shock results in selective synthesis of ATF4 just as 
ER stress does. A heat shock also induces IRE1-dependent XBP1 splicing. 
XBP1s inhibits the activity of the HSPB1 promoter as well as that of the Dro-
sophila melanogaster Hsp70 promoter (Chapter 3). The DNAJB9 promoter 
(a known target of XBP1s) is also activated upon heat stress. Surprisingly, 
this activation is not via XBP1s, but requires an as yet unidentifi ed transcrip-
tion factor (Chapter 2). The responsiveness of a canonical heat shock pro-
moter, HSPB1, to XBP1s and that of a canonical UPR promoter, DNAJB9, to 
heat stress suggest that there is crosstalk between the two stress systems. 
Identifi cation of critical nodes in the chaperoning network.
The only known way to upregulate the stress system is to cause cellu-
lar stress, which ultimately may be deleterious. To fi nd ways to boost the 
defence and repair system without the deleterious effects, we need to know 
more about the system, its critical nodes and rate limiting steps. Depleting 
cells of cytoplasmic chaperones by overexpression of a dominant nega-
tive HSF1 (dnHSF1) mutant results in an inhibition of the glucocorticoid 
response. We show that the glucocorticoid response in chaperone depleted 
cells can be restored by DNAJA1 or B1 but not by HSP90AA1 or HSPA1A 
(Chapter 4). Overexpression of dnHSF1 also results in a lesser folding ca-
pacity in all cellular compartments, including the ER and peroxisomes. This 
system provides a good model to pinpoint critical nodes of the chaperoning 
network in each cellular compartment (Chapter 5).
Which genes are under control of HSF1 under non-stress conditions?
An unexpected target of dnHSF1 is phosphomevalonate kinase (PMVK), an 
enzyme in the cholesterol biosynthetic pathway. We show that the PMVK 
gene contains an HSE in the region encoding the 5’ UTR.  PMVK mRNA 
and protein levels were strongly downregulated not only when dnHSF1 
(HSF379) was expressed, but also when an HSF1 mutant (HSF448), which 
has a weak dominant positive effect on traditional HSF1 responsive promot-
ers, was expressed. PMVK transcript levels, although downregulated by 
dnHSF1 and HSF448, are not upregulated during proteotoxic stress. The 
activation of the PMVK promoter by sterol depletion was also not HSF1 de-
8 Scope of thesis 
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pendent. Whether the PMVK HSE plays a physiological role remains unclear 
(Chapter 6).
The microarray analysis of HEK293 cells overexpressing dnHSF1 resulted 
in a set of genes that are likely to be direct targets of HSF1. Comparison of 
our microarray results with the published data using HSF-/- cells (siRNA or 
knock-out) showed far fewer transcriptome changes in the dnHSF cells, sug-
gesting that HSF1 does participate in gene regulation even when not acti-
vated. We used another model system in which cells still express HSF1, but 
in an inactive form. To that end we have used the HSF1-K80Q mutant which 
is unable to bind DNA (Chapter 7). Using this model we determined which 
genes are under control of HSF1 under non-stress conditions. The aging cell 
differs from the HSF1-/- cells in that the ageing cell still contains HSF1, al-
though inactive, and differs from the dnHSF1 cells in that HSF1 is no longer 
bound to its target promoters. The model system using HSF1-K80Q could be 
a closer mimic of the aging cell to further probe the change in stress re-
sponse with age. However, we found almost no overlap between the genes 
of which the transcript level changed signifi cantly in non-stressed HeLa cells 
upon siRNA HSF1 treatment or upon overexpression of HSF1- K80Q in 
HEK293 cells. Either the genes controlled by HSF1 in the non-stressed state 
are largely cell specifi c or the effect of deleting HSF1 from a cell is signifi -
cantly different from blocking HSF1 activity by overexpression of a non-DNA 
binding HSF1 mutant (Chapter 7). 
What are the consequences of loss of regulation by HSF1 for cellular robust-
ness?
HSF1-K80Q and dnHSF1 inhibited recovery from heat shock and some 
stress induced transcripts remained high in cells allowed to recover from 
heat shock for 24 hrs. The activity of some transcriptions factors, which nor-
mally decays after heat shock, is maintained when HSF1 activity is blocked 
(Chapter 7). In the fi nal chapter, the results described in this thesis are sum-
marized and discussed.
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Abstract
The heat shock response (HSR) and the unfolded protein response (UPR) 
are both activated by proteotoxic stress, although in different compartments, 
and share cellular resources. How these resources are allocated when both 
responses are active is not known. Insight in possible crosstalk will help 
understanding the consequences of failure of these systems in (age-related) 
disease. In heat stressed HEK293 cells synthesis of the canonical UPR tran-
scription factors XBP1s and ATF4 was detected as well as HSF1 indepen-
dent activation of the promoters of the ER resident chaperones HSPA5 (BiP) 
and DNAJB9 (ERdj4). However, the heat stress activation of the DNAJB9 
promoter, a XBP1s target, was not blocked in cells expressing a dominant 
negative IRE1α mutant, and thus did not require XBP1s. Furthermore, the 
DNA element required for heat stress activation of the DNAJB9 promoter 
is distinct from the ATF4 and ATF6 target elements; even though inhibition 
of eIF2α phosphorylation resulted in a decreased activation of the DNAJB9 
promoter upon heat stress, suggesting a role for an eIF2α phosphorylation 
dependent product. The initial step in the UPR, synthesis of transcription 
factors, is activated by heat stress but the second step, transcriptional trans-
activation by these factors, is blocked and these pathways of the UPR are 
thus not productive. Expression of canonical ER chaperones is part of the 
response of heat stressed cells but another set of transcription factors has 
been recruited to regulate expression of these ER chaperones.
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Introduction
All cells contain an extensive network of chaperones to maintain proteosta-
sis. When proteostasis is disturbed, additional chaperones are synthesized 
to restore protein folding or to increase removal of irreversibly unfolded 
proteins by targeting these for degradation. For reviews see [1-4]. Eukaryotic 
cells have two evolutionarily highly conserved systems to combat proteo-
toxic stress: the heat shock (HS) system and the unfolded protein response 
(UPR). The HS system is the major response to stress conditions in the 
cytosol [5], while cells respond to the accumulation of unfolded proteins in 
the lumen of the endoplasmic reticulum by activating the UPR. 
The UPR induces a transient attenuation of protein synthesis and a tran-
scriptional activation of genes to expand the protein-folding capacity of the 
ER. These responses are mediated by three ER-localized transmembrane 
proteins: inositol requiring 1α (IRE1 α), PKR-like endoplasmic reticulum 
kinase (PERK), and activating transcription factor 6 (ATF6) [6-9]. Under 
non-stressed conditions, these proteins are sequestered by the chaperone 
HSPA5 (BiP). Unfolded proteins in the ER compete for HSPA5 and IRE1α, 
PERK and ATF6 are released [10]. Activation of IRE1α results in the re-
moval of a 26-nucleotide intron from XBP1 mRNA allowing the synthesis of 
the transcription factor XBP1 [11,12]. Activation of PERK, an eIF2α kinase, 
leads to phosphorylation of eIF2α and thus to an overall inhibition of the 
initiation of protein synthesis [13]. Paradoxically, it also results in the prefer-
ential translation of some downstream ORFs, known as stress induced leaky 
scanning [14]. Stress induced leaky scanning is essential for the translation 
of the ATF4 ORF [15,16]. In addition to ATF4 mRNA, GADD34 [17] and ATF5 
ORFs [18,19] are also subject to translational upregulation in response to 
eIF2α phosphorylation. GADD34 is a regulatory subunit of protein phos-
phatase I and mediates eIF2α -P dephosphorylation. The gene for GADD34 
is also one of the targets of ATF4. GADD34 is thus part of a feedback loop 
[20,21]. ATF4, together with XBP1s   and ATF6, directs the transcriptional 
response of the UPR. The heat shock response (HSR) shows some paral-
lels with the UPR. The HSR is mediated by a single transcription factor, heat 
shock factor 1 (HSF1) [22]. Like the mediators of the UPR, HSF1 is seques-
tered by chaperones. In unstressed cells HSF1 is in the cytoplasm in a com-
plex containing the chaperone Hsp90. Unfolding proteins compete for Hsp90 
and upon its release from the Hsp90 complex HSF1 is activated [23-26]. 
HSF1 enhances the transcription of the so-called heat shock genes, genes 
that encode cytoplasmic chaperones such as HSPA1A (Hsp70), DNAJB1 
(Hsp40) and HSPB1 (Hsp27) [27]. Like the UPR, a heat shock also results in 
activation of an eIF2α kinase, in this case both PKR and HRI [28,29]. In ad-
dition initiation of translation is inhibited through inhibition of the cap-binding 
complex [30-32]. 
It is likely that there is cross-talk between the HSR and the UPR. These 
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Materials and Methods
two responses share a resource, the proteasome, which degrades both the 
irreversibly folded cytoplasmic and ER proteins – the latter via the (ER)-
associated degradation (ERAD) pathway [33] - and they share the eIF2α 
kinase regulatory pathway. The HSR and the UPR also compete for resourc-
es in the, not unlikely, case that a stressor causes protein unfolding in both 
cellular compartments. Indeed, a heat stress has been shown to transiently 
induce XBP1 splicing [34] and to lead to an increase in HSPA5 and DNAJB9 
(ERdj4) mRNA levels [35], both typical UPR responses. We show here that 
heat stress induces an UPR like response, but that this response is not 
productive. The activation of the HSPA5 and DNAJB9 promoters is a late 
response of cells recovering from heat stress and the DNAJB9 promoter is 
not activated through the usual UPR induced transcription factors.
Cell culture
 Flp-In T-REx-HEK293 cells (Invitrogen) were manipulated according to the 
manufacturer’s instructions to generate the stable cell lines  HEK-dnIRE1α, 
HEK-dnHSF1 and HEK-cDNA5, which carry a single copy of the tetracy-
cline-inducible plasmids pcDNA5- dnIRE1α, pcDNA5-dnHSF1, and pcDNA5-
FRT/TO, respectively. The cells were cultured at 37oC in the presence of 
humidifi ed 5% CO2 in high glucose DMEM medium supplemented with 10% 
fetal calf serum and 100 U/ml penicillin and 100 μg/ml streptomycin. Blasti-
cidin (1.65 μg/ml; Invitrogen) and 100 μg/ml hygromycin were also added to 
the culture medium during maintenance of the cell lines, but were omitted 
during experiments. 
Plasmid Construction
The C-terminal truncation mutant of dnHSF1 containing codons 1-379 from 
HSF1 was previously described [41]. The truncated dnIRE1α lacks the se-
quence of kinase and ribonuclease domains [55]. pGEM-T-hIRE1αDelC-29 
was made by PCR amplifying the 1.75-kb IRE1α cDNA from HEK293 cDNA 
using the IRE1up and IRE1-delClow primers and cloning the PCR fragment 
into the pGEM-T vector. pcDNA5-FRT-TO-IRE1αDelC was made by clon-
ing the 1.75-kb HindIII-XhoI fragment of pGEM-T-hIRE1αDelC-29 into the 
HindIII and XhoI sites of pcDNA5/FRT/TO. pcDNA5-dpHSF1 was made by 
digesting pcDNA5/FRT/TO-dnHSF1 with BamHI(bl) and XhoI(bl) resulting in 
HSF1 AA1-201, then the SmaI-BglII(bl) fragment from pOTB-HSF1 (C-termi-
nal fragment of HSF1 AA316- 529) was inserted into HSF1 1-201, generat-
ing pcDNA5/FRT/TO-HSF1Δ202-315 (dpHSF1).
The reporter constructs were made in the pGL3 basic vector (Promega). 
The Drosophila melanogaster Hsp70 (Hsp70Ab), HSP70A1A (-313, +196), 
HSPB1 (-685, +36) and HSPA5 (-2742, +202) promoter constructs were de-
scribed previously [41,32]. The HSPA1B (-573, +13), and the DNAJB9 (-375, 
+153) promoter clones were constructed by PCR on DNA isolated from 
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human lymphocytes cells using the primers listed in table 1. PCR fragments 
were cloned into pGEM-T-Easy vector (Promega) and, after sequencing; the 
promoter sequence was cloned into the pGL3 basic vector. DNAJB9 promot-
er deletion constructs were generated by digesting pGL3- DNAJB9 (-376, 
+153) with SacI and XhoI (-254, +153) or PmlI (-109, +153). Blunt ends were 
generated and ligated.
The XBP1s expression construct was generated by PCR on cDNA manu-
factured from total RNA isolated from Flp-In T-REx 293 cells which were ex-
posed to tunicamycin stress. The PCR product was cloned into the pcDNA5/ 
FRT/TO HindIII-XhoI sites.
pcDNA5/FRT/TO-ATF4-ORF was made by  amplifying the 1200-bp ATF4 
ORF fragment from pcDNA5/FRT/TO-ATF4cDNA. The PCR fragment was 
treated with HindIII/EcoRI(bl) and cloned into the HindII and BamH1(bl) sites 
sites of pcDNA5/FRT/TO. pcDNA3.1-ATF6α (1-373) was kindly provided by 
Prof. Dr. Kazutoshi Mori [56]. 
pCMV-ATF4cDNA-T2A-luciferase was made by cloning the 1333 fragment of 
the ATF4cDNA PCR product (via T-vector) into the HindIII and EcoRI sites of 
pCMC-T2A-Luc [57]. The constitutively active GADD34 construct has been 
previously described [58].  pGL3-promoter-UPRE and pGL3-promoter-ERSE 
were made by annealing the corresponding primers (see Table 1) and clon-
ing the double-stranded oligo into the NheI and BglII sites of pGL3-promoter.
Reporter assays
At 24 h before transfection, 0.4x105 HEK-cDNA5, HEK-dnIRE1α or HEK-
dnHSF1 cells were plated per well in a 24-well plate. Transient transfections 
were performed using FuGENE-6 (Roche) according to the manufacturer’s 
instructions. 200 ng plasmid was transfected, 20 ng βactin-β-galactosidase 
was used as a transfection effi ciency control. At 24 hours after transfection 
doxycyclin was added. At 48 hours after transfection cells were harvested 
or exposed to a stressor. Cells were harvested and lysed in 200 μl reporter 
lysis mix (25 mM Bicine, 0.05% Tween 20, 0.05% Tween 80) for 10 min. For 
the β-galactosidase assay, 20 μl cell lysate was mixed with 100 μl Galacton 
solution (100 mM Na-phosphate pH 8.2, 10 mM MgCl2, 1% Galacton-Plus; 
Tropix). After 30 min incubation at room temperature, 150 μl accelerator II 
(Tropix) was added and luminescence was measured with the Lumat LB 
9507 tube luminometer (Berthold). For the luciferase assay, 20 μl cell lysate 
was mixed with 50 μl luciferin solution (Promega) and luminescence was 
measured with the Lumat luminometer. All reporter gene assays were per-
formed in triplicate. Relative activities of luciferase reporter genes were de-
termined by dividing luciferase values by the corresponding β-galactosidase 
values to correct for varying transfection effi ciencies.
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Total RNA isolation & RT-PCR 
RNA isolation, DNase treatment of the RNA and the reverse transcriptase 
reaction were performed as described [32]. Cells were harvested after the 
treatments and at the times indicated, washed twice with ice-cold PBS and 
after washing the cells, RNA was isolated with TRIzol (Invitrogen) according 
to manufacturer’s recommendation. For QPCR analysis, cDNA was 10-fold 
diluted. Quantitative real-time PCR was performed using the StepOnePlus™ 
Real-Time PCR System with Power SYBR® Green PCR Master mix (Applied 
Biosystems) using the following amplifi cation protocol: 2 minutes at 50°C 
followed by 40 cycles of 15 seconds at 95°C and 1 minute at 60°C. Per reac-
tion 3 μl of diluted cDNA was used and the DNA was amplifi ed using prim-
ers for the sequences of interest, listed in table 1. To amplify XBP1 cDNA, 
PCR was for 32 cycles (95 oC for 30s; 58 oC for 30s; and 72 oC for 2 min or 
4 min in the fi nal cycle) using XBP1 PCR up and low oligo’s with Taq DNA 
polymerase. 398 and 424 bp fragments representing spliced (XBP1s) and 
unspliced (XBP1u) XBP1, plus a hybrid (XBP1h) migrating as a fragment 
of approximately 450 bp, were documented after staining 3% agarose gels 
with ethidium bromide. XBP1h represents a mixture of two hybrid structures. 
Each structure contains one strand from XBP1s and one strand from XBP1u 
and is formed in the fi nal annealing PCR step [59]. XBP1h has also been 
observed by others [60,61]. 
Western blotting
Immunoblot analysis was performed with cell lysates from HEK-cDNA5 and 
HEK-dnHSF1 cells as described previously [41]. For western blot analysis, 
polyclonal HSF1 antibody (SPA-901; Stressgen) was used at a 1: 15,000 
dilution, HSPA1A antibody 4G4 (ab5444; Abcam) was used at a 1:5,000 
dilution, polyclonal HSPA5 antibody, kindly donated by Prof. Dr. Ineke  
Braakman, was used at a dilution of 1:1000, polyclonal DNAJB1 antibody 
(anti-Hsp40; SPA-400; Stressgen) at a 1:10,000 dilution, HSPB1 antibody, 
obtained from Dr. A. Zantema, at a dilution of 1:400, polyclonal XBP1 anti-
body [(M-186): sc-7160; Santa Cruz Biotechnology], at a dilution of 1:200, 
polyclonal ATF4 antibody  [(C-20): sc-200; Santa Cruz Biotechnology], at a 
dilution of 1:1000, monoclonal eIF2α antibody was at a 1:500 dilution, poly-
clonal phosphorylated eIF2α antibody (E2152; Sigma) was used at a 1:1,000 
dilution, monoclonal γ-tubulin antibody (GTU-88; Abcam) at 1:1000 dilution 
and monoclonal β-actin antibody (AC-15, Sigma-Aldrich) at a dilution of 
1:5,000. Blots were incubated with fl uorescent secondary antibodies IRDye® 
800 CW conjugated goat (polyclonal) Anti-Rabbit IgG and IRDye®  800CW 
conjugated goat (polyclonal) Anti-Mouse IgG. (926-32211 and 926-32210, 
respectively; LI-COR Biosciences) according to the manufacturer’s instruc-
tions and scanned using a LI-COR Odyssey infrared scanner. Signals were 
quantifi ed using Odyssey version 2.1 software. 
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Oligo name Oligo sequence (5’        3’) Oligo name Oligo sequence 
(5’        3’)
IRE1 up 
IRE1delC low
HSPA1B promoter up
HSPA1B promoter low
DNAJB9 promoter up
DNAJB9 promoter low
XBP1s expression up
XBP1s expression low
XBP1 PCR up
XBP1 PCR low
hATF4 up
hATF4 low
pcDNA5-ATF4ORF up
pcDNA5-ATF4ORF low
ERSE up 
ERSE low
UPRE RE up
UPRE RE low
agctaagcttaccatgccggcccggcggct
agctctcgagtcatccatggcccaggacatccttg
agctctcgagaactatattgcattatctctttcct
agctagatctggccgttttccggac
aacgcgtcttacaacaaatcgctgcgcaatag
accatggtggcgctggcgaccctgacgatc
agctaagcttaccatggtggtggtggcagccgc
agctctcgagttagacactaatcagctggggaa
ctggaacagcaagtggtaga
tctacccagaaggacccagt
agctaagctttttctactttgcccgcccacag
agctgaattcggggacccttttcttccccct
agctaagcttctcacggcattcagcagc
agctgaattccaccacactggactag
ctagccgaccaatgatggtcgaccacgcgtgg
gatcccacgcgtggtcgaccatcattggtcgg
ctagcacaggtgctgacgtggcattca
gatctgaatgccacgtcagcacctgtg
EDEM QPCR up
EDEM QPCR low
HSPA5 QPCR up
HSPA5 QPCR low
HSPC4 (GRP94) QPCR up
HSPC4 (GRP94) QPCR low
CHOP QPCR up 
CHOP QPCR low
GADD34 QPCR up
GADD34 QPCR low
DNAJB9 QPCR up
DNAJB9 QPCR low
DNAJB1 QPCR up
DNAJB1 QPCR low
HSPA1A QPCR up
HSPA1A QPCR low
GAPDH up
GAPDH low
aaagattccaccgtccaagtc
gtatcattgctccggaggtt
ggccgcacgtggaatgac
tccaatatcaacttgaatgtatgg
ctgggactgggaacttatgaatg
tccatattcgtcaaacagacca
accaagggagaaccaggaaacg
tcaccattcggtcaatcagagc
cctctacttctgccttgtctccag
ttttcctccttctcctcggacg
tggtggttccagtagacaaagg
cttcgttgagtgacagtcctgc
ttccccagacatcaagaacc
accctctcatggtccacaac
ccgagaaggacgagtttgag
acaaaaacagcaatcttggaaagg
ttccccatggtgtctgagc
atcttcttttgcgtcgccag
Table 1  Oligonucleotides that were used.
Results
Activation of the eIF2α-phosphorylation dependent regulatory pathway dur-
ing a heat shock.
During both ER stress and heat stress eIF2α is phosphorylated (Fig. 1A), 
where heat stress induced phosphorylation of eIF2α is most likely mediated 
by PKR and HRI, while ER stress activates PERK.  When eIF2α is phos-
phorylated. ATF4 mRNA is selectively translated and a similar increase in 
ATF4 levels in cells recovering from heat shock and in DTT or tunicamycin 
treated cells was seen (Fig. 1B; the multiple ATF4 bands most likely repre-
sent phosphorylated forms [36]). eIF2α phosphorylation decayed rapidly in 
cells recovering from heat shock (Fig. 1A) and to show that the increase in 
ATF4 is indeed due to eIF2α-P dependent de novo translation, we designed 
reporter constructs in which translation of the luciferase code is dependent 
upon translation of the preceding ATF4 ORF by linking that ORF to the luci-
ferase code with the T2A viral frameshift region. Upon translation of the T2A 
sequence, the ribosome frameshifts, releasing the protein, but continues 
translation of the downstream ORF [37,38], in our constructs the luciferase 
coding region (see fi g. 1C). As expected, placing the ATF4 cDNA sequence, 
including the upstream ORFs, before the T2A-luciferase ORF was strongly 
inhibitory: the luciferase yield from the pCMV-ATF4 constructs was in un-
stressed cells about 5% of that obtained from the control, pCMV-T2A-luc 
(data not shown). Dephosphorylating the little eIF2α-P present in unstressed 
cells by expressing the C-terminal domain of GADD34 (C-term GADD34), a 
constitutively active mutant of the regulatory subunit of eIF2α dephosphory-
lase, caused a further decrease of the luciferase yield (the effi cacy of exo-
genous expression of the C-term GADD34 in dephosphorylation of eIF2α-P 
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is shown in fi g. 1D). Heat stressing the cells resulted in a sharp increase in 
luciferase yield from the ATF4 constructs, an increase that is completely pre-
vented by exogenous expression of C-term GADD34 (Fig. 1E). These data 
show that the increase in ATF4 levels in heat stressed cells is due to eIF2α-P 
dependent translation initiation just as it is in ER stressed cells.
allowed to recover for the indicated time before harvesting. Cell lysates were subjected to SDS-
PAGE and levels of phosphorylated eIF2α (eIF2α-P) were determined by western blotting with 
eIF2α as a loading control (panel A) or levels of ATF4 were determined by western blotting with 
β-actin as a loading control (panel B). The asterisk indicates a non specifi c band. C) Schematic 
representation of the luciferase reporter constructs containing the ATF4 ORF. Translation of 
the luciferase code is dependent upon translation of the preceding ATF4 open reading frame. 
D) Expression of C-term GADD34 decreases the level of eIF2α-P. HEK-cDNA5 cells were 
transfected with GADD34 or with an empty vector. Cell lysates of unstressed HEK-cDNA5 cells 
or HEK-cDNA5 cells exposed to tunicamycin or HS were subjected to SDS-PAGE and levels 
of phosphorylated eIF2α (eIF2α-P) were determined by western blotting.  eIF2α was used as 
a loading control. E) Translation of the ATF4 ORF in heat shocked cells is eIF2α-P dependent. 
HEK-cDNA5 cells were transfected with a mixture (4:1:5) of the indicated luciferase reporter, 
a β-actin-β-gal reporter, and the expression construct for C-term GADD34 or an empty vector. 
At 48 h after transfection, cells were exposed to a heat shock of 30’ at 45oC (HS) or left at 
37oC (Control). When heat shocked, cells were allowed to recover for 7 hours and harvested. 
Harvested cells were assayed for reporter gene activities. The results are the average of three 
independent transfections (standard deviations are indicated by error bars).
Figure 1   eIF2α-P dependent translation 
of the ATF4 ORF upon heat stress. 
A, B) eIF2α-P and ATF4 levels in ER or 
heat stressed cells. HEK-cDNA5 cells were 
treated with 10 mM DTT or 5 μg/ml tuni-
camycin for the indicated time to induce ER 
stress. Alternatively cells were exposed to 
a heat shock of 30’ at 45oC (HS) or left at 
37oC (37oC). When heat shocked, cells were 
B
C D
A
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Activation of the ATF6 dependent regulatory pathway during a heat shock
The data presented above show that the ATF4 branch of the UPR is also 
activated in heat stressed cells. To determine whether a heat stress also ac-
tivates the ATF6 arm of the UPR we used two reporter genes. One is driven 
by the UPRE [39]; the other by the ERSE [40]. Both DNA elements are 
targeted by ATF6 as evidenced by the increased activity upon exogenous 
expression of the soluble form of ATF6 (ATF6 1-373), but not uniquely, as 
these elements are also targets of XBP1s (Fig. 2A). To exclude an effect of 
XBP1s we inactivated this branch of the UPR by expression of a dominant 
negative mutant of IRE1α. Fig. 2B shows that expression of dnIRE1α inhi-
bited tunicamycin induced XBP1 splicing. The activity of the UPRE reporter 
increased more than six fold after tunicamycin induced ER stress, while 
heat shock caused only a twofold induction. DnIRE1α expression strongly 
inhibited the ER stress induced activity, while the mild activation after heat 
shock was still observed (Fig. 2C left, black bars). The ERSE reporter was 
less responsive to stress and an increase of only twofold was seen after heat 
shock or tunicamycin treatment. In presence of dnIRE1α, tunicamycin no 
longer induced the reporter, while the heat shock induced activity remained. 
(Fig. 2C right, white bars) These results suggest that the increased activity of 
both the UPRE and the ERSE driven reporter genes in tunicamycin treated 
cells, but not in heat shocked cells, is dependent upon XBP1s. Only the 
UPRE driven reporter gene shows a slight activation in tunicamycin treated 
dnIREα cells, potentially due to ATF6. If so, ATF6 could also be responsible 
for the XBP1s independent activity seen in heat shocked cells. The activity 
of the ERSE driven reporter gene is completely dependent upon XBP1 in 
tunicamycin cells, no sign of a possible ATF6 contribution is seen. Hence we 
cannot conclude that the heat shock induced activity of this reporter is due to 
ATF6; it may well be due to other transcription factors. 
Heat shock induces XBP1 mRNA splicing.
The XBP1 branch of the UPR has been reported to be activated in heat 
shocked cells [34],  and we therefore expected to see an inhibition of the 
UPRE driven reporter gene in heat shocked dnIRE1α cells. However, we 
saw little effect (see Fig. 2C) and thus looked to see if XBP1 mRNA is 
spliced in heat shocked cells under our experimental conditions. Directly 
after heat shock or after 3 hrs of recovery, XBP1 mRNA was indeed com-
pletely spliced (Fig. 3A). After about 8 hrs unspliced XBP1 mRNA was 
again detected (Fig. 3B). Figure 3A shows that heat-induced XBP1 splicing 
was strongly inhibited by the expression of dnIRE1α, indicating that heat 
shock induced XBP1 splicing is, as expected, IRE1α dependent. Recovery 
from XBP1 splicing is dependent on a healthy heat shock system. In heat 
stressed MEF HSF1 -/- cells XBP1 splicing was prolonged [34]. In agree-
ment, we found that expression of a dominant negative HSF1 mutant [41] 
also delays the reappearance of unspliced XBP1 after heat stress (Fig. 3B). 
XBP1 splicing in cells recovering from heat stress is transient and XBP1 
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Figure 2   UPRE and ERSE directed reporter 
gene activity.
 A) Effect of exogenous expression of ATF6 or 
spliced XBP1 on the activity of the UPRE-luci-
ferase and ERSE-luciferase reporter constructs. 
HEK-cDNA5 cells were transfected with a mixture 
(4:1:5) of the indicated luciferase reporter, a 
β-actin-β-gal reporter, and pcDNA3.1-ATF6α 
(1-373), pcDNA5-XBP1s or an empty vector 
pcDNA5/FRT/TO. At 48 hours after transfection, 
cells were harvested and assayed for reporter 
gene activities. B) dnIRE1α blocks XBP1 splicing. 
HEK-dnIRE1α cells were cultured in the absence 
or presence of doxycycline. Cells were treated 
with 10 μg/ml tunicamycin for 90’ to induce XBP1 
splicing. Total RNA samples were analyzed by 
RT-PCR. PCR products represent unspliced 
(XBP1u), spliced (XBP1s) and a hybrid of spliced 
and unspliced XBP1 PCR products (XBP1h; see 
also Materials and methods). C) HEK-cDNA5 and 
HEK-dnIRE1α cells were transfected with a mix-
ture (9:1) of the indicated luciferase reporter and a 
βactin-βgal reporter. At 24 hours after transfection 
dnIRE1α expression was induced by adding doxy-
cycline. At 48 hours after transfection, cells were 
exposed to a heat shock of 30’ at 45oC (HS) or left 
at 37oC (37oC). When heat shocked, cells were 
allowed to recover for 18 hours and harvested. 
To induce ER stress, cells were exposed to 2 μg/
ml tunicamycin for 24 hours. Harvested cells were 
assayed for reporter gene activities. 
protein can no longer be detected in cells that have recovered for 18 hrs 
from a heat shock, although it is present 6 hrs after heat shock (Fig. 3C).
The DNAJB9 promoter becomes activated upon heat stress, independent of 
XBP1s.
The data presented above show that the UPR is induced by heat shocking 
cells but leave some doubt as to whether the typical UPR transcriptional 
response is also seen: an UPRE driven reporter gene was only inhibited by 
dnIRE1α in tunicamycin treated cells, not in heat shocked cells (Fig. 2C). We 
thus tested the heat shock inducibility of two canonical UPR promoters, the 
human DNAJB9 (ERdj4) promoter and HSPA5 (BiP) promoter. The DNAJB9 
promoter is a target of XBP1s [42,43] and ATF4 [44]; the HSPA5 promoter 
is activated by ATF6 via an ERSE [45] and also by ATF4 [46]. The ATF4, 
ATF6 and XBP1s sensitivity of our HSPA5 and DNAJB9 promoter constructs 
was tested by assaying their response to exogenous expression of either 
ATF4, ATF6 or XBP1s. The HSPA5 promoter was most sensitive to exog-
enous ATF6 expression (Fig. 4A, white bars) while the DNAJB9 promoter 
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Figure 3   A) HEK-dnIRE1α cells were cultured 
in the absence or presence of doxycycline. Cells 
were exposed to a heat shock of 30’ at 45oC (HS) 
or left at 37oC (no stress). When heat shocked, 
cells were allowed to recover for the indicated pe-
riods at 37oC. Total RNA samples were analyzed 
by RT-PCR. B) HEK-dnHSF1 cells were cultured 
in the absence or presence of doxycycline for the 
indicated time. Cells were exposed to a heat shock (30’, 45°C), harvested at the indicated time 
point after heat shock, and subjected RT-PCR analysis to investigate the effect of HEK-dnHSF1 
on XBP1 splicing after heat stress. C) XBP1s levels in heat stressed cells. HEK-cDNA5 cells 
were exposed to a heat shock of 30’ at 45oC or left at 37oC. When heat shocked, cells were 
allowed to recover for the indicated time before harvesting. To induce ER stress, cells were 
treated with 5 μg/ml tunicamycin for 90 minutes. After 5 hours recovery cells were harvested. 
Cell lysates were subjected to SDS-PAGE and levels of XBP1s were determined by western 
blotting with γ-tubulin as a loading control.
responded best to exogenous XBP1s expression (Fig. 4A, light gray bars; 
see Fig. S1 for expression levels of exogenous XBP1s and ATF4 protein). 
In cells recovering from a heat shock for 6 hrs, luciferase constructs driven 
by either the DNAJB9 or the HSPA5 promoter were not active, while human 
HSPA1A (Hsp70) or HSPA1B promoter driven luciferase genes were fully ac-
tive. However, a HSPB1 promoter driven luciferase gene was also inactive, 
even though the HSPB1 promoter is a canonical heat shock promoter (Fig. 
4B).  When the activity of the same constructs is assayed in cells that were 
allowed to recover from a heat shock overnight (18 hrs), the activity of the 
HSPA1 promoter driven constructs was already decaying (relative to pGL3 
control), but that of the HSPB1, DNAJB9 and HSPA5 promoter constructs 
was higher. Apparently these three promoters are delayed responders to 
a heat shock. The delayed activity of at least the HSPB1 and HSPA5 pro-
moter constructs refl ects that of the endogenous genes: the protein products 
were only detectable in cells after overnight recovery from the heat shock 
(Fig. 4C). As expected, the activity of the HSPA5 and DNAJB9 promoters 
increased upon tunicamycin treatment of the cells, while that of the HSPA1A 
promoter did not (Fig. 4D). 
The increased activity of the HSPA5 and DNAJB9 promoters in heat 
shocked cells raised the question whether other ER stress responsive genes 
are also activated. We thus looked at the changes in transcript levels of 
six ER stress responsive genes (HSPA5, DNAJB9, GRP94, EDEM, CHOP 
and GADD34) in heat shocked or tunicamycin treated cells and compared 
this with the changes in HSPA1A and DNAJB1 mRNA levels (Fig. 5). The 
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Figure 4   Stress response of various promoters. A) ATF4, ATF6 and XBP1s activate the 
HSPA5 and DNAJB9 promoters. HEK-cDNA5 cells were transfected with a mixture (4:1:5) of the 
indicated luciferase reporter, a β-actin-β-gal reporter, and pcDNA5-XBP1s, pcDNA5-ATF4ORF, 
pcDNA3.1-ATF6α (1-373) or the empty vector pcDNA5/FRT/TO. At 24 hours after transfection 
doxycyclin was added to induce expression of XBP1s or ATF4. At 48 hours after transfection, 
cells were harvested and assayed for reporter gene activities. For the levels of exogenously 
expressed XBP1 and ATF4, see Fig. S1. B) Heat shock response of various promoters. HEK-
cDNA5 cells were transfected with the indicated promoter reporter construct and a β-actin-β-
galactosidase reporter (9:1 ratio). At 48 h after transfection, cells were exposed to a heat shock 
of 30’ at 45oC or left at 37oC. When heat shocked, cells were allowed to recover for 6 hours 
or 18 hours, and assayed for reporter gene activities. The luciferase activity of the promoter 
constructs is relative to the activity of pGL3 control. C) HEK-cDNA5 cells were exposed to a 
heat shock of 30’ at 45oC or left at 37oC. When heat shocked, cells were allowed to recover 
for the indicated time before harvesting. Cell lysates were subjected to SDS-PAGE and levels 
of HSPA1A, HSPA5 and HSPB1 were determined by western blotting. D) ER stress activation 
of various promoters. HEK-cDNA5 cells were transfected with the indicated promoter reporter 
construct and a β-actin-β-galactosidase reporter (9:1 ratio). At 48 h after transfection, cells were 
exposed to 2 μg/ml tunicamycin for 18 hours, and assayed for reporter gene activities. The 
luciferase activity of the promoter constructs is relative to the activity of pGL3 control.
Figure 5   Relative changes in transcript levels of ER responsive genes in heat shocked and 
tunicamycin treated cells. 
HEK-cDNA5 cells were treated with 2 μg/ml tunicamycin for 24 hours to induce ER stress. 
Alternatively cells were exposed to a heat shock of 30’ at 45oC (HS) or left at 37oC (37oC). When 
heat shocked, cells were allowed to recover for the indicated time before harvesting. Total RNA 
was isolated and transcript levels were measured by QPCR. Fold induction of mRNA levels is 
plotted relative to GAPDH mRNA levels.
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transcript levels of the ER responsive genes all increased upon tunicamycin 
treatment and, with the exception of DNAJB9 and GADD34, were higher 
than in heat shocked cells. The HSPA1A and DNAJB1 mRNA levels did not 
increase in tunicamycin treated cells. A (modest) increase in the transcript 
level of all genes tested was seen in cells 6 hours after heat shock. Tran-
script levels were generally higher in cells 18 hrs after heat shock, with the 
exception of the two canonical ATF4 target genes (CHOP and GADD34) and 
the two canonical heat shock genes (HSPA1A and DNAJB1).  These data 
show that these six ER responsive genes are active in heat shocked cells; 
generally, as also indicated by the activity of the promoter constructs, as a 
delayed response. The relative level of the transcripts in heat shocked cells 
is, however, different from that in tunicamycin treated cells (Fig. 5). 
To determine whether the heat shock induced activity of the HSPA5 and 
DNAJB9  promoters (see Fig. 4B) is a result of the activity of the transcrip-
tion factor HSF1, we tested promoter activity in HEK-dnHSF1 cells. As 
shown in fi gure 6B, the expression of dnHSF1 effectively blocks the heat 
shock induced activity of the DmHsp70Ab, the HSPA1A, the HSPA1B, 
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and the HSPB1 promoter constructs, but not that of the DNAJB9 promoter 
construct, while the HSPA5 promoter construct is only slightly inhibited (note 
that the levels of HSF1 and dnHSF1 remain constant in cells recovering from 
heat shock; Fig. S2). To confi rm that the DNAJB9 and the HSPA5 promoter 
constructs do not respond to HSF1, we also tested the effect of a dominant 
positive HSF1 mutant. Expression of this mutant strongly upregulated the 
endogenous HSPA1A, DNAJB1 and HSPB1 protein levels, indicating an ac-
tivated heat shock response (Fig. 6C). Expression of dpHSF1 also resulted 
in increased activity of the DmHsp70Ab and the HSPB1 promoter constructs 
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Figure 6   HSF1 dependency of various promoters. A) Expression of dnHSF1. HEK-dnHSF1 
were cultured in the absence or presence of doxycycline to induce expression of dnHSF1. 
After harvesting the cells were subjected to SDS-PAGE and levels of endogeneous HSF1 and 
dnHSF1 were determined by western blotting with  β-actin as a loading control. B) The effects of 
dnHSF1 on basal and heat shock induced activity of various promoters. Cells were transfected 
with a mixture of the indicated luciferase reporter and a β-actin-β-galactosidase reporter (9:1 ra-
tio). At 24 hours after transfection doxycyclin was added to induce expression of dnHSF1. At 48 
hours after transfection, cells were exposed to a heat shock of 30’ at 45oC or left at 37oC. When 
heat shocked, cells were allowed to recover for the indicated periods at 37oC. Harvested cells 
were assayed for reporter gene activities. C) Expression of dpHSF1 leads to increased HSP lev-
els. HEK-cDNA5 cells were tranfected with pcDNA5-dpHSF1. At 24 hours after transfection cells 
were cultured in the absence or presence of doxycycline to induce expression of dpHSF1. At 48 
hours after transfection cells were harvested and subjected to SDS-PAGE and levels of endog-
enous HSF1, dpHSF1, HSPA1A, DNAJB1 and HSPB1 were determined by western blotting. D) 
The effect of dpHSF1 on the activity of various promoters. HEK-cDNA5 cells were transfected 
with a mixture (4:1:5) of the indicated luciferase reporter, a βactin-βgal reporter, and pcDNA5-
dpHSF1. At 24 hours after transfection doxycycline was added to induce expression of dpHSF1. 
At 48 hours after transfection, cells were harvested and assayed for reporter gene activities. 
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in the absence of stress, yet no effect was seen for the DNAJB9 or HSPA5 
promoter constructs (Fig. 6D). We conclude that the DNAJB9 and HSPA5 
promoters are not a target of HSF1. 
The activation of canonical UPR promoters in cells recovering from a heat 
shock does suggest that heat shocked cells mount the UPR response. We 
thus tested whether the DNAJB9 promoter construct is activated by a heat 
shock when the XBP1 branch of the UPR is blocked. As shown in fi gure 7A, 
in tunicamycin treated cells, activation of the DNAJB9 promoter construct is 
fully dependent upon XBP1s, as the response is absent in dnIRE1α cells. 
However, in heat shocked dnIRE1α cells, the DNAJB9 promoter construct 
is fully active. Hence endogenous XBP1s is not involved in the heat shock 
activation of the DNAJB9 promoter. XBP1s is not inactivated in heat shocked 
cells, as bypassing IRE1α by exogenous expression of XBP1s did increase 
the activity of the DNAJB9 promoter (Fig. 7B). One possibility is that the 
DNAJB9 promoter construct is activated by ATF4, which is also upregulated 
in heat shocked cells (Fig. 1). ATF4 synthesis requires eIF2α phosphoryla-
tion and we thus checked whether activation of the DNAJB9 construct was 
dependent upon eIF2α phosphorylation. As control we used the HSPA5 
promoter construct, known to be induced by eIF2α phosphorylation [46]. 
As shown in fi gure 8, the activity of these two promoter constructs both in 
unstressed and in heat stressed cells was indeed blocked when eIF2α is 
dephosphorylated by exogenous expression of the C-terminal domain of 
GADD34, showing that the transcriptional activation is the consequence of 
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Figure 7   DNAJB9 promoter activity is not regulated by XBP1s in heat shocked cells. A) Ac-
tivity of the DNAJB9 promoter in HEK-dnIRE1α cells.  HEK-dnIRE1α cells were transfected with 
a mixture of the indicated luciferase reporter and a β-actin-β-galactosidase reporter (9:1 ratio). 
At 24 hours after transfection doxycyclin was added to induce expression of dnIRE1α. At 48 
hours after transfection, cells were exposed to a heat shock of 30’ at 45oC or left at 37oC. When 
heat shocked, cells were allowed to recover for 18 hours and harvested. Alternatively, cells were 
exposed to 2 μg/ml Tunicamycin for 18 hours. Harvested cells were assayed for reporter gene 
activities. B) The DNAJB9 promoter can be activated by exogenous XBP1s. HEK-cDNA5 cells 
were transfected with a mixture (4:1:5) of the indicated luciferase reporter, a β-actin-βgal re-
porter, and pcDNA5-XBP1s or the empty vector pcDNA5/FRT/TO. At 24 hours after transfection 
doxycyclin was added to induce expression of XBP1s. At 48 hours after transfection, cells were 
exposed to a heat shock of 30’ at 45oC or left at 37oC. When heat shocked, cells were allowed 
to recover for 18 hours, harvested and assayed for reporter gene activities. 
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Discussion
stress induced differential translation. 
If the transcription factor involved in the heat shock activation of the DNAJB9 
promoter is ATF4, then the ATF4 responsive element in that promoter should 
also be the element mediating the heat shock inducibility of the DNAJB9 
promoter. The DNAJB9 promoter contains a CRE-like element around -140 
and a CCAAT box around -65. ATF4 preferentially binds a CRE, but was also 
shown to bind CCAAT box although less effi ciently [47]. Deleting the pro-
moter to -109 resulted in loss of the heat shock inducibility but the truncated 
promoter could still be activated by ATF4 and XBP1s (Fig. 8). Hence the 
DNA region required for heat shock inducibility and that required for activa-
tion by ATF4 do not co-localize and we therefore conclude that the heat 
shock induction of the DNAJB9 promoter is not mediated by ATF4 (see Fig. 
9). The heat insensitive DNAJB9 promoter construct was also still activated 
by exogenous expression of ATF6, also excluding ATF6 as the transcription 
factor responsible for DNAJB9 promoter activation after heat shock.
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Figure 8   eIF2α-P dependent DNAJB9 and 
HSPA5 promoter activity. Activity of DNAJB9 and 
HSPA5 promoter in heat shocked cells is eIF2α-P 
dependent. HEK-cDNA5 cells were transfected 
with a mixture (4:1:5) of the indicated luciferase 
reporter, a β-actin-β-gal reporter, and the expres-
sion construct for GADD34 or an empty vector. 
At 48 hours after transfection, cells were exposed 
to a heat shock of 30’ at 45oC (HS) or left at 37oC 
(37oC). When heat shocked, cells were allowed 
to recover for 18 hours and harvested. Harvested 
cells were assayed for reporter gene activities.
In agreement with a previous study [34], we found that a heat shock elic-
its the typical ER stress markers: phosphorylation of eIF2α and splicing of 
XBP1 mRNA. In addition, we show that ATF4 is synthesized, that XBP1s 
is made, that consensus ERSE and UPRE elements direct transcriptional 
activation in heat shocked cells and that canonical UPR promoters, HSPA5 
and DNAJB9, are activated in heat shocked cells as also seen previously 
in microarray studies [35]. The response resembles a typical UPR, albeit 
with some differences in the relative mRNA levels. However, when we tried 
to identify the transcription factors involved in the transcriptional activation 
of UPR promoters in heat shocked cells, we found that those factors differ 
from the traditional ones responsible for the UPR (ATF4, XBP1 and ATF6). 
XBP1s plays a major role in the transcriptional activation directed by the 
ERSE or UPRE elements in tunicamycin treated cells, but is not involved in 
the transcriptional activation directed by these elements after a heat shock 
as the heat shock response is not blocked in dnIRE1α cells. Similarly, when 
the response of the DNAJB9 promoter is further dissected, then it is clear 
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that the activation of this promoter during heat shock is distinct from the 
activation during the UPR: deleting the promoter to -109 does not affect the 
activation by ATF4 or ATF6, has some effect on the activation by XBP1s but 
the heat shock induction is lost. Hence neither ATF4, ATF6 nor XBP1s plays 
a role in the heat shock activation of this promoter. Our experiments also 
exclude that the DNAJB9 promoter is a target of HSF1.  As blocking eIF2α 
phosphorylation also blocks the heat shock response of the DNAJB9 (and 
of the HSPA5) promoter, the activity of the transcription factor responsible is 
somehow translationally controlled. We have tested ATF5 and CHOP (a tar-
get of ATF4) but neither activated either the DNAJB9 or the HSPA5 promoter 
(data not shown).
eIF2α phosphorylation is a common response to different stressors, not only 
cytoplasmic or ER proteotoxic stress, but also lack of amino acids [48]. ATF4 
synthesis is thus also common to various types of stress and the pattern of 
transcriptional activation by ATF4 needs to be tailored to fi t the type of stress. 
The targets of ATF4 are thus also determined by stress specifi c auxiliary fac-
tors [49]. Therefore, it is perhaps not surprising that ATF4 does not transac-
tivate all its usual UPR targets during the heat shock response. XBP1s syn-
thesis however is uniquely controlled by IRE1α dependent splicing and we 
expected XBP1s to be active irrespective of other stress responses. XBP1s 
transactivation activity itself is not blocked in heat shocked cells, as exog-
enous XBP1s does activate the DNAJB9 promoter construct in heat shocked 
cells (Fig. 7). Endogenous XBP1s activity in heat shocked cells is predicted 
to be transient. We fi nd only a minor fraction of spliced XBP1 mRNA in cells 
recovering for 5 hrs from a heat shock and we do not detect XBP1s in cells 
that have recovered for 18 hrs. It is possible that the activity of endogenous 
XBP1s is masked by that of another transcription factor targeting the same 
DNAJB9 promoter. Alternatively, endogenous XBP1s may be inactivated 
by acetylation [50] or sumoylation [51] during the fi rst few hours after heat 
shock. Exogenous XBP1s, which continues to be expressed, might escape 
from such inhibition at later times.
At least in yeast the UPR becomes activated during heat stress, in addi-
tion to the heat shock response [52,53]. Here, the heat shock response and 
the UPR cooperate and the heat shock response can rescue a defective 
UPR [54]. Our data suggest that after a heat shock mammalian cells fi rst 
devote their resources to increasing the cytoplasmic chaperoning capac-
ity - and only later switch to augmenting the ER chaperones. Accumulation 
of HSPA1A is detected within 6 hrs after heat shock, while HSPA5 levels 
increase later (Fig.4). At the time that the DNAJB9 and the HSPA5 promot-
ers become active, the heat shocked induced UPR (as indicated by XBP1 
splicing) has already decayed. Perhaps that is why another set of transcrip-
tion factors needed to be recruited. This set of transcription factors could 
also be active in ER-stressed cells, and thus be part of the traditional UPR 
response, but have gone undetected because of the overlapping ATF4, ATF6 
and XBP1 activity.
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Figure 9   DNAJB9 promoter deletion constructs. A) Schematic representation of the DNAJB9 
promoter region. B) Heat shock inducibility of DNAJB9 deletion constructs. HEK-pcDNA5 
cells were transfected with a mixture of the indicated luciferase reporter and a β-actin-β-
galactosidase reporter (9:1 ratio). At 48 hours after transfection, cells were exposed to a heat 
shock of 30’ at 45oC or left at 37oC. When heat shocked, cells were allowed to recover for 18 
hours, harvested and assayed for reporter gene activities. C,D,E) Effect of exogenous XBP1s, 
ATF4 or ATF6 expression on the activity of promoter deletion constructs. HEK-cDNA5 cells 
were transfected with a mixture (4:1:5) of the indicated luciferase reporter, a β-actin-β-gal 
reporter, and an expression construct as indicated or the empty vector pcDNA5/FRT/TO. At 24 
hours after transfection doxcycyclin was added to induce XBP1s C) or ATF4 expression D). At 
48 hours after transfection, cells were harvested and assayed for reporter gene activities. 
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Figure S1
The levels of exogenously expressed XBP1s 
(left panel) or ATF4 (right panel) were deter-
mined by western blotting with β-actin as a 
loading control. See also legend to Fig. 4A.
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The levels of dnHSF1 and endogenous HSF1 
in HEK-pcDNA5 and HEK-dnHSF1 were 
determined by western blotting. Cells were har-
vested after heat shock at the times indicated. 
Equal amounts of cellular protein were loaded.
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Abstract
A heat shock also evokes the unfolded protein response and thus the pro-
duction of spliced XBP1 protein (XBP1s). To address the question whether 
the activation of XBP1 during heat stress has an effect on typical heat shock 
genes, we tested the effect of overexpressing XBP1s on the activation of 
genes involved in the heat shock response. We show here that XBP1s in-
hibited the expression of HSPB1 in non stressed and stressed cells. XBP1s 
also inhibited the activity of HSPB1 and Drosophila melanogaster Hsp70 
promoter constructs after heat stress, including constructs that only con-
tained the HSE region. The BAG3 and SERPINH1 genes were found to be 
targets of both HSF1 and XBP1 in published ChIP-on-chip experiments. The 
heat stress induced transcriptional activation directed by either the BAG3 
or the SERPINH1 heat shock element in promoter constructs was inhibited 
by XBP1s but at the mRNA levels XBP1s enhanced the heat shock induced 
increase in BAG3 or SERPINH1 transcripts.  XBP1s did bind to the HSE 
containing promoter regions of BAG3 and SERPINH1 as assayed by ChIP. 
XBP1s binding decreased in heat shocked cells, suggesting that XBP1s 
might be inactivated by a heat shock. Together our data show that XBP1s 
modulates the expression of some HSF1 target genes; an effect that ap-
pears to be mediated by the HSE containing region.
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Introduction
The heat shock (HS) response and unfolded protein response (UPR) are two 
fundamental, yet distinct, cellular responses that are evoked by proteotoxic 
stress. The HS response is activated by proteotoxic stress in the cytoplasm 
and is mainly regulated at the level of transcription by heat shock factor 1 
(HSF1) [1]. Proteotoxic stress in the ER activates the UPR. In mammals the 
UPR consists of three arms, regulated by three ER transmembrane pro-
teins: inositol requiring 1 (IRE1α), PKR-like endoplasmic reticulum kinase 
(PERK), and activating transcription factor 6 (ATF6). The ER chaperone 
protein HSPA5 serves as a master UPR regulator and plays an essential role 
in repression of IRE1α, PERK and ATF6 by binding to these proteins in non 
stressed cells. Upon accumulation of unfolded proteins in the ER, the unfold-
ed proteins bind and sequester HSPA5, thus freeing IRE1α, PERK and ATF6 
to elicit their activation. Active IRE1α initiates a spliceosomal-independent 
mRNA splicing and removes a 26-nucleotide intron from unspliced mam-
malian XBP1 mRNA. This introduces a frameshift and leads to the produc-
tion of active XBP1s, a basic leucine zipper type transcription factor [2]. The 
splicing of XBP1 mRNA is a central mechanism of the IRE1α pathway [3]. 
XBP1s is not only part of a stress response system; it has also other roles. 
In some organs and cells XBP1s  is required for protein secretion [4-6] and 
XBP1s was shown to control growth and survival of hepatocytes [7]. There 
are confl icting reports about the role of XBP1s in maintaining cellular integ-
rity. XBP1s has been implicated to infl uence cell survival positively [8-12]. 
However, others suggest a negative role for XBP1s in cell survival [8, 13, 
14]. These confl icting results stress that the role of XBP1s is condition and 
cell type dependent. Therefore expression of XBP1s is tightly regulated.
We have previously shown that heat stress does activate IRE1α and that 
splicing of XBP1 mRNA can be detected in heat stressed cells [15]. How-
ever, the XBP1s target gene DNAJB9 (ERdj4) was not activated by XBP1s 
– its activation in heat shocked cells is mediated by other factors. This fi nd-
ing made us wonder whether XBP1s does affect the heat shock response 
at all. We thus tested the effect of inhibiting XBP1 splicing or the effect of 
overexpressing XBP1s on the activation of genes involved in the heat shock 
response. We show here that XBP1s does affect the expression of at least 
some HSF1 target genes, an effect that appears to be mediated by the HSE, 
the DNA binding site of HSF1.
Materials and Methods
Cell culture
Flp-In T-REx-293 cells (Invitrogen) were manipulated according to the 
manufacturer’s instructions using the T-REx system (Invitrogen) to gener-
ate the stable cell lines HEK-dnIRE1α, HEK-XBP1s and HEK-cDNA5 that 
carry a single copy of the tetracycline-inducible plasmids pcDNA5- dnIRE1α, 
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pcDNA5-XBP1s and pcDNA5-FRT/TO, respectively (see also [15, 16]). The 
cells were cultured at 37oC in the presence of humifi ed 5% CO2 in high glu-
cose DMEM medium supplemented with 10% fetal calf serum and 100 U/ml 
penicillin and 100 μg/ml streptomycin. Blasticidin (1.65 μg/ml; Invitrogen) and 
100 μg/ml hygromycin were also added to the culture medium during 
maintenance of the cell lines, but were omitted during experiments.
Plasmid Construction
pcDNA5-dnIRE1α, has been described previously [15]. The XBP1s expres-
sion construct was generated by PCR on cDNA manufactured from total 
RNA isolated from Flp-In T-REx 293 cells which were exposed to tunicamy-
cin stress. The PCR products were cloned into the pcDNA5/ FRT/TO 
HindIII-XhoI sites. 
The reporter constructs were made in the pGL3 basic vector (Promega). 
The Drosophila melanogaster Hsp70 (Hsp70Ab), the HSPB1 (-685, +36) 
promoter construct and the DNAJB9 (-375, +153) promoter construct were 
described previously [15-17]. The HSPB1 (-1098, +36) promoter region was 
isolated by PCR on DNA isolated from human lymphocytes cells and insert-
ed in the pGL3 basic vector. The HSPB1 (-210, +36) reporter construct was 
made by digesting the HSPB1 (1098, +36) promoter with KpnI-EcoRI (blunt). 
pGL3-promoter-Hsp70Ab HSE and pGL3-promoter-HSPB1 HSE were made 
by annealing the corresponding primers and cloning the double-stranded 
oligo into the BglII and NheI sites of pGL3-promoter. pGL3-promoter- 
SERPINH1 HSE, pGL3-promoter- BAG3 Δ HSE and pGL3-promoter- 
BAG3 HSE were made by annealing the corresponding primers and cloning 
the double-stranded oligo into the NheI and XhoI sites of pGL3-promoter.
Reporter assays
In general: at 24 h before transfection, 0.4x105 HEK-cDNA5 or HEK-
dnIRE1α or HEK-XBP1s cells were plated per well in a 24-well plate. Tran-
sient transfections were performed using FuGENE-6 (Roche) according to 
the manufacturer’s instructions. 200 ng plasmid was transfected of which 
20 ng was β-actin-β-galactosidase as a transfection effi ciency control. At 24 
hours after transfection doxycycline was added unless indicated differently. 
At 48 hours after transfection cells were harvested or exposed to a stressor 
before harvesting. Cells were harvested and lysed in 200 μl reporter lysis 
mix (25 mM Bicine, 0.05% Tween 20, 0.05% Tween 80) for 10 min. For the 
β-galactosidase assay, 20 μl cell lysate was mixed with 100 μl Galacton 
solution (100 mM Na-phosphate pH 8.2, 10 mM MgCl2, 1% Galacton-Plus; 
Tropix). After 30 min incubation at room temperature, 150 μl accelerator II 
(Tropix) was added and luminescence was measured with the Lumat LB 
9507 tube luminometer (Berthold). For the luciferase assay, 20 μl cell lysate 
was mixed with 50 μl luciferin solution (Promega) and luminescence was 
measured with the Lumat luminometer. All reporter gene assays were per-
XBP1s modulates the expression of some HSF1 target genes
71
formed in triplicate.
Western blotting
Immunoblot analysis was performed with cell lysates from HEK-dnIRE1α, 
HEK-XBP1s and HEK-cDNA5 cells. Cell pellets were homogenized in 
buffer containing 50 mM Tris–HCl pH 7.5, 150 mM NaCl, 1% Triton X-100, 
100 mM NaF, 20 mM Na4P2O7, 1 mM PMSF and protease inhibitors (Com-
plete Mini; Roche). Then 4x sample buffer (200 mM Tris–HCl 6.8, 20% 
β-mercaptoethanol, 8% SDS, 40% glycerol and 0.4% Bromophenolblue) was 
added and the lysates were incubated at 95oC for 5 min. Protein samples 
were separated in 12% polyacrylamide gels and transferred to nitrocellulose 
transfer membrane (Protran) using a Bio-Rad Mini-PROTEAN II Electro-
phoresis cell according to the manufacturer’s instructions. For western blot 
analysis, polyclonal HSF1 antibody (SPA-901; Stressgen) was used at a 
1: 15,000 dilution, HSPA1A antibody 4G4 (ab5444; Abcam) was used at a 
1:5,000 dilution, polyclonal DNAJB1 antibody (anti-Hsp40; SPA-400; Stress-
gen) at a 1:10,000 dilution, monoclonal HSP90AA1 antibody (610418, BD 
Biosciences) at a 1:1,000 dilution, HSPB1 antibody, obtained from Dr. A. 
Zantema, at a dilution of 1:400, polyclonal HSPA5 antibody, kindly donated 
by Prof. Dr. Ineke  Braakman, was used at a dilution of 1:1000, polyclonal 
XBP1 antibody (M-186): sc-7160; Santa Cruz Biotechnology), at a dilution 
of 1:200, polyclonal ST13 antibody (ab13490; Abcam) at a 1:1,000 dilution, 
polyclonal STIP1 antibody (ab65046; Abcam) a 1:1,000 dilution,  polyclonal 
BAG3 antibody, kindly donated by Prof. Dr. Harrie Kampinga, was used at a 
dilution of 1:2000, monoclonal γ-tubulin antibody at 1:1000 dilution (GTU-88; 
Abcam) and monoclonal β-actin antibody (AC-15, Sigma-Aldrich) at a dilu-
tion of 1:5,000. Blots were incubated with fl uorescent secondary antibodies 
IRDye® 800 CW conjugated goat (polyclonal) Anti-Rabbit IgG and IRDye®  
800CW conjugated goat (polyclonal) Anti-Mouse IgG. (926-32211 and 926-
32210, respectively; LI-COR Biosciences) according to the manufacturer’s 
instructions and scanned using a LI-COR Odyssey infrared scanner. Signals 
were quantifi ed using Odyssey version 2.1 software.
QPCR analysis
Cells were harvested after the treatments and at the times indicated, washed 
twice with ice-cold PBS and after washing the cells, RNA was isolated with 
TRIzol (Invitrogen) according to manufacturer’s recommendation. 1 μg 
of RNA was treated with DNaseI (Amplifi cation grade; RNase-free; Invit-
rogen). Subsequently, 5 mM MgCl2, RT-buffer, 1 mM dNTPs, 18.75 units 
AMV reverse transcriptase, 20 units RNase inhibitors and 1.25 μM oligo(dT) 
were added to a total volume of 20 μl. Reverse transcription was performed 
for 10 minutes at 25°C, 60 minutes at 42°C and 5 minutes at 95°C. For 
QPCR analysis, cDNA was 10-fold diluted. Quantitative real-time PCR was 
performed using the StepOnePlus™ Real-Time PCR System with Power 
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Results
The effect of XBP1s on heat shock responsive genes. 
To uncouple the synthesis of XBP1s from a proteotoxic stress response, 
we placed the XBP1s coding sequence under the control of a tetracycline 
inducible promoter in T-REx HEK293 cells, thereby making XBP1s expres-
sion independent of activation of IRE1α and ensuring continuous expression 
of XBP1s. Induction of expression of XBP1s led to the expected increase in 
XBP1 mRNA and protein as well as an increase in the transcript levels of the 
UPR target genes DNAJB9 and HSPA5. The HSPA5 protein levels increased 
accordingly (Fig. S1). Together these data show that XBP1s is active. We 
then tested whether turning on expression of XBP1s in otherwise non-
stressed cells had an effect on HSF1 target genes. To our surprise, expres-
sion of XBP1s resulted in a rapid loss of the HSPB1 mRNA and protein (Fig. 
1A, B). The protein levels of other HSF1 targets, such as DNAJB1, did not 
SYBR® Green PCR Master mix (Applied Biosystems) using the following 
amplifi cation protocol: 2 minutes at 50°C followed by 40 cycles of 15 sec-
onds at 95°C and 1 minute at 60°C. Per reaction 3 μl of diluted cDNA was 
used and the DNA was amplifi ed using primers for the sequences of interest, 
listed in Table 1. 
Chromatin Immunoprecipitation
HEK-XBP1s or HEK-cDNA5 cells were cultured for 24 h in the presence of 
doxycycline. Chromatin immunoprecipitation was performed as described in 
[18] except that cells were crosslinked for 15 minutes with 1% formaldehyde. 
After quenching with 125 mM glycine, cells were washed twice with ice cold 
PBS and resuspended in ice cold lysis buffer (50 mM HEPES-KOH pH 7.6, 
140 mM NaCl, 1 mM EDTA pH 8.0, 1% (v/v) Triton X-100, 0.1% NaDOC and 
1X protease inhibitor complete). Sonicated chromatin was centrifuged for 5 
min at 4°C and then incubated overnight in incubation buffer (fi nal concen-
tration; 12 mM HEPES-KOH pH 7.6, 90 mM NaCl, 0.6 mM EDTA pH 8.0, 
0.09% SDS, 0.6% Triton X-100, 0.1% BSA) together with purifi ed anti-HSF1 
antibody (SPA-901; Stressgen) or XBP1 antibody ([M-186]: sc-7160; Santa 
Cruz Biotechnology) and protein A/G beads (Santa Cruz Biotechnology).  
Negative control without adding antibody was included. Beads were washed 
six times with different buffers at 4°C: twice with 0.1% SDS, 0.1% NaDOC, 
1% Triton X-100, 150 mM NaCl, HEG (1 mM EDTA, 0.5 mM EGTA and 20 
mM HEPES-KOH pH 7.6), once with the same buffer  but with 500 mM NaCl, 
once with 0.25 M LiCl, 0.5% NaDOC, 0.5% NP-40, HEG and twice with HEG. 
Precipitated chromatin was eluted with 400 μl of elution buffer (1% SDS, 0.1 
M NaHCO3), incubated at 65°C for 4 h in the presence of 200 mM NaCl, 
phenol extracted and precipitated with 20 μg of glycogen at -20°C overnight. 
ChIP experiments were analyzed by qPCR. Effi ciency of ChIP was calcu-
lated as percentage of input. The primers used are listed in Table 1.
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Oligo name Oligo sequence (5’        3’)
Cloning
ChIP
QPCR
HSPB1 promoter -685, +36 up
HSPB1 promoter -685, +36 low
HSPB1 -1098, +36 up
XBP1(s) expression up
XBP1(s) expression low
Hsp70Ab HSE up
Hsp70Ab HSE low
HSPB1 HSE up
HSPB1 HSE low
SERPINH1 HSE up
SERPINH1 HSE low
BAG3 Δ HSE up
BAG3 Δ HSE low
BAG3 HSE up
BAG3 HSE low
HSPA5 ChIP fwd
HSPA5 ChIP rev
SERPINH1 ChIP fwd
SERPINH1 ChIP rev
BAG3 ChIP fwd
BAG3 ChIP rev
HSPA1A ChIP fwd
HSPA1A ChIP rev
DNAJB1 ChIP fwd
DNAJB1 ChIP rev
GAPDH_QPCR_fwd
GAPDH_QPCR_rev
HSPA1A_QPCR_fwd
HSPA1A_QPCR_rev
XBP1_QPCR_fwd
XBP1_QPCR_rev
DNAJB1_QPCR_fwd
DNAJB1_QPCR_rev
DNAJB9_QPCR_fwd
DNAJB9_QPCR_rev
BAG3_QPCR_fwd
BAG3_QPCR_rev
HSPA5_QPCR_fwd
HSPA5_QPCR_rev
HSPB1_QPCR_fwd
HSPB1_QPCR_rev
SERPINH1_QPCR_fwd
SERPINH1_QPCR_rev
ST13_QPCR_fwd
ST13_QPCR_rev
agtcgacaggcatgcaccaccatgcccagc
ccatggtggctgactctgctctggacgtctg
agctgctagccagtggtgagatctcggctc
agctaagcttaccatggtggtggtggcagccgc
agctctcgagttagacactaatcagctggggaa
ctagctctattctcgttgcttcgagagagcgcgcctcgaatgttcgcgaaaagagcg
gatccgctcttttcgcgaacattcgaggcgcgctctctcgaagcaacgagaatagag
ctagctttccttaacgagagaaggttccagatgagggctgaaccctg
gatccagggttacgccctcatctggaaccttctctcgttaaggaaag
ctagaggagctggggcgccctccggaagcgtttccaactttccagaagtttctcgggacggc
tcgagccgtcccgagaaacttctggaaagttggaaacgcttccggagggcgccccagctcct
ctagagattatagccgatgactcagggcggagctccgcatccaaccccgggccgcggccaacttctc
tcgagagaagttggccgcggcccggggttggatgcggagctccgccctgagtcatcggctataatct
ctagagattatagccgatgactcagggcggagctccgcatccaaccccgggccgcggccaacttctctggactggac-
cagaagtttctagccggccc
tcgagggccggctagaaacttctggtccagtccagagaagttggccgcggcccggggttggatgcggagctc-
cgccctgagtcatcggctataatct
tgcctcggggtcagaagtcgc
caggtctagaaatacaggccgc
agggaggcagtaggacccag
cgtgactctcgctctcgagc
gattatagccgatgactcagggcg
agtgtctggaaatagcctcc
ctctggagagttctgagcag 
tataagtcgtcacggagacc
cgatgtcgcgtgtcgctgaa
cgaccagtcccggactctata
gcagctgaaagaagcccaagt
tgtcttccatgccaattgca
ccgagaaggacgagtttgag
acaaaaacagcaatcttggaaagg
ctggaacagcaagtggtaga
tctacccagaaggacccagt
ttccccagacatcaagaacc
accctctcatggtccacaac
tggtggttccagtagacaaagg
cttcgttgagtgacagtcctgc
ctccattccggtgatacacga
tggtgggtctggtactccc
ggccgcacgtggaatgac
tccaatatcaacttgaatgtatgg
cgcgctcagccggcaactc
agccatgctcgtcctgccgc
ttgagttggacacagatg
gcactaggaagatgaagg
agaagttcaacctagggcacaga
ttgatctctcgctcttcacgttt
Table 1  Oligonucleotides that were used.
change (Fig. 1A, C; Fig. S1), nor was the DNAJB1 mRNA level affected (Fig. 
1B). Exogenous expression of XBP1s also inhibited the heat shock induced 
increase in HSPB1 protein and mRNA levels (Fig. 1B, C). XBP1s had an 
inhibitory effect on the heat shock induced increase in the HSPA1A mRNA 
level as well, although no effect on the protein level was seen (Fig. 1B, S1). 
The heat shock induced increase in both DNAJB1 mRNA and protein levels 
was not affected by XBP1s expression (Fig. 1B, C). 
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Figure 1   HSPB1 expression strongly decreased in presence of XBP1s.
(A) (Co-)chaperone levels in presence of XBP1s. HEK-cDNA5 and HEK-XBP1s cells were cul-
tured in the presence or absence of doxycycline. Cells were exposed to doxycycline for different 
periods of time. Cell lysates were subjected to SDS-PAGE and levels of DNAJB1, and HSPB1 
were determined by western blotting. γ-tubulin was used as a loading control. 
(B) HEK-XBP1s cells were exposed to a heat shock of 30’ at 45oC (HS) or left at 37oC (Control). 
When heat shocked, cells were allowed to recover for the indicated time before harvesting. 
Total RNA was isolated and transcript levels relative to GAPDH mRNA levels were measured by 
QPCR. The fold induction of mRNA levels is plotted relative to the level in non-stressed control 
cells. (C) Heat shock response of DNAJB1 and HSPB1 in the presence of XBP1s. HEK-cDNA5 
and HEK-XBP1s cells were cultured in the presence or absence of doxycycline and exposed to 
a heat shock of 30’ at 45oC or left at 37oC. When heat shocked, cells were allowed to recover 
for the indicated time before harvesting. Cell lysates were subjected to SDS-PAGE and levels 
of DNAJB1 and HSPB1 were determined by western blotting. β-actin was used as a loading 
control.
These data led us to examine the effect of exogenous expression of XBP1s 
on the activity of HSPB1 promoter. We have previously shown that the heat 
shock induced activity of the HSPB1 gene, as evidenced by that of HSPB1 
promoter reporter constructs, is late relative to that of the HSPA1A promoter 
constructs, being higher in cells that had recovered overnight from a heat 
shock than in cells 6 hours after heat shock [15]. We thus assayed the activ-
ity of a set of HSBP1-luciferase reporter genes in cells that had recovered 
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for overnight 18 hrs. The activity of all these constructs was strongly inhib-
ited by exogenous expression of XBP1s (Fig. 2A), and the effect of XBP1s 
on the activity of the reporter genes in heat shocked cells thus mimics its 
effect on endogenous HSPB1 mRNA levels (Fig. 1B). Note however, that in 
unstressed cells XBP1s activated the HSPB1 promoter constructs (Fig 2A), 
while, in contrast, endogenous HSPB1 mRNA levels went down (Fig. 1B). 
The HSPB1 gene is a somewhat unusual heat shock gene in that it is also 
constitutively expressed in some tissues. The HSPB1 promoter also has only 
a single, imperfect HSE (see also Table 1) and for the heat shock induced 
activity of this promoter HSF1 may be necessary but not suffi cient. We 
thus tested the effect of exogenous expression of XBP1s on reporter gene 
constructs driven by the Drosophila melanogaster (dm)Hsp70Ab promoter, 
of which the activity is thought to be solely dependent upon the HSF1 HSE 
interaction. As shown in Fig. 2B, the activity of the dmHsp70Ab promoter 
also decreased in presence of XBP1s. We also tested a human HSPA1A 
promoter construct but found no effect of XBP1s (data not shown). However, 
the human HSPA1A promoter construct has a high activity in non-stressed 
cells and the increase in activity as a result of heat shock is relatively slight. 
In contrast, the dmHsp70Ab promoter construct is virtually silent in non-
stressed cells. The high background of the HSPA1A promoter construct may 
obscure the effect of XBP1s that is seen on the endogenous HSPA1A mRNA 
level (Fig. 1B).
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Figure 2   Heat shock response of two heat shock protein promoters in presence of XBP1s
(A-B) The effect of XBP1s expression on the activity  of HSPB1 (A) and dmHsp70Ab promoter 
constructs (B). HEK-XBP1s were transfected with a mixture of reporter vector and β-actin-β-
galactosidase (9:1 ratio). At 24 hours after transfection, the expression of XBP1(s) was induced 
by adding 0.1 μg/ml doxycycline. At 48 hours after transfection, cells were exposed to a heat 
shock of 30’ at 45oC (HS) or left at 37oC (Control). When heat shocked, cells were allowed to 
recover for the indicated periods of time and harvested. Promoter activities were determined 
by dividing fi refl y luciferase values by β-galactosidase values to correct for varying transfection 
effi ciencies. The results are the average of four independent transfections (standard deviations 
are indicated by error bars).
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Figure 3   XBP1s sensitivity of two heat shock promoters.
(A) The effect of dnIRE1α expression on the activity of the HSPB1 and the Hsp70Ab promoter 
constructs. HEK-dnIRE1α cells were transfected with a mixture of reporter vector and β-actin-β-
galactosidase (9:1 ratio). At 24 hours after transfection, the expression of dnIRE1α was induced 
by adding 0.1 μg/ml doxycycline. At 48 hours after transfection, cells were exposed to a heat 
shock of 30’ at 45oC (HS) or left at 37oC (Control). When heat shocked, cells were allowed to 
recover for the indicated periods of time and harvested. Relative luciferase activities were calcu-
lated as detailed in the legend to Fig. 2.
(B) The effect of XBP1s expression on the heat shock response of two HSE containing con-
structs. HEK-XBP1s cells were transfected with a mixture of the indicated luciferase reporter 
and a β-actin-β-galactosidase reporter (9:1 ratio). At 24 hours after transfection, the expression 
of XBP1s was induced by adding 0.1 μg/ml doxycycline. At 48 hours after transfection, cells 
were exposed to a heat shock of 30’ at 45oC (HS) or left at 37oC (Control). When heat shocked, 
cells were allowed to recover for the indicated periods of time and harvested. Relative luciferase 
activities were calculated as detailed in the legend to Fig. 2.
In order to map the interaction site of XBP1s on a promoter, we need to use 
reporter constructs. As shown above, the two promoter constructs that report 
an effect of XBP1s are the HSPB1 and the dmHsp70Ab reporter constructs. 
To confi rm that the activity of these constructs is sensitive to XBP1s, we 
turned to T-REx HEK293 expressing a dominant negative IRE1α mutant. In 
these cells, XBP1 mRNA cannot be spliced and these cells thus lack XBP1s. 
In heat shocked dnIRE1α expressing cells the activity of the dmHsp70Ab 
and the HSPB1 promoter constructs was higher than in control cells (Fig. 
3A), again suggesting that XBP1s inhibits the activity of these promoters. 
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The regulatory element shared by these promoters is of course the HSE. To 
test whether XBP1s acts via the region containing the HSE, we cloned a 50 
bp sequence containing the two dmHsp70Ab HSEs and a 41 bp sequence 
containing the single HSPB1 HSE in front of the SV40 promoter (see Table 
1 for the sequence of these regions). The dmHsp70Ab HSE construct was 
nicely responsive to a heat shock and its activity was strongly inhibited by 
exogenous XBP1s (Fig. 3B). The HSPB1 promoter contains a single, not 
quite perfect, HSE and the activity of the construct containing this HSE was 
increased only two fold in heat shocked cells. The activity was again inhibit-
ed by exogenous XBP1s (Fig. 3B). These data show that the region contain-
ing the HSE is a target of XBP1s. We could not detect a consensus XBP1 
binding site (CCACG or ACGT; [19, 20]) in the dmHsp70Ab or the HSPB1 
HSE regions nor do these regions shown any sequence similarity besides 
the HSE (GAAnnTTCnnGAA) [21]. XBP1s thus appears to act either directly 
or indirectly via the HSE.
Possible common HSF1 and XBP1 target genes. 
The data reported above show that at least some HSF1 target genes are 
also targets of XBP1s. In an effort to identify other common HSF1 and 
XBP1s target genes systematically, we compared the ChIP-on-chip data 
identifying mouse XBP1s binding sites [19] with the ChIP-on-chip data pin-
pointing human HSF1 targets ([22], [23]) yielding 12 candidate genes. We 
then looked whether the sequence containing the potential mouse XBP1s 
binding site was conserved in the promoter region of the corresponding 
human gene and whether this region contained or was close to a predicted 
HSE. Four human genes met these criteria: BAG3, SERPINH1, ST13 and 
UBB (Fig. S2). We selected BAG3 and SERPINH1 for further study.  In both 
the human and the mouse BAG3 genes the putative XBP1 binding region is 
located around the transcription initiation site and a putative HSE is located 
just downstream in the 5’ UTR (Fig. S2). In the SERPINH1 gene the putative 
HSE is within the putative XBP1 binding region. The transcription initiation 
sites of the human  and mouse genes have been mapped upstream of the 
putative XBP1 binding region which places the sequence in the 5’ UTR (Fig. 
S2).  (see Fig. S2). We did not look further at the ST13 gene as it was not 
heat shock responsive (Fig. S1 and data not shown), although the promoter 
region does contain a functional HSE ([16]), or at the UBB gene as it is not 
known as a typical HSF1 target. Note that none of these putative XBP1 bind-
ing sites contain a consensus XBP1 site [19].
We fi rst tested whether the transcript levels of BAG3 and SERPINH1 were 
infl uenced by expression of XBP1s. As shown in Fig. 4A, the level of BAG3 
and SERPINH1 mRNAs increased in heat shocked XBP1s expressing 
cells. The level of BAG3 mRNA, but not that of SERRPINH1 mRNA, also 
increased in non stressed cells. We could not detect a marked increase in 
BAG3 protein in XBP1s expressing cells (Fig. S1).
To determine whether the putative BAG3 and SERPINH1 XBP1 binding sites 
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Figure 4   XBP1 sensitivity of several HSE’s.
 (A) Relative changes in transcript levels of the BAG3 and SERPINH1 genes in stressed or 
non-stressed cells with or without XBP1s overexpression. HEK-XBP1s cells were exposed to a 
heat shock of 30’ at 45oC (HS) or left at 37oC (Control). When heat shocked, cells were allowed 
to recover for the indicated time before harvesting. Total RNA was isolated and transcript levels 
relative to GAPDH mRNA levels were measured by QPCR. The fold induction of mRNA levels is 
plotted relative to the level in non-stressed control cells.
(B) The effect of XBP1s expression on the activity of several HSE containing constructs. HEK-
XBP1s cells were transfected with a mixture of the indicated luciferase reporter and a β-actin-β-
galactosidase reporter (9:1 ratio). At 24 hours after transfection, the expression of XBP1s was 
induced by adding 0.1 μg/ml doxycycline. At 48 hours after transfection, cells were exposed to a 
heat shock of 30’ at 45oC (HS) or left at 37oC (Control). When heat shocked, cells were allowed 
to recover for the indicated periods of time and harvested. Relative luciferase activities were 
calculated as detailed in the legend to Fig. 2.
The left panel shows the effect of XBP1s on the activity of the HSE containing constructs before 
stress; the right panel that in heat shocked cells.
and HSE’s could be involved in this effect of XBP1s, we cloned the relevant 
sequences in front of the SV40 promoter in the pGL3 promoter vector and 
tested the effect of XBP1s expression and/or a heat shock on the activity 
of the resulting reporter genes. Both constructs were poorly active in non 
stressed cells. Expression of XBP1s increased activity. However, at least in 
the case of the BAG3 construct, this increased activity is mediated by the 
region containing the HSE, and not by that containing the putative XBP1s 
binding site, as deletion of the HSE abolished activity. In heat shocked cells 
both constructs were quite active, showing that they indeed contain HSE’s 
(Fig. 4B). Deleting the putative HSE from, but retaining the putative XBP1 
binding region in, the BAG3 reporter construct led to a loss of the heat shock 
induced activity. As in the case of the constructs containing either the 
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dmHsp70Ab HSE or the HSPB1 HSE regions (Fig. 3B), the activity of the 
BAG3 HSE construct was inhibited by exogenous expression of XBP1s (Fig. 
4B). The effect of XBP1s on the SERPINH1 construct was only marginally 
inhibitory. 
Binding of exogenous XBP1s to HSF1 target promoter regions. 
The data presented above indicate that exogenous expression of XBP1s 
does affect the expression level of HSF1 target genes. We thus attempted 
to show that XBP1s binds to the regions containing the HSE and/or affects 
the binding of HSF1 to the HSE. In electromobility shift assays (EMSA’s) we 
could not detect XBP1s binding to the putative XBP1s binding or interac-
tion sites in the BAG3, HSPB1 or dmHsp70Ab promoters.  However, this is 
probably an experimental problem as we could also not detect an interaction 
of XBP1s with a known target site (data not shown). The HSE sequences did 
interact with HSF1 as evidenced by the bandshift using extracts from heat 
shocked cells; bands which could be supershifted with antiHSF1 (data not 
shown). However, the intensities or the mobilities of the bandshifts were not 
affected by the presence of XBP1s, indicating that XBP1s does not affect the 
binding of HSF1 to the selected HSEs as measured in this assay.
In unstressed cells overexpressing XBP1s, binding of XBP1s to the putative 
XBP1s binding sites in the promoter regions of the BAG3 and SERPINH-
1genes as well as to the known XBP1s binding site in the promoter of the 
HSPA5 gene, a known XBP1s target gene (Fig. S1), could be detected by 
ChIP (Fig. 5A). The percentage recovery is low (compare for example the 
ChIP data obtained with HSF1 shown in Fig. 5B) but this could be a techni-
cal problem due to ineffi cient precipitation by the XBP1 antibody. We did 
not detect signifi cant binding of XBP1s to the HSPA1A or DNAJB1 promoter 
regions in unstressed cells (Fig. 4A). Unfortunately we have been unable to 
recover regions from the HSPB1 promoter in ChIP assays. In cells that had 
recovered from a heat shock for 6 hours (Fig. 5A, 6h after HS), XBP1s bind-
ing was always less than in non stressed cells or in cells that had recovered 
after 24 hours, suggesting that XBP1s might lose its DNA binding activity 
during heat shock. 
In unstressed cells there is very little binding of HSF1 to its target promoter 
regions as assessed by ChIP. In stressed cells a marked increase in HSF1 
binding is seen 6h after heat shock; this binding is lost again after 24 hrs 
after heat shock as expected from the transient activation of HSF1 (Fig. 
5B). There appeared to be some effect of XBP1s on HSF1 binding in heat 
shocked cells: the extent of binding of HSF1 to the BAG3 and SERPINH1 
HSEs increased, while that to the HSEs of the HSPA1A and DNAJB1 pro-
moters decreased. At fi rst glance, this seems to agree with the increase in 
BAG3 and SERPINH1 mRNA levels, and the decrease in HSPA1A mRNA 
level. However, we did not see an effect of XBP1s on the level of the DNA-
JB1 transcript in heat shocked cells, while HSF1 binding to this promoter 
also decreased in the presence of XBPs. 
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Figure 5   ChIP analysis of XBP1 and HSF1 binding.
(A) Chromatin immunoprecipitation (ChIP) using nuclear extracts from control and XBP1s 
expressing cells was performed with an XBP1 antibody or no antibody added. Bound chroma-
tin was analyzed by QPCR using a primer set surrounding the HSE of the BAG3, SERPINH1, 
HSPA1A or DNAJB1 promoter. A primer set for the HSPA5 promoter was used as well. Cells 
were either non-stressed or harvested 6 hrs or 24 hrs after heat shock, as indicated.
(B) As in (A) except that an antibody against HSF1 instead of XBP1 was used.
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Discussion
Together our data suggest that XBP1s can modulate the heat shock re-
sponse and inhibits the expression of at least dmHsp70Ab and HSPB1 while 
enhancing that of BAG3 and SERPINH1. The mechanism by which XBP1s 
does affect the heat shock response of these genes remains to be resolved. 
Our data point to the HSE as the common target of XBP1s and HSF1. 
However, the effect of XBP1s on HSE containing promoter constructs was 
always activating in non-stressed cells and inhibitory in heat shocked cells, 
while the response of the endogenous genes was either negative (HSPB1, 
HSPA1A) or positive (BAG3, SERPINH1). Furthermore, we could not detect 
XBP1s binding sites in these regions even though in ChIP-on-chip experi-
ments at least some of these regions were identifi ed as XBP1s binding 
sites; a fi nding confi rmed by our ChIP data. There is also some discrepancy 
between the DNA binding data and the expression data. According to our 
ChIP data, XBP1s binding is lost from the HSPA5 promoter in heat shock 
cells, suggesting that XBP1s is inactivated in heat shocked cells, possibly 
by sumoylation [24], a post-transcriptional modifi cation that also inactivates 
HSF1 [25]. Alternatively, XBP1s could be deacetyled and thus be less active 
as well as less stable [26]. An inactivation of XBP1s in heat shocked cells 
would be in agreement with our previous results showing that, although a 
heat shock does activate the UPR, the downstream UPR target genes are 
not activated; these are activated in a later stage by other transcription fac-
tors [15]. We thus cannot exclude the possibility that the effect of XBP1s is 
indirect. For example, it has been recently demonstrated that XBP1s en-
hances the proteosomal degradation of the transcription factor FoxO1[27]. 
The experimental set-up used here is artifi cial in that we overexpressed 
XBP1s continuously, while under physiological conditions XBP1s expression 
in heat shocked cells is only transient and the effect of XBP1s may then be 
marginal. However, in some, mostly secretory, cell types XBP1s is expressed 
at high levels and in those cells the effect of XBP1s on HSF1 target genes 
could be marked. In particular, our experiments predict an inverse relation 
between expression of HSPB1 and XBP1s which might provide an explana-
tion for the pro-apoptotic phenotype linked with XBP1s overexpression in 
certain cell-types. This prediction remains to be tested.
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Figure S1: Characterization HEK-XBP1s cell-line.
(A) XBP1s expression levels before or after treatment with doxycycline were determined using 
SDS-PAGE followed by western blotting. β-actin was used as a loading control.
(B) Relative changes in transcript levels of various genes in XBP1s expressing cells. HEK-
XBP1s cells were exposed to a heat shock of 30’ at 45oC (HS) or left at 37oC (Control). When 
heat shocked, cells were allowed to recover for the indicated time before harvesting. Total RNA 
was isolated and transcript levels relative to GAPDH mRNA levels were measured by QPCR. 
The fold induction of mRNA levels is plotted relative to the level in non-stressed control cells.
(C) Effect of XBP1s expression and/or heat shock on the level of HSF1 and of several (co)-
chaperones. Left panel: HEK-cDNA5 and HEK-XBP1s cells were cultured in the presence or 
absence of doxycycline. Cells were exposed to doxycycline for different periods of time. Cell 
lysates were subjected to SDS-PAGE and levels of the (co)-chaperones as well as HSF1 as 
indicated were determined by western blotting. γ-tubulin was used as a loading control. Right 
panel: HEK-cDNA5 and HEK-XBP1s cells were cultured in the presence or absence of doxy-
cycline and exposed to a heat shock of 30’ at 45oC (HS) or left at 37oC (Control). When heat 
shocked, cells were allowed to recover for the indicated time before harvesting. Cell lysates 
were subjected to SDS-PAGE and levels of several (co)-chaperones and HSF1were determined 
by western blotting. β-actin was used as a loading control.
S2
SERPINH1:        
                                                  +88 
                                                  ______________________ 
SERPINH1h CGGGGAGGTTTTGAGGGAGGTCTTTGGCTTTTTTTGGCG-----GAGCTGGGGCGCCCTC 
serpinh1m -------------GGGGAGGTCTTTGGCTTTTTTTCTCCTCTCCGAGCCACGGCGCCCTC 
           *********************  *      ****   ********* 
                                                  +11 
 
                                               +143 
            _______________________________________ 
SERPINH1h CGGAAGCGTTTCCAACTTTCCAGAAGTTTCTCGGGACGGGCAGGAGGGGGTGGGGACTGC 
serpinh1m CGGAAGCGTTTCCAACTTTCCAGAAGTTTCTTGGGACAGGCAGGAGGGGGTGGGGCCAGC 
  ******************************* ***** ***************** * ** 
                                                +71 
BAG3:               
            -21 
                      __________________________________________________ 
BAG3h  GCCC-GCCGCGATTATAGCCGATGACTCAGGGCGGAGCTCCGCATCCAACCCCGGGCCGC 
Bag3m  GCCCCGCCGCGATTATAGCCTATGACTCAGGGCGGAGCTCCGCATCCAACCCACGGCGGC 
  **** *************** *******************************  *** ** 
                      -32 
 
     +40                           +70 
            _________________________________________ 
BAG3h  GGCCAACTTCTCTGGACTGGACCAGAAGTTTCTAGCCGGCCAGTTGCTACCTCC-CTTTA 
Bag3m  CGCCAAGTTCTCTGGATGGGACCAGAAGTTTCTAGCCGGCCAGTTGCTGCCTTCTCTTTA 
             ***** *********  ****************************** *** * ***** 
                    +29                           +59                        
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Figure S2: Genomic orientation HSE’s SERPINH1, BAG3, ST13 and UBB.
Mouse genes with XBP1s binding sites identifi ed by ChIP-on-chip analysis [19] were compared 
with the ChIP-on-chip data pinpointing human HSF1 targets [22], [23]. The sequence containing 
the potential mouse XBP1s binding site was checked for conservation in the promoter region 
of the corresponding human gene. Shown is the alignment of the mouse (Mus musculus, m) 
and human (Homo sapiens, h) sequences of the promoter regions of the genes indicated. The 
numbering is relative to the transcription initiation site as predicted from the RefSeq mRNA 
sequences (www.ncbi.nlm.nih.gov). The sequence of the putative XBP1 binding region is boxed; 
the sequence of the predicted HSE is marked in gray. 
The black lines above the human sequences indicate the region which was cloned into the 
pGL3-promoter. The sequence covered by the grey line above the human BAG3 sequence is 
not included in the pGL3-promoter- BAG3 Δ HSE construct, while it is included in the pGL3-
promoter- BAG3 construct.
ST13:
 
                                         -95 
ST13h  TATGCGCAGGGAGGCAGGCAACAGCACGAACAGCCACGCTTCTAGAAGATTCTAGGGAGC 
st13m  TTCGCCGATCGAAGCAGGCATTGTCACGGGCAGCTACACTTCTAGAAGGTTCTAGGCGGA 
  *  **  *  ** *******    ****  **** ** ********** *******  * 
                                         -139 
 
                                         -33 
ST13h  GCGCAGGAGCAGCGCAGAGGGAGTAGGAATGAGCAGGCGGAGGACCCGAGGTCACGAGAC 
st13m  GCACAGGTCCAGAG--GTAGGAGTGGGAATGAGCGAGCGAAGG-CCCGGGGTCACGAGGC 
  ** ****  *** *  *  ***** *********  *** *** **** ********* * 
                                         -79 
 
       
UBB: 
 
                                        -268              
UBBh     CGCCTTCGCAGGCCTAACCAATCAGTGCCGGCGCTGCAAGGAAGTTTCCAGAGCTTTCGA 
Ubbm     CATCTTTG-ACTCCTCACCAATCAGCGCTGGCGCCGCAAGGAGGTTTCCAGAGCTTTCGA 
         *  *** * *  *** ********* ** ***** ******* ***************** 
                                  -308 
 
                                        -206 
UBBh      GGAAGGTTTCTTCAACTCAAATTCATCCGCCTGATAATTTTCTTATATTTTCCTAAAGAA 
ubbm        GGGAGGGCCCTTTAACTTGGATTCATCCGCGTGATGATTTTTTCAATTTTTTGCACGAGA 
          ** ***   *** ****   ********** **** ***** * *  ****   *    * 
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To probe the limiting nodes in the chaperoning network which maintains 
cellular proteostasis, we expressed a dominant negative mutant of heat 
shock factor 1 (dnHSF1), the regulator of the cytoplasmic proteotoxic stress 
response. Microarray analysis of non stressed dnHSF1 cells showed a two- 
or more fold decrease in the transcript level of 10 genes, amongst which the 
(co-)chaperone genes HSP90AA1, HSPA6, DNAJB1 and HSPB1. Glucocor-
ticoid signalling, which requires the Hsp70 and the Hsp90 folding machines, 
was severely impaired by dnHSF1, but fully rescued by expression of 
DNAJA1 or DNAJB1, and partially by ST13. Expression of DNAJB6, 
DNAJB8, HSPA1A, HSPB1, HSPB8 or STIP1 had no effect while 
HSP90AA1 even inhibited. PTGES3 (p23) inhibited only in control cells. Our 
results suggest that the DNAJ co-chaperones in particular become limiting 
in a depleted chaperoning network. Our results also suggest a difference be-
tween the transcriptomes of cells lacking HSF1 and transcriptomes of cells 
lacking HSF1 and cells expressing dnHSF1.
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All cells contain an extensive network of chaperones which together maintain 
proteostasis, i.e. this network aids in the folding of the primary peptide chain, 
the refolding of unfolding proteins and the removal of misfolded proteins (for 
reviews, see [1-8]). Two of the major nodes in the network are the Hsp70 
and Hsp90 folding machines. At the core of these machines are Hsp90 and 
Hsp70, the proteins that promote folding; the activity and substrate specifi city 
is controlled by a number of co-factors and co-chaperones. For Hsp70 it is 
the DNAJ (Hsp40) proteins that determine substrate specifi city. DNAJs also 
stimulate ATP hydrolysis by Hsp70. The human genome contains over 40 
DNAJ genes [9-11]. Some of these are highly tissue specifi c, others may be 
dedicated to a particular substrate or cooperate only with a specifi c Hsp70 
and some may be redundant [12]. 
The diversity of DNAJs does show that these are important determinants 
of the activity and specifi city of the Hsp70 folding machine. The chaperon-
ing capacity of the cell is enhanced by additional chaperone synthesis as 
part of a proteotoxic stress response, either the heat shock response in the 
case of cytoplasmic stress or the unfolded protein response in the case of 
ER stress. That an increase in chaperones is required to combat proteotoxic 
stress suggests that under normal conditions the chaperone capacity of a 
cell is limiting. Indeed, exogenous expression of aggregation-prone proteins, 
such as proteins with an expanded glutamine tract (polyQ), is toxic unless 
chaperones are also over-expressed [13-17]. Cytoplasmic proteotoxic stress 
signals to heat shock factor 1 (HSF1), which then activates the transcription 
of a number of genes encoding a variety of chaperones, together known as 
the heat shock proteins. In the absence of stress, HSF1 is generally believed 
to be kept inactive in the cell by direct interaction with Hsp90, p23 and im-
munophilins (for reviews, see [18-20]). HSF1 null mice show the expected 
stress-related phenotypes, such as a complete lack of the heat shock 
response and the inability to develop thermotolerance. However, they also 
suffer from neuronal, developmental and germ cell defects [21-26], which 
cannot be directly linked to the heat shock response and which strongly 
suggests that HSF1 also regulates gene expression under non-stress 
conditions. Microarray analysis resulted in the identifi cation of 49 genes (19 
related to immune response) that are expressed at reduced levels in HSF1 
null fi broblasts compared with wild type cells cultured under physiological 
conditions. The immune response of HSF1 null mice was shown to be se-
verely impaired [27]. More recently, direct evidence for the stress independ-
ent regulation of genes by HSF1 was provided in the case of the multi-drug 
resistance gene 1 [28], and the IL-6 gene [29]. Furthermore HSF1 inhibits 
heregulin induced transcription in breast carcinoma cells [30].
A number of studies have shown that the quality of the heat shock response 
diminishes with aging [31-37], a decrease that may be the result of a de-
crease in the activity of the deacetylase SIRT1 [38]. Senescence of cultured 
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human fi broblasts is accompanied with a diminishing heat shock response 
and a reduction in the affi nity of HSF1 for the heat shock element (HSE; 
[34]). Aging-related failure of HSF1 will interfere with an organisms’ ability 
to combat cellular stress and increase the susceptibility to protein folding 
disease [6, 8, 13, 14, 39-41]. Moreover, with accumulating evidence showing 
that HSF1 also regulates gene expression under non-stress conditions (see 
above), its decline may already cause phenotypic defects in the absence of 
exogenous stress [3, 4].
Here we have used a dominant negative HSF1 mutant to inhibit HSF1 
activity. As expected, a number of chaperone and co-chaperone genes 
were downregulated by dnHSF1. To test which (co-)chaperone is limiting in 
dnHSF1 expressing and thus chaperone depleted cells, we used the glucor-
ticoid response to probe the chaperoning network. Maturation of the steroid 
hormone receptor is known to be controlled by both the Hsp70 and the 
Hsp90 folding machinery (for review, see [42]) and augmenting the 
chaperone network by either stress [43] or expression of a constitutively 
active HSF1 mutant [44] potentiates the glucocorticoid response. We show 
here that it is, unexpectedly, primarily the DNAJ (Hsp40) proteins which 
become limiting when the chaperoning network is depleted.
Recombinant DNA constructs
Oligonucleotides that were used to generate recombinant DNA constructs 
are listed in Table 1. Plasmid pLmHSF1SN that contains the code for the 
HSF448 mutant was kindly donated by Dr. Wang [45]. The 1.36-kb XhoI 
fragment of pLmHSF1SN was cloned into pcDNA5-FRT/TO (Invitrogen), 
resulting in plasmid pcDNA5-HSF448. The code for the HSF1 mutant 
HSF379 was PCR amplifi ed from pLmHSF1SN using the HSF379 primer 
set and cloned into the HindIII and XhoI sites of pcDNA5-FRT/TO, yielding 
plasmid pcDNA5-HSF379 (dnHSF1). The promoter constructs pGL3-HspB1 
(-685/+36), pGL3-DNAJA1 (-464/+167), pGL3-DNAJB1 (-508/+38), pGL3-
Hsp90AA1 (-188/+18), pGL3-ST13 (-400/+141), pGL3-STIP1 (-1264/+145), 
pGL3-PTGES3 (-1108/+104), pGL3-RMB23 (-1265/+189), pGL3-PMVK 
(-1183/+147), pGL3-BiP (-2742/+202), pGL3-CHOP (-936/+2), and pGL3-
HSPA1A (-313/+196) were made by PCR amplifying the promoter fragments 
from human genomic DNA using the respective “prom” primer sets and 
cloning the fragments into pGL3-Basic (Promega). The expression plasmids 
pcDNA5-HSPB1, pcDNA5-HSPB8, pcDNA5-ST13, pcDNA5-STIP1, and 
pcDNA5-PTGES3 were made by PCR amplifying the cDNAs from HEK293 
RNA using the respective “exp” primer sets and cloning the cDNAs into 
pcDNA5-FRT/TO. Expression plasmids pcDNA5-V5-DNAJA1, pcDNA5-
V5-DNAJB1, pcDNA5-V5-DNAJB6, and pcDNA5-V5-DNAJB8 were kindly 
donated by J. Hageman (University of Groningen, The Netherlands; [46]). 
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Expression construct pCMV-SPORT6-Hsp90AA1 was obtained from Im-
agenes (www.imagenes-bio.de). The Hsp90AA1 coding sequence was com-
pleted at the 5’ end by inserting the corresponding fragment PCR amplifi ed 
from human cDNA SacII-MscI. Plasmid pOTB7-STIP1 was obtained from Im-
agenes. The EcoRI (blunt) - XhoI fragment of pOTB7-STIP1 was cloned into 
the HindIII (blunt) and XhoI sites of pcDNA5-FRT/TO, resulting in plasmid 
pcDNA5-STIP1. The glucocorticoid-responsive reporter plasmid pGRE-Luc 
was made by annealing the GRE primer set and cloning the double stranded 
oligo into the NheI and BglII sites of pGL3-promoter (Promega). The Dro-
sophila melanogaster Hsp70-luciferase reporter construct pHL and the 
Hsp70 expression construct were described earlier [47]. Plasmid pRL-CMV 
was obtained from Promega. All plasmid constructs were sequence verifi ed.
Tissue culture, transfections, and reporter gene assays 
Flp-In T-REx-293 cells (Invitrogen) were manipulated according to the manu-
facturer’s instructions using the T-REx system (Invitrogen) to generate the 
stable cell lines HEK-HSF448, HEK-HSF379 and HEK-cDNA5 that carry a 
single copy of the tetracycline inducible plasmids pcDNA5-HSF448, 
pcDNA5-HSF379, and pcDNA5-FRT/TO, respectively. The cells were 
cultured at 37°C / 5% CO2 in high glucose DMEM medium supplemented 
with 10% fetal calf serum and 100 units/ml penicillin and 100 μg/ml strepto-
mycin. Blasticidin (1.65 μg/ml; Invitrogen) and 100 μg/ml hygromycin were 
also added to the culture medium during maintenance of the cell lines, but 
were omitted during experiments. Transient transfections were performed 
using FuGENE-6 (Roche) according to the manufacturer’s instructions. Cells 
were seeded on 24-well plates and on the next day transfected with ~ 0.2 
μg plasmid per well. For testing the heat shock response in stable HEK293 
cell lines, cells were transfected with 160 ng pHL, and 40 ng pCMV-RL. At 
48 h after transfection, cells were either left at 37oC/ 5% CO2 (control) or 
incubated at 45ºC for 30’ (heat shock). After 6 h recovery at 37oC/ 5% CO2, 
cells were harvested for reporter gene analysis. For analysis of promoter 
activities, cells were transfected with a mixture of 160 ng luciferase reporter 
plasmid and 40 ng β-actin-β-galactosidase or pCMV-RL per well. For test-
ing glucocorticoid responsiveness, the culture medium of the cells was fi rst 
replaced with medium supplemented with 10% steroid-free fetal calf serum 
(Hyclone), and then the cells were transfected with a mixture of 150 ng 
pGRE-Luc and 50 ng β-actin-β−galactosidase per well. At 24 h after trans-
fection, the culture medium was replaced with medium containing varying 
concentrations of dexamethasone (Centrafarm). At 48 h after transfection 
cells were lysed in 200 μl reporter lysis mix (25 mM Bicine, 0.05% Tween 20, 
0.05% Tween 80) for 10 min. For the β-galactosidase assay, 40 μl cell lysate 
was mixed with 100 μl Galacton solution (100 mM Na-phosphate pH 8.2, 
10 mM MgCl2, 1% Galacton-Plus (Tropix). After 30 min incubation at room 
temperature, 150 μl accelerator II (Tropix) was added and luminescence 
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was measured with the Lumat LB 9507 tube luminometer (Berthold). For the 
luciferase assay, 40 μl cell lysate was mixed with 50 μl luciferin solution and 
luminescence was again measured with the Lumat luminometer. All reporter 
gene assays were performed in triplo.
RNA isolation and microarray analysis 
HEK-HSF379 or HEK-cDNA5 cells were either left untreated or treated with 
doxycyclin for 48 hours. Total RNA was isolated using Trizol according to 
the manufacturer’s instructions (Invitrogen) and copied into Cy3-labeled 
(untreated cells) or Cy5-labeled (doxycycline treated cells) cRNA using the 
Agilent Low RNA Input Linear Amp Kit PLUS, or the reverse for the repeat 
array. Labeled cRNA samples were hybridized to an Agilent Whole Human 
Genome Microarray Kit (4 x 44K). The arrays were scanned using an Agilent 
Microarray Scanner. Image analysis and feature extraction were done with 
Feature Extraction (version 9.5.1, Agilent). Only genes that passed the 
GeneSpringGX standard quality control criteria (free trial available at www.
genespring.com) were included in the analysis. We used a cut-off level of 
2-fold changed expression (average signal intensity across the array) and an 
arbitrarily chosen signal cut-off of > 50.
Western blot analysis
Cell pellets were homogenized in buffer containing 50 mM Tris-HCl pH 7.5, 
150 mM NaCl, 1% Triton X-100, 100 mM NaF, 20 mM Na4P2O7, 1 mM PMSF 
and protease inhibitors (Complete Mini; Roche). Then 4X sample buffer (200 
mM Tris-HCl 6.8, 20% β-mercaptoethanol, 8% SDS, 40% Glycerol and 0.4% 
Bromophenolblue) was added and the lysates were incubated at 95°C for 
5 min. For detection of eIF2α phosphorylation, samples were prepared as 
described [48]. Protein samples were separated in 12% polyacrylamide gels 
and transferred to nitrocellulose transfer membrane (Protran) using a Bio-
Rad Mini-PROTEAN II Electrophoresis cell according to the manufacturer’s 
instructions. For western blot analysis, polyclonal HSF1 antibody (SPA-901; 
Stressgen) was used at a 1: 15,000 dilution, Hsp70 antibody 4G4 (ab5444; 
Abcam) was used at a 1:5,000 dilution, polyclonal DNAJB1 antibody (anti-
Hsp40; SPA-400; Stressgen) at a 1:10,000 dilution, monoclonal Hsp90 an-
tibody (610418, BD Biosciences) at a 1:1,000 dilution, HSPB1 antibody, ob-
tained from dr. A. Zantema, at a dilution of 1:400, monoclonal eIF2α antibody 
was at a 1:500 dilution, polyclonal phosphorylated eIF2α antibody (E2152; 
Sigma) was used at a 1:1,000 dilution, monoclonal V5 antibody (R96025; In-
vitrogen) was used at a 1:5,000 dilution, polyclonal ST13 antibody (ab13490; 
Abcam) at a 1:1,000 dilution, polyclonal STIP1 antibody (ab65046; Abcam) 
a 1:1,000 dilution, monoclonal p23 antibody (ab2814; Abcam) at a 1:1,000 
dilution, polyclonal HSPB8 antibody, obtained from dr. W. Boelens, at a 
dilution of 1:1,000, and monoclonal β-actin antibody (AC-15, Sigma-Aldrich) 
at a dilution of 1:5,000. Blots were incubated with fl uorescent secondary 
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antibodies IRDye® 800 CW conjugated goat (polyclonal) Anti-Rabbit IgG and 
IRDye™ 680 conjugated goat (polyclonal) Anti-Mouse IgG. (926-32211 and 
926-32220 respectively, LI-COR Biosciences) according to the manufac-
turer’s instructions and scanned using a LI-COR Odyssey infrared scanner. 
Signals were quantifi ed using Odyssey version 2.1 software.
Oligo name Oligo sequence (5’        3’)  Oligo name Oligo sequence (5’        3’)
HSF379-for
HSF379-rev
PMVKprom-for
PMVKprom-rev
RBM23prom-for
RBM23prom-rev
STIP1prom-for
STIP1prom -rev
HSPB1prom -for
HSPB1prom -rev
ST13prom -for
ST13prom -rev
PTGES3prom -for
PTGES3prom -rev
DNAJA1prom-for
DNAJA1prom-rev
DNAJB1prom-for
DNAJB1prom-rev
CHOPprom-for
CHOPprom-rev
agctaagcttaccatggatctgcccgtgggcc
agctctcgagctacaggcaggctacgctgaggc
agctaagcttactcaggtaaaacaggagatgtg
agctccatggccaaacagatatggggagaaaag
agctctcgagtatccaagacccaaaggggcc
agctccatggcagttccgggtccccgcag
agctaagcttgtggggcaggtggaattaaag
agctccatggcgcagcgcggtccggaacc
agtcgacaggcatgcaccaccatgcccagc
accatggtggctgactctgctctggacgtctg
agctaagcttccccttccggcggaggcg
agctccatggtagggaggtggtgg
agctaagcttaataccttagtgcttattatgaagc
agctccatggtgaacggggcagggggacg
agtcgaccacgcgtgaaaaacagcaagac
accatggtggctgaggccggtgtgtgaggga
aagtcgaccagacacaggttaggtagttcgtcc
accatggccccctcctgcggcccgccga
tgagctctgtcacccaggctggagtgc
tagatctctgacctcgggagcgcctggctg
BiPprom-for
BiPprom-rev
HSP90prom-for
HSP90prom-rev
HSPA1Aprom-for
HSPA1Aprom-rev
HSP90AA1exp-for
HSP90AA1exp-rev
HSPB1exp-for
HSPB1exp-rev
HSPB8exp-for
HSPB8exp-rev
ST13exp-for
ST13exp-rev
PTGES3exp-for
PTGES3exp-rev
GRE-up
GRE-low
tctcgaggtatttttagtagagactgggcac
accatggtgccagccagttgggcagcag
agctaagcttgcgcaggcgctgttcctgg
agctccatggcgcccggaggccacaccc
aagatcttgaagcgcaggcggtcagca
aaagcttccggttccctgctctctgtc
tccgcggtcacttagccaagatgcctg
tggccaatcatagagatatctgcacc
agctaagcttaccatgaccgagcgccgcgtc
agctctcgagttacttggcggcagtctcatcg
agctaagcttaccatggctgacggtcagatg
agctctcgagtcaggtacaggtgacttcctggct
agctaagcttaccatggacccccgcaaagtg
agctaagcttaccatggacccccgcaaagtg
agctggatccaccatgcagcctgcttctgcaaagtg
agctctcgagttactccagatctggcattttttc
ctagcggtacattttgttctagaacaaaatgtaccggta-
cattttgttct
gatctagaacaaaatgtaccggtacattttgttctagaacaaaat-
gtacc
Dominant negative HSF1 mutants. 
To block HSF1 signalling in human HEK293 cells we decided to use a 
dominant negative mutant reasoning that, given the interaction of HSF1 with 
other cellular components, the effect of a transcriptionally inactive mutant 
could well be different from the effect of HSF1 being completely absent. 
Two dominant negative HSF1 mutants containing, respectively, the fi rst 379 
(HSF379) and fi rst 448 (HSF448) amino acids have been described (re-
viewed by [49]). HSF379 lacks both the potent trans-activation domain at the 
extreme C-terminus and the weaker, more N-terminal, trans-activation do-
main, whereas HSF448 still has the weak trans-activation domain. The heat 
shock-mediated induction of endogenous Hsp70 was completely abolished 
by HSF379, showing its potent dominant-negative activity (Fig. 1). Surpris-
ingly, HSF448 was a very poor inhibitor of heat shock-mediated induction of 
Hsp70 (data not shown). Moreover, HSF448 caused a signifi cant increase in 
the basal expression of Hsp70 (Fig. 1). Since this observation was in confl ict 
with earlier data showing the dominant-negative activity of HSF448 [45], we 
tested the activities of both HSF1 mutants in a luciferase reporter gene as-
say. As expected, HSF379 completely inhibited the heat shock mediated in-
Table 1  Oligonucleotides that were used to generate recombinant DNA constructs
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duction of the D. melanogaster Hsp70 promoter (Fig. 2). In the experiments 
reported below HSF379 was used to inhibit HSF1 activity and will be re-
ferred to as dnHSF1. 
Transcriptome changes in the presence of dnHSF1. 
If HSF1 plays a role even in the absence of exogenous stress, then exog-
enous expression of a dominant negative HSF1 mutant in unstressed cells 
should change the transcriptome. We therefore compared the 
transcriptomes of HEK cells with or without doxycycline and with or without 
dnHSF1using a two-color 44K Agilent Human Expression Profi le Array. The 
transcripts of only 10 genes showed a more than two fold lower level in the 
presence of dnHSF1 (Table 2 in bold and Table 3). Four of these, namely 
HSPA6 (hsp70B’), HSP90AA1 (Hsp90), DNAJB1 (Hsp40) and HSPB1 
(Hsp27), encode chaperones (Table 2 in bold). The steady state level of the 
corresponding proteins was also reduced in dnHSF1 expressing cells (Fig. 
3; note that the HSPA6 mRNA level is very low in non-stressed  HEK293 
cells;[50]). Surprisingly, there was a distinct difference between dnHSF1 
expressing cells and mouse embryonic fi broblasts lacking HSF1: the 
hsf-/hsf- MEFs contain wild type levels of Hsp90 and DNAJB1. 
The levels of the transcripts of a number of other chaperone genes did not 
quite meet the “two fold” lower in the presence of dnHSF1 cut-off, but did 
come close (AHSA2 for example; Table 2). To test whether HSF responsive-
ness is a general property of genes encoding (co-)chaperones, we looked 
at the response of all known members of the HSP gene families (HSPH, 
HSPA, DNAJ and HSPB) as well as other known (co-)chaperones coding 
genes expressed in HEK 293 cells (Table 2). Of the HSPA (Hsp70) genes, 
only HSPA6 responded strongly to dnHSF1. Similarly, very few members 
of the large DNAJ (Hsp40) family were downregulated by HSF1. This is 
rather surprising as the DNAJ proteins determine the substrate specifi city of 
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Figure 1  The HSF1 mutants HSF379 and HSF448 have different effects on basal and heat 
shock-induced Hsp70 expression. Parental Flp-In HEK293 cells and HEK293 cells carrying 
a stably integrated copy of the pcDNA5-HSF379 (HEK-HSF379) or pcDNA5-HSF448 (HEK-
HSF448) plasmid were cultured in the absence or presence of doxycycline. Cells were exposed 
to a heat shock (30’, 45°C), harvested at the indicated time point (h) after heat shock, and 
subjected to western blot analysis using an anti-Hsp70 antibody.
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and stimulate the activity of the Hsp70 folding machine and are thus critical 
nodes in the chaperoning network of the cell. Also most of the Hsp70 and 
Hsp90 co-chaperones are not responsive to dnHSF1. For example, of the 
14 Hsp90 co-factors listed in a recent review [51], only the two AHA1 ho-
mologs as well as STIP1 and, to a lesser extent, ST13, responded strongly 
to dnHSF1 (Table 2). 
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To confi rm the effect of HSF1 on the promoter activity of some of the genes 
downregulated by dnHSF1, we isolated the promoters and compared their 
activities in HEK-dnHSF1 cells and HEK-cDNA5 cells. The promoters of 
the STIP1, ST13, DNAJA1, DNAJB1 (see Table 2), and PMVK (selected 
because it is the strongest downregulated non-chaperone gene, Table 3) 
genes had signifi cantly reduced activities in HEK-dnHSF1 cells compared 
with control cells, whereas the promoters of the unfolded protein response 
target genes CHOP and BiP, two genes with similar expression levels in 
HEK-dnHSF1 and control cells, were not or only slightly affected by dnHSF 
(Fig. 4). Note that these promoter activities were measured in unstressed 
cells, explaining why the activity of the promoter of the canonical heat stress 
inducible HSPA1A (Hsp70) gene is only inhibited by about 50%; note also 
that the activities of isolated promoter regions do not necessarily refl ect the 
activity of the endogenous promoter which could also be controlled by chro-
matin structure and/or elements lacking from the isolated promoter region. 
The HSPB1 gene for example has been reported to have heat shock ele-
ments in its fi rst intron as well [52].
Lack of heat shock proteins could cause stress in the cells, which in turn 
could activate a non-HSF dependent stress response (see also [53]). To 
determine whether exogenous expression of dnHSF1 caused stress we 
determined whether expression of dnHSF1 is associated with an increased 
Figure 2  The effects of dnHSF on basal and heat 
shock-induced activity of an Hsp70 promoter. HEK293 
cells carrying a stably integrated copy of the HSF379 
(dnHSF1) were cultured in the absence (-) or presence (+) 
of doxycycline. Cells were transfected with a mixture of the 
Drosophila melanogaster Hsp70-luciferase reporter (pHL) 
and the Renilla Luciferase control plasmid pCMV-RL. At 48 
hrs after transfection, cells were exposed to a heat shock of 
30’ at 45°C (HS) or left at 37oC (37oC). When heat shocked, 
cells were allowed to recover for 6 h and harvested. Hsp70 
promoter activities were determined by dividing fi refl y 
luciferase values by the corresponding renilla luciferase 
(experiments using the HSF448 line) or β-galactosidase 
(experiments using the dnHSF1 line) values to correct for 
varying transfection effi ciencies. The relative luciferase 
activity in cells cultured at 37oC in absence of the various 
HSF1 mutants was set at 1. The results are the average of 
three independent transfections (standard deviations are 
indicated by error bars).
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level of phosphorylated eIF2α. Activation of eIF2α kinases is a common 
response to a variety of stresses (for review, see [54]). As shown in Figure 
5, the basal level of eIF2α phosphorylation is not increased by the expres-
sion of dnHSF1. In addition, the decay of eIF2α phosphorylation after a heat 
shock is not notably affected by expression of dnHSF1 (Fig. 5). This is in 
accordance with previous reports showing that cells lacking HSF1 are not 
impaired in their ability to recover from heat stress but do not built up ther-
mostability after a heat stress [26, 55]. 
Gene 
name
Acc. Nr. dnHSF1/Ctrl Alternative name
ave sd
HSPH family
HSPH1
HSPH2
HSPH3
HSPH4
NM_006644
NM_002154
NM_014278
NM_006389
0.78
0.66
0.61
1.19
0.08
0.04
0.21
0.33
heat shock 105kDa/110kDa protein 1
heat shock 70kDa protein 4
heat shock 70kDa protein 4-like 
hypoxia up-regulated 1
HSPA family
HSPA1A/B1
HSPA1L
HSPA2
HSPA5
HSPA6
HSPA8
HSPA9
HSPA12A
HSPA12B
HSPA13
HSPA14
NM_005345
NM_005527 
NM_021979
NM_005347
NM_002155
NM_153201
NM_004134
NM_025015
NM_052970
NM_006948
NM_016299
0.93
not on array2
1.22
1.18
0.463
0.87
0.90
1.10
nd4
0.57
0.85
0.18
not on array2
0.20
0.35
0.10
0.08
0.08
0.20
nd4
0.53
0.13
hsp72
heat shock 70kDa protein 1-like
GRP78, BiP
HSP70B’
HSC70
mortalin-2 (mitochondrial protein)
KIAA0417
STCH
HSP90 family
HSP90AA1
HSP90AB1
HSP90B1
TRAP1
NM_005348
NM_007355
NM_003299
NM_016292
0.38
0.89
1.16
1.06
0.06
0.06
0.36
0.05
Hsp90α
Hsp90β
Grp94
TNF receptor-associated protein 1 (mitochondrial Hsp90)
DNAJ (Hsp40) family
DNAJA1
DNAJA2
DNAJA3
DNAJA4
DNAJB1
DNAJB2
DNAJB3
DNAJB4
DNAJB5
DNAJB6
DNAJB7
DNAJB8
DNAJB9
DNAJB11
DNAJB12
DNAJB13
NM_001539
NM_005880
NM_005147
NM_018602
NM_006145
NM_006736
NM_001001394 
NM_007034
NM_012266
NM_005494
NM_145174
NM_153330
NM_012328
NM_016306
NM_001002762
NM_153614
0.64
1.30
1.00
nd4
0.25
0.60
nd4
0.94
0.97
0.93
nd4
nd4
1.22
1.15
1.04
nd4
0.10
0.42
0.13
nd4
0.05
0.07
nd4
0.09
0.10
0.12
nd4
nd4
0.17
0.39
0.11
nd4
HDJ2
hsp40
HSJ1
Table 2  Effect of exogenous expression of dnHSF1 on the transcript levels of the members 
of the families of heat shock proteins and their co-chaperones.
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DNAJB14
DNAJC1
DNAJC2
DNAJC3
DNAJC4
DNAJC5
DNAJC5B
DNAJC5G
DNAJC6
DNAJC7
DNAJC8
DNAJC9
DNAJC10
DNAJC11
DNAJC12
DNAJC13
DNAJC14
DNAJC15
DNAJC16
DNAJC17
DNAJC18
DNAJC19
DNAJC20
DNAJC21
DNAJC22
DNAJC23
DNAJC24
DNAJC25
DNAJC26
DNAJC27
DNAJC28
DNAJC29
DNAJC30
NM_024920
NM_022365
NM_014377
NM_006260
NM_005528
NM_025219 
NM_033105
NM_173650
NM_014787
NM_003315
NM_014280
NM_015190
NM_018981
NM_018198
NM_021800
NM_015268
NM_032364
NM_013238
NM_015291
NM_018163
NM_152686
NM_145261
NM_172002
NM_194283
NM_024902
NM_007214
NM_181706
NM_001015882
NM_005255
NM_016544
NM_017833
NM_014363
NM_032317
0.87
1.17
0.89
0.97
0.994
nd4
nd4
1.053 
0.873 
1.01
0.92
0.98
1.11
1.12
1.05
0.99
1.08
0.68
1.09
1.04
0.99
0.99
1.073
0.79
1.06
0.98
0.87
0.99
1.07
0.98
0.733
0.93
1.04
0.04
0.23
0.06
0.18
0.10
nd4
nd4
0.07
0.18
0.15
0.06
0.10
0.24
0.14
0.19
0.17
0.16
0.24
0.10
0.11
0.14
0.13
0.12
0.18
0.08
0.08
0.11
0.08
0.19
0.10
0.18
0.04
0.06
zuotin related factor 1 (ZRF1)
cysteine string protein (CSP)
cysteine string protein beta (CSP-beta)
J-type co-chaperone HSC20 (RP3-366L4.2)
DnaJA5
hypothetical protein FLJ13236
SEC63
ZCSL3
DnaJ-like protein (bA16L21.2.1)
cyclin G associated kinase (GAK)
Ras-associated protein Rap1 (RBJ)
C21orf55
sacsin
WBSCR18
HSPB (sHsp) family
HSPB1
HSPB2
HSPB3
HSPB4
HSPB5
HSPB6
HSPB7
HSPB8
HSPB9
HSPB10
NM_001540
NM_001541
NM_006308
NM_000394
NM_001885
NM_144617
NM_014424
NM_014365
NM_033194
NM_024410
0.29 
nd4
nd4
nd4
0.993 
1.043 
nd4
nd4
0.68 
nd4
0.13
nd4
nd4
nd4
0.18
0.25
nd4
nd4
0.20
nd4
Hsp27
MKBP
αA-crystallin (CRYAA)
αB-crystallin (CRYAB)
Hsp20
cvHsp
HSP22
ODF1
Others
HSPD1
HSPE1
SERPINH1
CCT3
NM_002156
NM_002157
NM_001235
NM_005998
0.88
0.73
0.55
0.67
0.17
0.08
0.08
0.17
Hsp60, chaperonin
Hsp10, chaperonin 10
Hsp47
TCP1, subunit 3 (gamma)
Co-chaperones
AHSA1
AHSA2
BAG1
BAG2
BAG3
BAG4
BAG5
PTGES3
ST13
STIP1
STUB1
NM_012111
NM_152392
NM_004323
NM_004282
NM_004281
NM_004874
NM_001015049
NM_006601
NM_003932
NM_006819
NM_005861
0.63
0.51
1.03
1.10
1.31
1.283
0.99
0.88
0.63
0.53
0.97
0.07
0.04
0.16
0.13
0.18
0.43
0.17
0.14
0.08
0.06
0.06
AHA1 homolog 1
AHA1 homolog 2
p23
HIP
HOP
CHIP
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AIP
CDC37
FKBP4
FKBP5
PPID
PPP5C
SGTA
TOMM70A
TTC4
UNC45A
NM_003977
NM_007065
NM_002014
NM_004117
NM_005038
NM_006247
NM_003021
NM_014820
NM_004623
NM_018671
0.94
nd4
1.00
0.98
0.97
1.21
1.14
1.11
1.00
0.99
0.21
nd4
0.23
0.07
0.08
0.30
0.24
0.25
0.04
0.07
cyclophilin D
1 the array oligonucleotides do not discriminate between the transcripts of these two genes.
2 none of the oligonucleotides on the array hybridize with the transcript of this gene
3 the hybridization signal was signifi cant but below 100
4 the hybridization signal was not signifi cant
Glucocorticoid signalling is impaired by dnHSF1 and can be rescued by 
individual co-chaperones. 
Expression of dnHSF1 depletes the cell of a number of chaperones and is 
predicted to decrease the activity of both the Hsp70 and the Hsp90 fold-
ing machine. Both are known to be important for maturation and function of 
steroid hormone receptors (reviewed in [42], [56]) and we thus examined 
whether expression of dnHSF1 resulted in impaired glucocorticoid hormone 
signalling. A synthetic glucocorticoid-responsive element (GRE) was linked 
to a luciferase reporter and used to monitor the response of HEK-dnHSF1 
and HEK-cDNA5 cells to increasing concentrations of dexamethasone. 
Dexamethasone inducibility of the GRE was at least 50% inhibited in HEK-
dnHSF1 cells compared with HEK-cDNA5 cells (Fig. 6). At 10-6 M dexam-
ethasone, activity of the GRE was induced by 9-fold in HEK-cDNA5 cells 
and only by 4-fold in HEK-dnHSF1 cells, and at the highest concentration of 
dexamethasone the inducibility in HEK-cDNA5 cells was even 13-fold com-
pared with only 5-fold in HEK-dnHSF1 cells. 
If the impaired dexamethasone inducibility in the presence of dnHSF1 is due 
to a reduction in the expression levels of one or more (co-)chaperone genes, 
then it should be possible to rescue the glucocorticoid inducibility of the GRE 
in HEK-dnHSF1 cells by exogenous expression of those (co-)chaperones. 
We therefore tested the effect of exogeneous expression of different proteins 
Gene 
name
Acc. Nr. dnHSF1/Ctrl Description
ave sd
PMVK NM_006556 0.21 0.07 phosphomevalonate kinase 
KLRG1 NM_005810 0.35 0.14 killer cell lectin-like receptor subfamily G, member 1
CDKL3 NM_016508 0.39 0.17 cyclin-dependent kinase-like 3
KA21 NM_152349 0.41 0.32 truncated type I keratin KA21
ZNF473 NM_015428 0.48 0.07 zinc fi nger protein 473
MLH1 NM_000249 0.50 0.17 mutL homolog 1
Table 3  Non-chaperone encoding genes downregulated by dnHSF1.
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on the glucocorticoid response of the pGRE-Luc reporter in HEK-dnHSF1 
cells (Figs. 7 and 8).  
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Figure 3  Left panel. The decay 
of heat shock protein levels during 
expression of dnHSF1.
HEK-HSF379 cells were treated with 
doxycyclin for the time indicated and 
harvested. Right panel. The level of 
heat shock proteins in MEF wild type 
cells (+/+) and MEF cells lacking 
HSF1 (-/-) either before (-HS) or after 
heat shock and recovery (+HS). Cell 
lysates were subjected to SDS-PAGE 
and western blot analysis using the 
indicated antibodies.
Figure 4  Inhibition of promoter activity by dnHSF1. Control HEK-cDNA5 cells and HEK-
HSF379 cells were treated with doxycyclin. After 3 days, cells were transfected with the 
indicated promoter reporter constructs (see also Materials and Methods) and a β-actin-β-gal 
reporter. At 48 hr after transfection, cells were harvested and assayed for reporter gene activi-
ties. Promoter activities were determined by dividing luciferase values by the corresponding 
β-galactosidase values to correct for varying transfection effi ciencies. The bars correspond to 
the % activity of the promoter in the HEK-HSF379 cells compared with the control HEK-cDNA5 
cells. The results are the average of three independent transfections (standard deviations are 
indicated by error bars).
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The chaperone of which the expression is most effected by dnHSF1 is 
HSPB1. Although HSPB1 is not directly involved in the maturation of the 
glucocorticoid receptor, its lack may cause overloading of part of the folding 
network of the cell. However, exogenous expression of HSPB1 or of another 
sHsp, HSPB8, had no effect (Fig. 7). The level of Hsp90 is also affected 
by dnHSF1 but is apparently not limiting in the glucocorticoid response, as 
exogenous expression of Hsp90 was even inhibitory (Fig. 7). PTGES3 (p23) 
inhibited the GRE response in HEK-cDNA5 cells (Table 4) as previously 
reported [57, 58] but increased it slightly in HEK-dnHSF1cells. STIP1 (Hop), 
which is a co-chaperone of Hsp90 as well as of Hsp70 had no effect, either 
in HEK-cDNA5 (Table 4) or in HEK-dnHSF cells (Fig. 7). In contrast, ST13 
(Hip), an Hsp70 co-chaperone, did restore dexamethasone inducibility to al-
most the wild type level in HEK-dnHSF cells. Even more effective was exog-
enous expression of the Hsp70 co-chaperones DNAJA1 (HDJ2) or DNAJB1 
(Hsp40): this resulted in even higher dexamethasone inducibility in HEK-
dnHSF1 cells compared with HEK-cDNA5 cells (Fig. 7). The rescue effect of 
DNAJA1 and DNAJB1 was not a general property of Hsp40 family members, 
since two other members of the DNAJB family, DNAJB6 and DNAJB8, did 
not show any rescue activity (Fig. 7). Expression of Hsp70 (HSPA1A) itself 
had no effect (Fig. 7; note that neither overexpression of DNAJ proteins nor 
overexpression of HSPA1A in HEK-cDNA5 cells affected the GRE response, 
see Table 4). These data show that it is the primary folding of the glucocorti-
coid receptor by the Hsp70 machinery that is most affected in HEK-dnHSF1 
cells. As predicted by the wild-type level of DNAJB1 in hsf1-/hsf1- MEFs, 
these cells showed a wild-type glucocorticoid response (data not shown).
HSF1
dnHSF1
eIF2D
eIF2 -PD
time (h) after HS
37oC 6 24 h0
Figure 5  The effect of exogenous expression of dnHSF1 on eIF2α phosphorylation. HEK-
cDNA5 cells and HEK-HSF379 cells were treated with doxycyclin for 48 h. Cells were then 
exposed to a heat shock of 30’ at 45°C (HS) or left at 37oC (37oC). When heat shocked, cells 
were allowed to recover for the indicated time before harvesting. Cell lysates were subjected to 
SDS-PAGE and western blot analysis using the indicated antibodies.
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Comparison of the transcriptome of embryonic fi broblasts from HSF1 null 
mice with that of wild type cells identifi ed 49 genes (19 related to immune 
response) that were not upregulated by a heat shock in wild type cells but 
nevertheless were expressed at reduced levels in HSF1 null fi broblasts [27]. 
When HSF1 was depleted by RNA interference in HeLa cells, the expres-
sion level of 378 genes changed signifi cantly in the absence of stress [59]. 
The main effect, surprisingly, was an increase in expression, for 80% of 
the affected genes, the transcript level increased. In contrast, we found no 
signifi cant increase in expression in response to dnHSF1; dnHSF1 reduced 
the expression level of only 10 genes more than two-fold, with a lesser effect 
on a number of chaperone encoding genes (Tables 2 and 3). The difference 
between the effect of depleting HSF1 in MEFs and HeLa cells is very likely 
to be caused by the far greater dependence of transformed cells on HSF1 
[60]. HEK293 are less dependent on HSF1 than HeLa cells [60], but more 
so than MEFs. The response to blocking HSF1 in HEK293 cells might then 
be expected to be intermediate in the effect on the transcriptome but it is 
not. Clearly there is a difference between depleting HSF1 and expressing a 
dominant negative mutant. In part this difference may be due to a second-
ary effect: depletion of HSF1 would free the chaperones which are usually 
complexed with HSF1 while dnHSF1 might capture more chaperones. More 
importantly is probably the activity of HSF1 as a repressor of transcription. 
Figure 6  Exogenous expression of 
dnHSF1 reduces the glucocorticoid response. 
Control HEK-cDNA5 cells and HEK-HSF379 
cells were treated with doxycyclin. After 3 
days, cells were transfected with a glucocor-
ticoid-responsive luciferase reporter (pGRE-
Luc) and a β-actin-β-gal reporter. At 24 hr 
after transfection, cells were either left un-
treated or exposed to the indicated concentra-
tions of dexamethasone. At 48 h after trans-
fection, cells were harvested and assayed for 
reporter gene activities. Promoter activities 
were determined by dividing luciferase values 
by the corresponding β-galactosidase values 
to correct for varying transfection effi cien-
cies. The bars correspond to the activity of 
the glucocorticoid-responsive promoter in the 
presence of dexamethasone compared to the 
activity in untreated cells, which was set at 
100%.  Gray bars show the results for control 
HEK-cDNA5 cells; black bars those for HEK-
HSF379 cells. The results are the average 
of three independent transfections (standard 
deviations are indicated by error bars).
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Recently, it has been shown that HSF1 binds to MTA1, a co-repressor, to 
form a complex repressing estrogen-dependent transcription in breast carci-
noma cells [30]. Similarly, HSF1 has been reported to interact with C/EBPβ, 
an interaction which represses transcriptional activation [61]. The loss of 
HSF1 would release repression; expression of dnHSF1 could maintain it. 
Expression of dnHSF1 is an effi cient way of reducing the chaperoning 
capacity of the cell, as evidenced by the loss of the basal glucocorticoid 
response. Since the expression of so many genes playing roles at several 
stages of glucocorticoid receptor processing was suppressed in HEK-
dnHSF1 cells, we did not expect that over-expression of individual proteins 
would rescue the glucocorticoid response. Nonetheless, the individual 
co-chaperones DNAJA1, DNAJB1 and ST13/Hip were able to rescue the 
dnHSF-mediated inhibition of the glucocorticoid response fully; PTGES3/
p23 had some effect, whereas over-expression of Hsp90, or STIP1/Hop 
had no effect. Hsp90 was even inhibitory (Fig. 7). Both DNAJ and ST13/
Hop are co-chaperones of Hsp70 and function in the primary folding of the 
glucocorticoid receptor, but at different levels: DNAJ activates the ATPase 
of Hsp70, whereas ST13/Hip stabilizes the Hsp70-ADP state (reviewed by 
[42]). Apparently over-expression of DNAJA1 or DNAJB1 can compensate 
for a shortage of ST13/Hip and vice versa, as exogenous expression of ei-
ther protein restores glucocorticoid sensitivity. Together these data show that 
the limiting node of chaperoning network in dnHSF1 expressing cells is the 
Hsp70 folding machine, which is in turn is limited not by the level of Hsp70 
itself, but rather by its co-chaperones. In vitro folding studies of the gluco-
corticoid receptor have shown that DNAJB1 is required in catalytic amounts 
[62]. Our data also show that a lack of DNAJB1 can be compensated for 
by overexpression of DNAJA1. Functional redundancy between DNAJB1 
and another co-chaperone is also implied by the lack of a phenotype of the 
DNAJB1 knock-out mouse, which has only a minor defi ciency in acquired 
thermotolerance [63]. In the case of the progesterone receptor it has been 
shown that either DNAJA1 or DNAJB1 can assist in folding but by distinct 
mechanisms. DNAJA1 bound tightly to the progesterone receptor while 
DNAJB1 did so only transiently [64]. 
Heat stress or expression of a dominant positive HSF1 mutant potentiates 
the glucocorticoid response [43,44] suggesting that the chaperone network 
is limiting for this response in normal cells. The chaperone network is also 
limiting for luciferase refolding as this can be boosted by overexpressing 
Hsp70, an effect which can be blocked by expressing a dominant nega-
tive DNAJB1 mutant [65]. In contrast, exogenous expression of single (co-)
chaperones did not enhance the sensitivity of HEK-cDNA cells to dexame-
thasone, indicating that, unlike luciferase refolding, it is either a combination 
of chaperones and co-chaperones that is limiting or that other proteins are 
involved. In addition, exogenous expression of a dominant negative DNAJB1 
mutant did not block the dexamethasone response signifi cantly (data not 
shown).
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Figure 7  Effect of over-expression of (co)chaperones on glucocorticoid signaling in HEK- 
cDNA5 and HEK-dnHSF1 cells. Control HEK-cDNA5 cells (light gray bars) and HEK-HSF379 
cells (black bars) were treated with doxycyclin. After 3 days, cells were transfected with a mix-
ture (4:1:5) of glucocorticoid-responsive luciferase reporter (pGRE-Luc), a βactin-βgal reporter, 
and the expression construct indicated in the Figure. At 24 hr after transfection, cells were 
either left untreated or exposed to the indicated concentrations of dexamethasone. At 48 h after 
transfection, cells were harvested and assayed for reporter gene activities. Relative luciferase 
activities and -fold induction were determined as described in the legend to Figure 6. Standard 
deviations are indicated by the error bars.
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V5-DNAJB6
V5-DNAJB8
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HSPB1
HSPB8
HSP90AA1
PTGES3
STIP1
ST13
DNAJA1
DNAJB1
DNAJB6
DNAJB8
HSPA1A
1.0 + 0.1
0.8 + 0.1
1.1 + 0.3
0.8 + 0.1
1.0 + 0.1
1.1 + 0.1
1.0 + 0.1
1.0 + 0.1
0.9 + 0.1
0.9 + 0.2
0.8 + 0.2
0.8 + 0.1
0.7 + 0.1
0.9 + 0.2
0.7 + 0.1
0.9 + 0.1
0.9 + 0.1
1.0 + 0.1
1.0 + 0.1
0.8 + 0.1
0.9 + 0.1
0.8 + 0.2
0.9 + 0.2
0.8 + 0.1
0.9 + 0.3
0.6 + 0.1
0.9 + 0.2
1.1 + 0.2
1.1 + 0.1
1.0 + 0.2
0.8 + 0.1
0.8 + 0.1
1.0 + 0.4
Figure 8  Levels of exogenous expression of 
(co)chaperones. Expression plasmids for the (co)
chaperones indicated on the left were trans-
fected into either HEK-cDNA cells (control) or 
HEK-HSF379 cells (+DNA) and expression was 
induced by adding doxycyclin (+Dox), except for 
HSP90AA1, of which expression is constitutive.  
Protein levels were determined by western blot-
ting and staining with the corresponding antibody 
(see Materials and Methods). The arrowhead in-
dicates HSPB8. Note that in the case of DNAJA1, 
DNAJB6 and DNAJB8 antibody to the V5-tag 
carried by the exogenous proteins was used; the 
endogenous protein is thus not detected. β-actin 
was used as a loading control.
Table 4  Relative effect of exogenous expres-
sion of (co)-chaperones on glucocorticoid 
signaling in HEK-cDNA5 cells.
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Maintaining proteostasis during ageing is expected to prevent or at least 
ameliorate age-related protein folding and infl ammatory disease [6, 41]. 
One possible approach is to prevent the decline in HSF1 activity either by 
targeting HSF1 directly or by targeting longevity related factors which control 
HSF1 activity such as SIRT1 [38]. One potential drawback of this approach 
is that HSF1 also increases the risk of cancer, also an often age-related 
disease [60]. An alternative is to maintain the capacity of the chaperoning 
network by boosting a single (co)chaperones. The results reported here 
show that DNAJA1 and DNAJB1 are promising targets. The fi nding that MEF 
cells do have wild-type levels of DNAJB1 in the absence of HSF1 shows that 
HSF1 can be bypassed in the transcriptional regulation of the DNAJB1 gene. 
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Abstract
Expression of a dominant negative HSF1 mutant (dnHSF1), which amongst 
other effects depletes cells of HSF1 regulated chaperones, blocked post 
heat shock refolding of luciferase targeted to the cytoplasm, nucleus or 
peroxisomes, while refolding of endoplasmic reticulum (ER) targeted lucifer-
ase was inhibited by about 50%. Luciferase refolding in the cytoplasm could 
be partially restored by expression of HSPA1A and fully by both HSPA1A 
and DNAJB1. For full refolding of ER luciferase HSPA1A expression suf-
fi ced. Neither nuclear nor peroxisomal refolding was rescued by HSPA1A. 
A stimulatory effect of DNAJB1 on post heat shock peroxisomal luciferase 
refolding by was seen in control cells, while refolding in the cytoplasm or 
nucleus in control cells was inhibited by DNAJB1 expression in the absence 
of added HSPA1A. HSPB1 also improved refolding of peroxisomal luciferase 
in control cells, but not in dnHSF1 expressing cells. HSP90, HSPA5, HSPA6 
and phosphomevalonate kinase (PMVK) (of which the synthesis is also 
downregulated by dnHSF1) had no effect on peroxisomal refolding in either 
control or chaperone depleted cells. The chaperone requirement for post 
heat shock refolding of peroxisomal luciferase in control cells is thus unusual 
in that it can be augmented by DNAJB1 or HSPB1 but not by HSPA1A; in 
dnHSF1 expressing  cells expression of none of the (co-)chaperones tested 
was effective and an as yet to be identifi ed HSF1 regulated function is re-
quired. 
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Introduction
Proteins are made as linear chains but are active as intricately folded units 
often associated in larger assemblies. In dilute solution in vitro many proteins 
can fold without help, but in the in vivo high protein concentration environ-
ment proteins need help from molecular chaperones which prevent protein 
aggregation and provide a folding surface. Molecular chaperones also bind 
unfolded proteins and either help these to refold or target these for degrada-
tion by the proteasome or via autophagy [1]. Cells contain an unknown but 
probably large number of chaperones dedicated to the folding of a single 
protein or assembly of a single complex (see for example [2]). The three 
main cellular compartments, cytoplasm, mitochondria and ER, each have 
a compartment dedicated general chaperoning network. These networks 
are similar in that they all contain related chaperones and associated fac-
tors which aid in folding (Hsp90 and Hsp70 machines; [3, 4]), chaperones 
which deliver substrates to the folding machines (DNAJ/Hsp40 proteins) and 
chaperones which can store unfolded protein for later refolding or degrada-
tion (the small heat shock proteins) [5]. For example, HSPA5 (GRP78, BiP) 
is the ER specifi c Hsp70 paralog and GRP94 the ER Hsp90 paralog [6], 
while HSPA9 [7] and TRAP1 [8] are the mitochondrial Hsp70 and Hsp90 
paralogs. The nuclear compartment does not have its own chaperoning net-
work. Nuclear proteostasis mostly relies on transient passage of cytoplasmic 
chaperones [9, 10] and the nucleus is a poor folding environment [11, 12]. 
Peroxisome specifi c chaperones have been found in plant [13, 14] but not in 
animal cells. In some, but not all [15, 16], studies chaperones were detected 
in the peroxisome proteome [17, 18], but it cannot be excluded that these 
were trace contaminants as these were either cytoplasmic, ER or mitochon-
drial proteins. Peroxisomes are thought to bud off from the ER but their 
matrix enzymes are imported from the cytoplasm [19]. Protein import in the 
peroxisome is unusual in that fully folded proteins and even oligomeric pro-
tein complexes can be imported [20]. Peroxisomal matrix proteins could thus 
be folded in the cytoplasm and no chaperoning would then be required in 
the peroxisomal matrix. However, the high peroxisomal production of ROS, 
together with the discovery of several ROS-metabolizing enzymes in peroxi-
somes [21-24] suggests that peroxisomes have to cope with oxidative stress, 
which makes it peculiar that no chaperones are found within this organelle. 
In spite of the lack of classical chaperones, heat denatured peroxisomal 
luciferase is refolded as effi ciently as it is in other cellular compartments [11], 
suggesting that peroxisomes can deal with unfolded proteins.
The chaperoning capacity of the various cellular compartments can be 
augmented by additional synthesis of chaperones when proteostasis in that 
compartment is sensed to fail. Mitochondria have an Unfolded Protein Re-
sponse, also referred to as UPRmt [25], as does the ER (UPRER ; [26]). Un-
folding proteins in the cytoplasm result in the activation of heat shock factor 
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1 (HSF1) and the increased transcription of the HSF1 target genes, amongst 
which those encoding cytoplasmic chaperones, the heat shock proteins. The 
result is a temporary increase in the chaperoning capacity allowing the cells 
to deal with unfolded proteins either by refolding or degradation. The higher 
level of chaperones also provides protection to a second proteotoxic insult. 
Heat shocking a cell thus provides it with thermotolerance, i.e. resistance to 
a second heat shock [27-30]. Such tolerance can be induced in all com-
partments, including the peroxisomes [11], even though the existence of a 
UPRper has not been demonstrated.
We have previously shown that even under physiological conditions and at 
normal growth temperatures (i.e. without stress) HSF1 regulates the level of 
cytoplasmic chaperones. Expression of a dominant negative mutant of HSF1 
in HEK293 cells depletes cells of the classical HSF1 regulated chaperones 
such as HSP90AA1 (Hsp90), HSPA1A (Hsp70), DNAJB1 (Hsp40) and 
HSPB1 (Hsp27) [31]. By exogenous expression of single chaperones, it can 
then be tested which chaperone is limiting for the folding/activity of a particu-
lar chaperone client. Besides providing a fundamental insight in the sub-
strate specifi city and the critical nodes of the protein folding network of the 
cell, such information is of interest as HSF1 loses its activity during aging, 
making the aging cell prone to protein folding disease [32, 33]. Increasing 
expression of a (co-) chaperone would be a way of restoring proteostasis. 
A common way to probe the chaperoning capacity of a cellular compart-
ment is to measure the refolding of heat denatured luciferase targeted to 
that compartment [11]. In control cells luciferase can be equally well refolded 
in the cytoplasm, the ER and the peroxisome, while the nucleus is a poor 
refolding environment. In vivo refolding of luciferase, at least in the cyto-
plasm, requires the Hsp70 folding machine [34] and can be increased by 
exogenous expression of HSPA1A [11, 35], HSPA1A and DNAJB1 [35] and 
HSPB1 [36]. We show here that expression of dnHSF1  affects the luci-
ferase refolding capacity not only in the cytoplasm or the nucleus, but also in 
the peroxisomes and the ER. We further show that only in the peroxisomes 
refolding cannot be restored by exogenous expression of HSPA1A and 
DNAJB1. Intriguingly, peroxisomal refolding seems to be sensitive to chang-
es in expression of HSPB1, a cytoplasmic protein.
Western blot analysis
Cell pellets were homogenized in buffer containing 50 mM Tris–HCl pH 7.5, 
150 mM NaCl, 1% Triton X-100, 100 mM NaF, 20 mM Na4P2O7, 1 mM PMSF 
and protease inhibitors (Complete Mini; Roche). Then 4x sample buffer 
(200 mM Tris–HCl 6.8, 20% β-mercaptoethanol, 8% SDS, 40% glycerol and 
0.4% Bromophenolblue) was added and the lysates were incubated at 95oC 
for 5 min. Protein samples were separated in 10% polyacrylamide gels and 
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transferred to nitrocellulose transfer membrane (Protran) using a Bio-Rad 
Mini-PROTEAN II Electrophoresis cell according to the manufacturer’s 
instructions. For western blot analysis, polyclonal HSF1 antibody (SPA-901; 
Stressgen) was used at a 1: 1,000 dilution, monoclonal HSP90 antibody 
(610418, BD Biosciences) at a 1:1,000 dilution, polyclonal HSPB1 antibody, 
obtained from Dr. A. Zantema, at a dilution of 1:400, monoclonal HSPA1A 
antibody 4G4 (ab5444; Abcam) was used at a 1:5,000 dilution, polyclonal 
HSPA5 antibody, kindly donated by Prof. Dr. Ineke Braakman, was used at 
a dilution of 1:1000, polyclonal DNAJB1 antibody (SPA-400; Stressgen) at a 
1:10,000 dilution, polyclonal PMVK antibody, obtained from Dr. H.R. Water-
ham [37], was used at a 1:500 dilution, monoclonal V5 antibody (R96025; 
Invitrogen) was used at a 1:5,000 dilution, polyclonal γ-tubulin antibody 
(GTU-88; Abcam) at a 1:1,000 dilution, and monoclonal β-actin antibody 
(AC-15, Sigma-Aldrich) at a dilution of 1:5,000. Blots were incubated with 
fl uorescent secondary antibodies IRDye® 800 CW conjugated goat (polyclo-
nal) Anti-Rabbit IgG and IRDye® 800CW conjugated goat (polyclonal) Anti-
Mouse IgG. (926-32211 and 926-32210, respectively; LI-COR Biosciences) 
according to the manufacturer’s instructions and scanned using a LI-COR 
Odyssey infrared scanner. Signals were quantifi ed using Odyssey version 
2.1 software.
Cell culture
Flp-In T-REx-293 cells were manipulated according to the manufacturer’s 
instructions using the T-REx system (Invitrogen). The stable cell lines 
HEK-dnHSF1 and HEK-cDNA5 have been described previously [31]. Flp-In 
T-REx-293 cells stably transfected with Per-superluc-eGFP selected with 
0.5 mg/ml Geneticin (Invitrogen) were described previously as well [11]. 
These cells were in addition stably transfected with the doxycycline-inducible 
plasmids pcDNA5-dnHSF1 or pcDNA5-FRT/TO to yield HEK-dnHSF1-Per-
superluc-eGFP and HEK-cDNA5-Per-superluc-eGFP. Cells were cultured at 
37oC/5% CO2 in high glucose DMEM medium supplemented with 10% fetal 
calf serum and 100 U/ml penicillin and 100 μg/ml streptomycin. Blasticidin 
(1.65 μg/ml; Invitrogen) and 100 μg/ml hygromycin were also added to the 
culture medium during maintenance of the cell lines, but were omitted during 
experiments. Cell lines stably transfected with Per-superluc-eGFP were also 
cultured with Geneticin (0.5 mg/ml). 
Microscopy
HEK-dnHSF1-Per-superluc-eGFP cells (cultured in presence or absence 
of doxycycline for 10 days) were plated on poly-L-lysine (0.001%, Sigma-
Aldrich) coated coverslips. 48 hours later, cells were fi xed in 4% paraformal-
dehyde. All images were obtained by Fluorescence Microscopy using the 
DMRA fl uorescence microscope with a Cohu CCD camera and QFluoro 1.2 
software.
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Recombinant DNA constructs
The C-terminal truncation mutant of dnHSF1 containing codons 1-379 from 
HSF1 as well as pcDNA5-HSPB1 and pcDNA5-HSP90AA1were described 
earlier [31]. The plasmids pcDNA5-V5-DNAJB1 and pcDNA5-V5-HSPA1A, 
pcDNA5-V5-HSPA6, Cyt-superluc-eGFP, ER-superluc-eGFP and Nuc-
superluc-eGFP were described in [11, 38]. pcDNA5-PMVK was made by 
PCR amplifying the cDNA from HEK293 RNA using the primers PMVK up 
5’-agctaagcttagtggccgcgtccat-3’ and PMVK low 5’-cctcagaatctagacccccc-3’ 
and cloning the PCR fragment (HindIII-XbaI(bl)) into pcDNA5-FRT/TO 
(HindIII-XhoI(bl)). 
Transfections, and reporter gene assays
Transient transfections were performed using FuGENE-6 (Roche) according 
to the manufacturer’s instructions. Cells were seeded on 24-well plates and 
on the next day transfected with 0.2 μg plasmid per well. 
For analysis of the refolding capacity in different organelles, cells were 
transfected with a mixture of 10 ng luciferase reporter plasmid and 30 ng 
β-actin-β-galactosidase and 160 ng expression plasmids. To transfect equal 
amounts of expression plasmid, transfections with one chaperone coding 
expression plasmid were supplemented with an empty vector. In experi-
ments using HEK- Per-superluc-eGFP 40 ng β-actin-β-galactosidase was 
used because no additional luciferase reporter was needed. Heat shock was 
performed at 45 °C for 30 min. Cells were harvested after a recovery period 
of 1, 2, or 3 h at 37 °C as indicated. Cycloheximide (0.2 mg/ml) was added 
prior to heat shock to block de novo synthesis of luciferase. Cells were lysed 
in 200 μl reporter lysis mix (25 mM Bicine, 0.05% Tween 20, 0.05% Tween 
80) for 10 min. For the β-galactosidase assay, 10 μl cell lysate was mixed 
with 100 μl Galacton solution (100 mM Na-phosphate pH 8.2, 10 mM MgCl2, 
1% Galacton-Plus;Tropix). After 30 min incubation at room temperature, 150 
μl accelerator II (Tropix) was added and luminescence was measured with 
the Lumat LB 9507 tube luminometer (Berthold). For the luciferase assay, 
10 μl cell lysate was mixed with 50 μl luciferin solution and luminescence 
was again measured with the Lumat luminometer. Data shown are the mean 
± S.D. of two or more independent experiments with 4 replicates each. The 
data points used to describe the refolding capacity of an organelle were 
obtained trough subtraction of the luciferase activity directly after heat shock. 
These values varied between 0.1% for nuclear luciferase and 15% for ER 
luciferase and are presented in S1-S3.
Results
Experimental design.
To measure the chaperoning capacity in the nucleus, cytoplasm or ER we 
used expression constructs for luciferase-eGFP targeted to these different 
compartments [11] transiently transfected into HEK293 cells with or without 
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expression of dominant negative HSF1. Transient transfection of an expres-
sion construct for luciferase-eGFP with a peroxisomal targeting sequence 
leads to mislocalization [11, 39]. To monitor refolding in peroxisomes we 
therefore used a cell line stably transfected with both the peroxisomal target-
ed luciferase-eGFP expression construct [11] and the tetracycline inducible 
dnHSF1 expression construct. In pilot experiments we found that expression 
of dnHSF1 needed to be induced for at least 48 h to see a decrease in the 
post heat shock refolding of cytoplasmic luciferase. Thus when cells ex-
pressing dnHSF1 were used, refolding was measured 96 h after induction of 
dnHSF1 expression. The fact that there is a delayed response to induction of 
dnHSF1 indicates that it is not the expression of dnHSF1 itself that leads to a 
reduced refolding capacity but that it is a secondary effect of the expression 
of dnHSF1, such as chaperone depletion. The amount of active luciferase 
remaining in cells harvested directly after heat shock varied between 1 and 
10% of the pre-heat shock value depending on the cellular compartment and 
the chaperone complement (Fig. S1). In the data presented below only the 
rate of refolding under the various experimental conditions is presented. 
Figure 1   Effect 
dnHSF1 on refolding 
capacities of different 
organelles.
Relative luciferase 
activity of A) Cyt-
superluc-eGFP in 
HEK-cDNA5 and 
HEK-dnHSF1 cells; B) 
Nuc-superluc-eGFP 
in HEK-cDNA5 and 
HEK-dnHSF1 cells; 
C) ER-superluc-eGFP 
in HEK-cDNA5 and 
HEK-dnHSF1 cells; D) 
Per-superluc-eGFP in 
HEK-cDNA5-Per-su-
perluc-eGFP or HEK-
Effect of dnHSF1 expression  on luciferase refolding in different cellular 
organelles.
Under our experimental conditions between 10% (cytoplasm) and 15% (ER, 
peroxisomes) of the luciferase was refolded 3 hrs post- heat shock in control 
cells. In the nucleus refolding was far less effi cient and after 3 hrs only 4% 
of the luciferase was refolded (Fig. 1). As expected, dnHSF1 expression, 
which also causes chaperone depletion, severely inhibited post-heat shock 
luciferase refolding in the cytoplasm and nucleus. Unexpectedly, peroxiso-
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dnHSF1-Per-superluc-eGFP cells. Cells were harvested after heat shock at the times indicated 
and the luciferase activity was measured. The luciferase activity shown is relative to the activity 
in non heat shocked cells transfected and cultured in parallel. The results are the average of 
four independent transfections (standard deviations are indicated by error bars).
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mal luciferase was also not refolded in dnHSF1 expressing cells. Refolding 
of ER targeted luciferase was less sensitive to dnHSF1 expression  and was 
inhibited by about 50% (Fig. 1). Luciferase refolding is known to be medi-
ated by the hsp70 folding machinery and refolding of cytoplasmic luciferase 
in dnHSF1 expressing cells could be completely restored by exogenous 
expression of both HSPA1A and DNAJB1. In control cells there was no syn-
ergistic effect between HSPA1A and DNAJB1 and expression of just DNA-
JB1even inhibited refolding (Fig. 2A), as previously reported [35]. The refold-
Figure 2   Effect dnHSF1 and 
HSPA1A or DNAJB1 on refolding 
capacities of different organelles.
Relative luciferase activity of A) 
Cyt-superluc-eGFP in HEK-cDNA5 
and HEK-dnHSF1 cells; B) Nuc-
superluc-eGFP in HEK-cDNA5 
and HEK-dnHSF1 cells; C) ER-
superluc-eGFP in HEK-cDNA5 and 
HEK-dnHSF1 cells; D) Per-super-
luc-eGFP in HEK-cDNA5-Per-su-
perluc-eGFP or HEK-dnHSF1-Per-
superluc-eGFP cells. Cells were 
co-transfected with the luciferase 
reporter gene and expression con-
structs for HSPA1A and/or DNAJB1 
and/or empty vector as indicated. 
Per-superluc-eGFP cells were 
transfected only with the expres-
sion constructs. Expression levels 
of exogenously expressed proteins 
are shown in Fig. S5. Cells were 
harvested after heat shock at the 
times indicated and the luciferase 
activity was measured. Relative 
luciferase activities were calculated 
as detailed in the legend to Fig. 1. 
The results are the average of four 
independent transfections (standard 
deviations are indicated by error 
bars).
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ing of nuclear luciferase in dnHSF1 expressing cells was not signifi cantly 
improved by expression of either HSPA1A, DNAJB1 or both, while HSPA1A 
or HSPA1A and DNAJB1 did increase refolding of nuclear luciferase in 
control cells (Fig. 2B). DNAJB1 again inhibited. Exogenous expression of 
HSPA1A, DNAJB1 or both had little effect on the refolding of ER targeted 
luciferase in control cells but HSPA1A did restore ER luciferase refolding in 
dnHSF1 expressing cells. Exogenous expression of DNAJB1 had no effect. 
ER resident DNAJ proteins, which are not HSF1 regulated, might take the 
role of DNAJB1 in the ER. Unlike ER luciferase, refolding of peroxisomal 
luciferase in dnHSF1 expressing cells could not be restored by exogenous 
expression of HSPA1A. The peroxisomal compartment was the only com-
partment in which exogenous expression of DNAJB1 had a stimulatory effect 
on refolding: very slight in dnHSF1 expressing cells but signifi cant in control 
cells (Fig. 2D). These data show that HSF1 regulated gene products do con-
tribute signifi cantly to the chaperoning capacity (as measured by post heat 
shock luciferase refolding) of all cellular compartments, including the ER and 
the peroxisomes. However, the critical nodes in the various compartments 
differ: HSPA1A restored the folding defi ciency in dnHSF1 expressing cells in 
the cytosol and ER but did not so in nuclei or peroxisomes.  The properties 
of the peroxisomal refolding network are unique in that it is the only com-
partment in which exogenous expression of DNAJB1 stimulated rather than 
inhibited refolding (in control cells).
The effect of chaperone depletion on refolding in ER and peroxisomes 
could be indirect: a defi cit in cytoplasmic chaperoning capacity could have 
as a secondary effect the overloading of the ER and peroxisomal refolding 
machinery. We therefore tested if exogenous expression of HSPA5, an abun-
dant ER chaperone, could compensate for depletion of the HSF1 regulated 
chaperones. Exogenous expression of HSPA5 had a signifi cant effect on 
the thermostability of luciferase in all compartments, except the nucleus, 
as it about doubled the yield of luciferase activity directly after heat shock 
(data not shown). Curiously, this protective effect during heat shock did not 
correlate with an improvement in refolding after heat shock: exogenous ex-
pression of HSPA5 actually inhibited refolding in all compartments (data not 
shown). 
Thermotolerance of peroxisomal refolding is dependent upon HSF1 regu-
lated gene products.
Hageman et al. (2007) have shown that the refolding activity of the cytosol, 
nucleus, ER and peroxisomes increases in cells that have recovered from 
a heat shock. Such thermotolerance is due to the increased synthesis of 
chaperones. To show that the thermotolerance of the refolding in different 
cellular compartments requires HSF1 regulated gene products, we tested 
whether dnHSF1 expressing cells can acquire thermostability in the different 
cellular compartments. As shown in Fig. 3A, in cells that have been pre-heat 
shocked about 45% of the cytosolic luciferase was refolded within 1 hour 
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post heat shock, while in naïve cells slightly more than 3% of the pre-heat 
shock luciferase activity was regained. Expression of dnHSF1 abolished the 
ability to induce thermotolerance, only 7% of the cytosolic luciferase was 
refolded in preconditioned dnHSF1 expressing cells (Fig. 3A). The acquired 
thermostability of nuclear compartment was less HSF1 dependent as 17% 
of the nuclear luciferase was refolded in preconditioned dnHSF1 express-
ing cells compared with 41% in normal preconditioned cells (Fig.3B). 23% 
of the luciferase targeted to the ER was refolded in preconditioned dnHSF1 
expressing cells compared with 39% in normal preconditioned cells (Fig.3C), 
showing that the ER is less dependent on HSF1 for gaining thermostability. 
No chaperones have been detected in peroxisomes, yet luciferase can be 
refolded in peroxisomes [11, Figs. 1, 2]. Additionally, the refolding activity of 
the peroxisomes was shown to be increased in cells that have recovered 
from a heat shock. As shown in Fig. 3D, in cells that have been pre-heat 
shocked about 55% of the peroxisomal luciferase was refolded within 1 hour 
post heat shock, while in naïve cells had regained 5% of the pre-heat shock 
luciferase activity. Expression of dnHSF1 abolished the ability to induce ther-
motolerance, only 15% of the peroxisomal luciferase was refolded in precon-
ditioned dnHSF1 expressing cells (Fig. 3D). These data show that it is the 
additional synthesis of HSF1 regulated gene products that is responsible for 
the improved refolding capacity of the peroxisomes in pre-heat shock cells 
and suggest that refolding of peroxisomal luciferase requires HSF1 regu-
Figure 3   HSF1 depen-
dent thermotolerance in 
different organelles. 
Thermotolerance in diffe-
rent cellular compartments. 
A) Cyt-superluc-eGFP in 
HEK-cDNA5 and HEK-
dnHSF1 cells; B) Nuc-
superluc-eGFP in HEK-
cDNA5 and HEK-dnHSF1 
cells; C) ER-superluc-
eGFP in HEK-cDNA5 
and HEK-dnHSF1 cells; 
D) Per-superluc-eGFP in 
HEK-cDNA5-Per-superluc-
eGFP or HEK-dnHSF1-
Per-superluc-eGFP cells. 
Cells were either given a 
pre-heat shock at 45oC 
for 30 minutes or left 
untreated. 13 hours later, a 
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second heat shock of 45oC for 30 minutes was applied. Cells were allowed to recover after heat 
shock for 1 hour. Relative luciferase activities were calculated as detailed in the legend to Fig. 1. 
The results are the average of four independent transfections (standard deviations are indicated 
by error bars).
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lated chaperones. However, we were not able to rescue the inhibitory effect 
of dnHSF1 on gaining thermotolerance in peroxisomes by overexpressing 
chaperones encoded by HSF1 target genes (data not shown). 
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Figure 4   Effect of HSPA6, 
HSPB1, HSP90AA1 and PMVK 
on refolding capacities of peroxi-
somes.
Relative luciferase activity of 
Per-superluc-eGFP in HEK-
cDNA5-Per-superluc-eGFP or 
HEK-dnHSF1-Per-superluc-
eGFP cells. Cells were transfect-
ed with an expression constructs 
for PMVK (A),  HSP90AA1 
(B), HSPA6 (C) or HSPB1 (D). 
The expression levels of the 
exogenously expressed proteins 
are shown in Fig. S5. Cells were 
harvested after heat shock at 
the times indicated and the lu-
ciferase activity was measured. 
Relative luciferase activities were calculated as detailed in the legend to Fig. 1. The results are 
the average of four independent transfections (standard deviations are indicated by error bars).
HSPB1 promotes peroxisomal refolding.
As shown above, cells depend on HSF1 regulated genes for peroxisomal 
refolding in naïve cells as well as for the ability to develop thermotolerance of 
peroxisomal refolding. Yet, exogenous expression of the most likely candi-
dates, the HSF1 dependent genes HSPA1A and DNAJB1, did not restore 
peroxisomal refolding (Fig. 2D). In the refolding assays, cycloheximide is 
added before the heat shock. The HSF1 regulated function must thus be 
one that is inhibited by dnHSF1 expression even in the non-stressed state. 
We have previously shown that of only 10 genes the transcript level is 
signifi cantly (more than two-fold) lower when dnHSF1 is expressed in non-
stressed cells [31]. Four of these encode (co)chaperone genes, HSP90AA1, 
HSPA6, DNAJB1 and HSPB1. Of the other six genes (PMVK, KLRG1, 
CDKL3, KA21, ZNF473, MLH1), only PMVK (phosphomevalonate kinase) 
looks like a possible candidate. The human PMVK sequence contains a 
putative peroxisomal targeting sequence [40] and was shown to be localized 
in peroxisomes [40, 41] although others have found PMVK to be mainly cyto-
plasmic [42]. A protein-protein interaction study detected multiple interactions 
of PMVK [43], which might indicate that PMVK could have a second role as 
a chaperone. We thus tested whether 
exogenous expression of PMVK, HSP90AA1, HSPA6 or HSPB1 could res-
cue the decreased refolding capacity of peroxisomes in dnHSF1 expressing 
cells. Exogenous expression of none of these four proteins improved peroxi-
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Figure 5   Effect HSPA1A and 
HSPB1 on refolding capacities of 
different organelles.
Relative luciferase activity of 
A) Cyt-superluc-eGFP in HEK-
cDNA5 and HEK-dnHSF1 cells; 
B) Nuc-superluc-eGFP in HEK-
cDNA5 and HEK-dnHSF1 cells; C) 
ER-superluc-eGFP in HEK-cDNA5 
and HEK-dnHSF1 cells; D) Per-
superluc-eGFP in HEK-cDNA5-
Per-superluc-eGFP or HEK-
dnHSF1-Per-superluc-eGFP cells. 
Cells were co-transfected with 
the luciferase reporter gene and 
expression constructs for HSPA1A 
and/or HSPB1 and/or empty 
vector as indicated. Per-superluc-
eGFP cells were transfected only 
with the expression constructs. 
Expression levels of exogenously 
expressed proteins are shown in 
Fig. S6. Cells were harvested after 
heat shock at the times indicated 
and the luciferase activity was 
measured. Relative luciferase ac-
tivities were calculated as detailed 
in the legend to Fig. 1. The results 
are the average of four independ-
ent transfections (standard devia-
tions are indicated by error bars).
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somal refolding in dnHSF1 expressing cells (Fig. 4A-B; note that the extent 
of peroxisomal refolding shown here is somewhat lower than shown in other 
fi gures, presumably due to a slightly harsher heat shock). Intriguingly, in 
control cells HSPB1 did improve peroxisomal refolding (Fig. 4D). 
HSPB1 cannot refold proteins but can maintain these in a refolding compe-
tent state and cooperate with the Hsp70 folding machine, which refolds the 
HSPB1 substrates. We thus tested whether the lack of an effect of 
HSPB1on peroxisomal refolding in dnHSF1 expressing cells was due to a 
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Discussion
We show here that expression of dnHSF1 not only affects cytoplasmic and 
nuclear refolding but, unexpectedly, also refolding in the ER and the per-
oxisomes. The obvious explanation would be that expression of dnHSF1 
depletes the cell of cytoplasmic, HSF1 regulated, chaperones. Peroxisomal 
matrix proteins are imported from the cytoplasm and thought to be folded by 
the cytoplasmic chaperones. How peroxisomes deal with unfolded proteins 
is not known. The ER has a retrograde export system for unfolded proteins 
(ERAD), which are then degraded in the cytoplasm. Peroxisomes are not 
known to have an export system but their import system shows a striking 
similarity to ERAD [44] with the crucial difference that ERAD exports while 
the peroxisomal system imports. Perhaps the peroxisomal import system 
is reversible and can also export when unfolded proteins accumulate in the 
peroxisomes. These proteins could then either be refolded and reimported or 
degraded. As we have shown here, peroxisomal refolding is fully dependent 
upon HSF1 activity and at fi rst glance appears to equal to, and to be due to, 
cytoplasmic refolding. However, a closer examination shows important dif-
ferences. Cytoplasmic refolding in control cells can be augmented by exog-
enous expression of HSPA1A and is thus limited by the Hsp70 machinery. 
Refolding of peroxisomal luciferase, in contrast, is limited by co-chaperones. 
In control cells it can be increased somewhat by exogenous expression of 
DNAJB1 which supplies substrate to Hsp70, and by HSPB1, which serves 
as a holding reservoir for Hsp70 refolding. Hsp70 activity itself is not limiting, 
as exogenous expression of HSPA1A has no effect on peroxisomal refolding. 
Peroxisomes thus appear to have Hsp70 activity in excess, while in the cyto-
plasm Hsp70 is limiting. A second important difference between cytoplasmic 
and peroxisomal refolding is that in cells expressing dn HSF1, refolding of 
peroxisomal luciferase cannot be restored by exogenous expression of any 
of the (co-)chaperones we tested, while expression of HSPA1A+DNAJB1 
fully restored cytoplasmic luciferase refolding. This difference could be due 
to a spatial restriction of the refolding of peroxisomal proteins. In plants, a 
membrane bound DNAJ protein recruits cytoplasmic Hsp70 to the peroxi-
somal surface [45] and peroxisomal proteins could thus be refolded locally 
lack of HSPA1A. It was not: exogenous expression of HSPA1A had no effect 
(Fig. 5). In contrast, in other cellular compartment an effect of HSPB1 did 
require HSPA1A. The limiting node in the peroxisomal chaperone network 
thus differs from that in other compartments. 
As exogenous expression of the traditional HSF1 target genes did not 
restore peroxisomal refolding in dnHSF1 expressing cells, we tested the 
effect of other chaperone family members as well. Exogenous expression of 
HSPH1, GRP94, HSPA8, HSP47(SERPINH1), DNAJA1, DNAJB2a, 
DNAJB2b, DNAJB6, DNAJB8, HSPB5 or HSPB8 had no effect on peroxiso-
mal protein folding (data not shown).
Chapter 5
122
on the cytosolic side of the peroxisomal membrane rather than dispersed in 
the cytoplasm. An alternative possibility to cytoplasmic refolding of peroxiso-
mal proteins is that peroxisomes do import chaperones under conditions of 
proteotoxic stress. It has been shown that peroxisomes import unfolded BSA 
along with HSPA8 (Hsc70) [46]. A transient accumulation of chaperones in 
peroxisomes during proteotoxic stress could then ensure refolding. Whatever 
the mechanism of peroxisomal refolding is, it requires a crucial component 
of which the function is somehow dependent upon HSF1 regulated gene ex-
pression. What that component is, is unknown; none of the chaperones test-
ed in our experiments restored peroxisomal refolding in dnHSF1 expressing 
cells. Expression of dnHSF1 did not impair import of peroxisomal targeted 
eGFP-luciferase: in cells cultured for 12 days with continuous expression of 
dnHSF1 peroxisomal eGFP-luciferase was not effected (Fig. S7).
The ER has its own set of chaperones. Except for SERPINH1 (Hsp47), the 
synthesis and level of the ER chaperones is not regulated by HSF1. Yet, we 
do fi nd that expression of dnHSF1 also results in a 50% inhibition of refold-
ing of ER targeted luciferase. We cannot rigorously exclude that some of 
the ER targeted luciferase is mislocalized in the cytoplasm. However, if that 
was the case we would expect that exogenous HSPA1A would improve ER 
luciferase refolding in control cells just as it improves cytoplasmic luciferase 
refolding. It did not. The most likely explanation is that somehow lack of 
cytoplasmic chaperones clogs up the ER refolding machinery. Cytoplasmic 
domains of integral membrane proteins are folded by cytoplasmic chaper-
ones. In addition cytoplasmic Hsp70s are implicated in ERAD [47, 48]. In our 
hands a lack of cytoplasmic chaperones due to dnHSF1 expression could 
not be relieved by exogenous expression of HSPA5, the ER resident Hsp70. 
If anything, exogenous expression of HSPA5 inhibited post-heat shock 
refolding. Curiously, HSPA5 was effective in preventing denaturation during 
heat shock and HSPA5 was the only exogenously expressed chaperone that 
did not show a direct correlation between protection during heat shock and 
of post-heat shock refolding, suggesting that in this case these are distinct 
processes. 
Previously we showed that the activity of the gluccocorticoid receptor, a 
client of both the Hsp70 and the Hsp90 machines, could be restored in 
dnHSF1 expressing cells by exogenous expression of DNAJB1 but not 
HSPA1A [31]. In contrast, exogenous expression of DNAJB1 did not re-
store refolding of luciferase, HSPA1A is required as well. Which node of the 
chaperoning network is critical thus depends on the substrate tested and the 
compartment in which the substrate is located. Increasing expression of 
(co-)chaperones to compensate for the loss of HSF1 regulated chaperones 
in aging cells thus needs to be tailored for specifi c substrates.
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Supplemental tables and figures
Figure S1 Effect dnHSF1 and HSPA1A or DNAJB1 expression on luciferase denaturation in 
different organelles Luciferase activity directly after HS of A) Cyt-superluc-eGFP in HEK-cDNA5 
and HEK-dnHSF1 cells; B) Nuc-superluc-eGFP in HEK-cDNA5 and HEK-dnHSF1 cells; C) 
ER-superluc-eGFP in HEK-cDNA5 and HEK-dnHSF1 cells; D) Per-superluc-eGFP in HEK-cD-
NA5-Per-superluc-eGFP or HEK-dnHSF1-Per-superluc-eGFP cells. Cells were co-transfected 
with the luciferase reporter gene and expression constructs for HSPA1A and/or DNAJB1 and/
or empty vector as indicated. Per-superluc-eGFP cells were transfected only with the expres-
sion constructs. Cells were harvested directly after heat shock and the luciferase activity was 
measured. Luciferase activities were calculated relative to those in non heat shocked cells 
transfected and cultured in parallel. The results are the average of four independent transfec-
tions (standard deviations are indicated by error bars).
Figure S2 Effect of exogenous expression 
of PMVK,  HSP90AA1, HSPA6 or HSPB1 on 
denaturation of peroxisomal luciferase.
Luciferase activity directly after HS of Per-
superluc-eGFP in HEK-cDNA5-Per-superluc-
eGFP or HEK-dnHSF1-Per-superluc-eGFP 
cells. Cells were transfected with an expression 
constructs for HSPA6, HSPB1, HSP90AA1 or 
PMVK. Cells were harvested directly after heat 
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shock and the luciferase activity was measured. Luciferase activities were calculated relative to 
those in non heat shocked cells transfected and cultured in parallel. The results are the average 
of four independent transfections (standard deviations are indicated by error bars).
Figure S3 Effect of exogenous expression of HSPA1A and HSPB1 on luciferase denaturation 
in different organelles Luciferase activity directly after HS of A) Cyt-superluc-eGFP in HEK-
cDNA5 and HEK-dnHSF1 cells; B) Nuc-superluc-eGFP in HEK-cDNA5 and HEK-dnHSF1 cells; 
C) ER-superluc-eGFP in HEK-cDNA5 and HEK-dnHSF1 cells; D) Per-superluc-eGFP in HEK-
cDNA5-Per-superluc-eGFP or HEK-dnHSF1-Per-superluc-eGFP cells. Cells were co-transfect-
ed with the luciferase reporter gene and expression constructs for HSPA1A and/or HSPB1 and/
or empty vector as indicated. Per-superluc-eGFP cells were transfected only with the expres-
sion constructs. Cells were harvested directly after heat shock and the luciferase activity was 
measured. Luciferase activities were calculated relative to those in non heat shocked cells 
transfected and cultured in parallel. The results are the average of four independent transfec-
tions (standard deviations are indicated by error bars).
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Figure S4 Exogenous expression of HSPA1A and DNAJB1.
Levels of exogenous expression of HSPA1A and DNAJB1. Expression plasmids for the (co-)
chaperones indicated were transfected into either A) HEK-cDNA cells, HEK-HSF379, B) 
HEK-cDNA5-Per-superluc-eGFP or HEK-dnHSF1-Per-superluc-eGFP cells and expression of 
dnHSF1 was induced by adding doxycyclin. Protein levels were determined by western blotting 
and staining with the corresponding antibody (see ‘‘Materials and methods’’). γ-tubulin was used 
as a loading control.
Figure S5 Exogenous expression of  
HSP90AA1, HSPA6, HSPB1 and PMVK.
Levels of exogenous expression of different (co-)
chaperones. Expression plasmids for HSP90AA1, 
HSPA6, HSPB1 and PMVK were transfected into 
either HEK-cDNA5-Per-superluc-eGFP or HEK-
dnHSF1-Per-superluc-eGFP cells and expression 
was induced by adding doxycyclin. Except for 
HSP90AA1, of which expression is constitutive. 
Protein levels were determined by western blot-
ting and staining with the corresponding antibody 
(see ‘‘Materials and methods’’). Note that in the 
case of HSPA6 antibody to the V5-tag carried by 
the exogenous proteins was used; the endog-
enous protein is thus not detected. β-actin was 
used as a loading control.
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Figure S6 Exogenous expression of HSPA1A and HSPB1.
Levels of exogenous expression of HSPA1A and HSPB1. Expression plasmids for the (co-)
chaperones indicated were transfected into either A) HEK-cDNA cells, HEK-HSF379, B) HEK-
cDNA5-Per-superluc-eGFP or HEK-dnHSF1-Per-superluc-eGFP cells and expression was 
induced by adding doxycyclin. Protein levels were determined by western blotting and staining 
with the corresponding antibody (see ‘‘Materials and methods’’). β-actin was used as a loading 
control.
Figure S7 Effect of 
dnHSF1 expression on the 
localization of peroxisomal 
targeted luciferase.
Confocal micrographs show-
ing eGFP of Per-superluc-
eGFP in control cells (HEK-
dnHSF1-Per-superluc-eGFP 
cultured in the absence of 
doxycycline) and in cells 
overexpressing dnHSF1 for 
12 days.
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Abstract
Phosphomevalonate kinase (PMVK) catalyzes the ATP dependent phosphor-
ylation of mevalonate 5-phosphate to produce mevalonate 5-diphosphate 
and ADP in the mevalonate pathway. We show here that the PMVK gene 
contains an HSE, the element binding heat shock factor 1 (HSF1; a tran-
scription factor activated upon cytoplasmic proteotoxic stress), in the region 
encoding the 5’ UTR. PMVK mRNA and protein levels were strongly down-
regulated not only when a dominant negative mutant of HSF1 (HSF379) was 
expressed, but also when an HSF1 mutant (HSF448), which has a weak 
dominant positive effect on traditional HSF1 responsive promoters, was 
expressed. The levels of PMVK mRNA were not affected by a heat shock 
and the activation of the PMVK promoter by sterol depletion was not HSF1 
dependent. Whether the PMVK HSE plays a physiological role remains 
unclear.
The 5’-Untranslated Region of the human PMVK gene contains an HSF1 binding site
131
Introduction
Cytoplasmic proteotoxic stress leads to activation of HSF1, which then medi-
ates transcription of several genes amongst which genes encoding for chap-
erones known as the heat shock proteins [1-3]. HSF1 null mice lack the heat 
shock response and additionally show neuronal and developmental defects 
[4-6]. The latter phenotypes cannot be linked to the heat shock response 
directly, suggesting that HSF1 also regulates transcription of several genes 
under normal, non stress conditions. Direct evidence for the regulation of 
genes by HSF1 under non stress conditions was found in heregulin treated 
breast carcinoma cells. HSF1 repressed the estrogen-dependent transcrip-
tion induced by heregulin [7]. It has also been discovered that Hsf1 defi cient 
mice show altered circadian period lengths, suggesting that HSF1 is of func-
tional importance for the circadian clock [8]. 
To identify HSF1 targets in the absence of stress we have used a dominant 
negative (dn)HSF1 mutant to inhibit HSF1 activity in non stressed cells. 
Besides some chaperone and co-chaperone genes also a number of genes 
not known as HSF1 targets were downregulated by dnHSF1 expression 
[9]. One of the latter is that encoding phosphomevalonate kinase (PMVK). 
PMVK is involved in the mevalonate pathway by catalyzing the ATP depend-
ent phosphorylation of mevalonate 5-phosphate to produce mevalonate 
5-diphosphate and ADP [10]. The mevalonate pathway is responsible for the 
synthesis of cholesterol from acetyl CoA and acetoacetyl CoA [10]. PMVK 
mRNA levels and the corresponding enzymatic activity are regulated in re-
sponse to cellular sterol levels [11].The PMVK gene region has been shown 
to bind HSF1 in ChIP-on-chip experiments [12], albeit weakly. Furthermore, 
a protein-protein interaction study showed multiple interactions of PMVK [13] 
which might suggest that PMVK has a second role as a chaperone. We thus 
selected the PMVK gene for further study. To elucidate the possible role of 
HSF1 in regulating PMVK levels, we fi rst mapped the HSF1 interaction site 
in the PMVK promoter region and found an HSE located in the PMVK gene 
region encoding the 5’ UTR. However, we failed to fi nd a function for this 
HSE: we could fi nd no evidence for an involvement of HSF1 in regulation of 
the activity of the PVMK gene either in heat stressed or in sterol depleted 
cells. 
Materials and Methods
Cell culture
Flp-In T-REx-293 cells were manipulated according to the manufacturer’s 
instructions using the T-REx system (Invitrogen) to generate the stable cell 
lines HEK-dnHSF1 (HSF379) , HEK-cDNA5, HEK-HSF448, HEK-HSF1 WT 
and HEK-HSF1-K80Q that carry a single copy of the tetracycline-inducible 
plasmids pcDNA5-dnHSF1, pcDNA5, pcDNA5-HSF448, pcDNA5-HSF1 WT 
and pcDNA5-HSF1-K80Q respectively. The cells were cultured at 37oC/5% 
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CO2 in high glucose DMEM medium supplemented with 10% fetal calf serum 
and 100 U/ml penicillin and 100 μg/ml streptomycin. Blasticidin (1.65 μg/
ml; Invitrogen) and 100 μg/ml hygromycin were also added to the culture 
medium during maintenance of the cell lines, but were omitted during experi-
ments. Transient transfections were performed using FuGENE-6 (Roche) 
according to the manufacturer’s instructions. 
RNA Isolation and Real Time Quantitative RT-PCR
Cells were washed twice with ice-cold PBS and after washing the cells, RNA 
was isolated with TRIzol (Invitrogen) according to manufacturer’s recommen-
dation. Isolated RNA samples were treated with RNase-free DNase I (Qia-
gen) for 15 minutes. cDNA was generated using the Reverse Transcription 
System from Promega following the manufacturer’s instructions. Quantitative 
real-time PCR was performed using the StepOnePlus™ Real-Time PCR 
System with Power SYBR® Green PCR Master mix (Applied Biosystems) 
using the following amplifi cation protocol: 2 minutes at 50°C followed by 
40 cycles of 15 seconds at 95°C and 1 minute at 60°C. Per reaction 3 μl of 
diluted cDNA was used and the DNA was amplifi ed using primers for the se-
quences of interest, listed in Table 1. Parallel PCR reactions were performed 
with 0.125 μg of the DNase treated RNA to test for DNA contamination. 
GAPDH mRNA was used as a control.
Transfections, and reporter gene assays
Transient transfections were performed using FuGENE-6 (Roche) accord-
ing to the manufacturer’s instructions. Cells were seeded on 24-well plates 
and on the next day transfected with 0.2 μg plasmid per well. For analysis of 
the PMVK promoter activity, cells were transfected with a mixture of 180 ng 
luciferase reporter plasmid and 20 ng β-actin-β-galactosidase except when 
the dpHSF1 was also expressed. In those experiments a mixture of 160 ng 
luciferase reporter plasmid, 20 ng expression plasmid or empty vector and 
20 ng β-actin-β-galactosidase was used. At 24 hours after transfection, the 
expression of dnHSF1, HSF448, HSF1 WT, HSF1 K80Q or dpHSF1 was 
induced by adding 0.1 μg/ml doxycycline. At 48 hours after transfection, cells 
were heat shocked for 30 minutes at 45 oC. Cells were harvested after a re-
covery period at 37oC. For sterol depletion, cells were seeded in phenol red 
free medium supplemented with 10% charcoal stripped fetal bovine serum, 
GlutaMAX , 100 U/ml penicillin and 100 μg/ml streptomycin. After 24 hours, 
1 or 10 μM lovastatin was added in phenol red free medium lacking serum 
and cells were cultured for an additional 24 hours. 
Cells were lysed in 200 μl reporter lysis mix (25 mM Bicine, 0.05% Tween 
20, 0.05% Tween 80) for 10 min. For the β-galactosidase assay, 10 μl cell 
lysate was mixed with 100 μl Galacton solution (100 mM Na-phosphate pH 
8.2, 10 mM MgCl2, 1% Galacton-Plus;Tropix). After 30 min incubation at 
room temperature, 150 μl accelerator II (Tropix) was added and lumines-
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cence was measured with the Lumat LB 9507 tube luminometer (Berthold). 
For the luciferase assay, 10 μl cell lysate was mixed with 50 μl luciferin solu-
tion and luminescence was again measured with the Lumat luminometer.
Recombinant DNA constructs
pcDNA5-dnHSF1, pcDNA5-HSF448 and pcDNA5-dpHSF1 have been 
described previously [14]. The pcDNA5-HSF1 silent mutation (HSF1 WT) 
and the pcDNA5-HSF1-K80Q mutant were made by performing site-directed 
mutagenesis on pcDNA5-HSF1 with respectively the HSF1 sil.mut and the 
HSF1-K80Q primers (listed in Table 1). 
The pGL3-PMVK (-1188, +142) promoter clone was constructed by PCR on 
DNA isolated from human lymphocytes cells. PCR fragments were cloned 
into pGEM-T-Easy vector (Promega) and, after sequencing, the promoter 
sequence was cloned into the pGL3 basic vector. pGL3-PMVK (-816,+142) 
was made by digesting pGL3-PMVK (-1183,+147) with KpnI and AFLII 
(blunt ends). pGL3-PMVK (-620,+142) was made by digesting pGL3-PMVK 
(-1188,+142) with KpnI and PvuII (blunt ends). PMVK-5’UTR-SV40 was 
made by amplifying the 5’ UTR region by PCR on pGL3-PMVK (-1188,+142) 
and inserting it in pGL3 promoter. PMVK-HSE-SV40 was made by anneal-
ing the corresponding primers and cloning the double-stranded oligo into the 
XhoI and NheI sites of pGL3-promoter. dmHsp70-HSE-SV40 was made by 
annealing the corresponding primers and cloning the double-stranded oligo 
into the XhoI and NheI sites of pGL3-promoter.
Chromatin Immunoprecipitation
HEK-dnHSF1 or HEK-cDNA5 cells were cultured for 48 h in the presence of 
doxycycline. Chromatin immunoprecipitation was performed as described in 
[15] except that cells were crosslinked for 15 minutes with 1% formaldehyde. 
After quenching with 125 mM glycine, cells were washed twice with ice cold 
PBS and resuspended in ice cold lysis buffer (50 mM HEPES.KOH pH 7.6, 
140 mM NaCl, 1mM EDTA pH 8.0, 1% (v/v) Triton X-100, 0.1% NaDOC and 
1X protease inhibitor complete). Sonicated chromatin was centrifuged for 5 
min at 4°C and then incubated overnight in incubation buffer (fi nal concen-
tration; 12 mM HEPES-KOH pH 7.6, 90 mM NaCl, 0.6 mM EDTA pH. 8.0, 
0.09% SDS, 0.6% Triton X-100, 0.1% BSA) together with purifi ed anti-HSF1 
antibody (SPA-901; Stressgen; 1:1000) or anti-CEBPβ (sc-150; Santa Cruz; 
1:1000) and protein A/G beads (Santa Cruz). Negative control without add-
ing antibody was included. Beads were washed six times with different buff-
ers at 4°C: twice with 0.1% SDS, 0.1% NaDOC, 1% Triton X-100, 150 mM 
NaCl, HEG (1 mM EDTA, 0.5 mM EGTA and 20 mM HEPES-KOH pH 7.6), 
once with the same buffer but with 500 mM NaCl, once with 0.25 M LiCl, 
0.5% NaDOC, 0.5% NP-40, HEG and twice with HEG. Precipitated chroma-
tin was eluted with 400 μl of elution buffer (1% SDS, 0.1 M NaHCO3), incu-
bated at 65°C for 4 h in the presence of 200 mM NaCl, phenol extracted and 
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Table 1  Oligonucleotides that were used.
precipitated with 20 μg of glycogen at -20°C overnight. ChIP experiments 
were analyzed by qPCR. Effi ciency of ChIP was calculated as percentage of 
input. The primers used are listed in Table 1.
Western blot analysis
Cell pellets were homogenized in buffer containing 50 mM Tris–HCl pH 7.5, 
150 mM NaCl, 1% Triton X-100, 100 mM NaF, 20 mM Na4P2O7, 1 mM PMSF 
and protease inhibitors (Complete Mini; Roche). Then 4x sample buffer (200 
mM Tris–HCl pH 6.8, 20% β-mercaptoethanol, 8% SDS, 40% glycerol and 
0.4% bromophenolblue) was added and the lysates were incubated at 95oC 
for 5 min. Protein samples were separated in 10% polyacrylamide gels and 
transferred to nitrocellulose transfer membrane (Protran) using a Bio-Rad 
Mini-PROTEAN II Electrophoresis cell according to the manufacturer’s 
instructions. For western blot analysis, monoclonal Hsp70 antibody 4G4 
(ab5444; Abcam) was used at a 1:5,000 dilution, polyclonal PMVK antibody, 
obtained from Dr. H.R. Waterham [16], was used at a 1:500 dilution and 
mouse monoclonal β-actin antibody (AC-15, Sigma-Aldrich) was used at a 
dilution of 1:5,000. Blots were incubated with fl uorescent secondary anti-
bodies IRDye® 800 CW conjugated goat (polyclonal) Anti-Rabbit IgG and 
IRDye® 800CW conjugated goat (polyclonal) Anti-Mouse IgG. (926-32211 
and 926-32210, respectively; LI-COR Biosciences) according to the manu-
facturer’s instructions and scanned using a LI-COR Odyssey infrared scan-
ner. Signals were quantifi ed using Odyssey version 2.1 software.
  Oligo name Oligo sequence (5’        3’)
Cloning
ChIP
QPCR
PMVK prom up
PMVK prom low
PMVK 5’UTR up
PMVK 5’UTR low
PMVK HSE up
PMVK HSE low
dmHsp70 HSE up
dmHsp70 HSE low
HSF1 sil. mut. (HSF1 WT)
HSF1-K80Q
PMVK ChIP fwd
PMVK ChIP rev
DNAJB1 ChIP fwd
DNAJB1 ChIP rev
GAPDH_QPCR_fwd
GAPDH_QPCR_rev
HSPA1A_QPCR_fwd
HSPA1A_QPCR_rev
HSP90_QPCR_fwd
agctaagcttactcaggtaaaacaggagatgtg
agctccatggccaaacagatatggggagaaaag
agctcccgggaaggttctgggcggggctggactgttc
agctccatggccaaacagatatggggagaaaag
ctagagggaaggttctgggcggggctggactgttctaagtgagttcgggtgc
tcgagcacccgaactcacttagaacagtccagccccgcccagaaccttccct
ctagctctattctcgttgcttcgagagagcgcgcctcgaatgttcgcgaaaagagcg
gatccgctcttttcgcgaacattcgaggcgcgctctctcgaagcaacgagaatagag
cagaaagtcgtcaacaagcttatccagttcctgatctcactg
catgtatggcttccggcaagtggtccacatcgagc
gtcagttaagcaggccaggc
ccaaacagatatggggagaaa
ggatgtcgcgtgtcgctgaa
cgaccagtcccggactctata
gcagctgaaagaagcccaagt
tgtcttccatgccaattgca
ccgagaaggacgagtttgag
acaaaaacagcaatcttggaaagg
gttggtcctgtgcggtcact
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Results
Expression of dnHSF1 in HEK293 cells lowers the PMVK mRNA level.
Previously we have compared the transcriptomes of non-stressed HEK cells 
with or without expression of a dominant negative HSF1 mutant (dnHSF1) 
using a two-color 44K Agilent Human Expression Profi le Array and found 
a two- or more fold decrease in the transcript level of 10 genes, amongst 
which the traditional HSF1 target genes HSP90AA1, HSPA6, DNAJB1 and 
HSPB1 [9]. One of the other genes of which expression was effected was 
the phosphomevalonate kinase (PMVK) gene of which the transcript levels 
decreased fi vefold in presence of dnHSF1. To validate the gene expression 
results obtained from the microarray analysis, we used Q-PCR. Expression 
of dnHSF1 resulted in a ~ 3 fold decrease of HSP90 mRNA levels, HSPA1A 
mRNA levels dropped ~ 1.5 times, DNAJB1 mRNA levels declined ~ 9 times 
and a ~ 3 fold drop of mRNA levels was seen for HSPB1 (Fig. 1), while the 
levels of PMVK mRNA decreased ~ 10 times (Fig. 1). The decline in PMVK 
mRNA level correlated with the protein levels of PMVK as the amount of 
PMVK protein in HEK-dnHSF1 cells decreased when dnHSF1 was ex-
pressed (Fig. S1A). 
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array data.
Relative changes in the transcript levels 
of various genes in HEK-dnHSF1 cells. 
Changes in HSP90, HSPA1A, DNAJB1, 
HSPB1 and PMVK mRNA levels relative to 
GAPDH mRNA levels upon overexpression 
of dnHSF1 were measured by QPCR. The 
fold induction of mRNA levels is plotted rela-
tive to the mRNA levels in control cells. 
Identifi cation of the HSF1 binding site in the human PMVK promoter.
To test which site determined the effect of dnHSF1 on the PMVK promoter 
we used luciferase reporter constructs driven by the PMVK promoter. Three 
different lengths of the PMVK promoter were used: -1188, +142; -816, +142 
and -620, +142 (depicted in Fig. 2A). DnHSF1 overexpression caused a 
decrease in the luciferase yield from all three constructs (Fig. 2B), while the 
activity of the SV40 promoter was not affected by dnHSF1 expression. We 
used a dominant positive HSF1 (dpHSF1; HSF1Δ202-315) (see Fig. S2 for 
a schematic representation of the HSF1 expression constructs used in this 
study) construct to mimic an activated heat shock response and monitored 
the effect on the activity of the PMVK promoter construct (-1188, +142). The 
relative luciferase activity increased, indicating that dpHSF1 activates the 
PMVK promoter (Fig. 2C). The sequence of the PMVK promoter (-1188, -1) 
did not contain an HSE, but a putative HSE was present in the 5’UTR (+1, 
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+142). Therefore we placed the 5’UTR sequence upstream of the SV40 
promoter (PMVK-5’UTR-SV40 (+1, +142)) and tested the effect of dnHSF1 
or dpHSF1 overexpression on the activity of this construct. Figure 2C shows 
that dnHSF1 inhibited and dpHSF1 increased the activity of the PMVK-
5’UTR-SV40 construct, suggesting that the site where HSF1 binds is located 
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Figure 2   PMVK promoter activity.
A) Schematic representation of the constructs used in the experiments and the sequence of 
predicted HSE located in the 5’UTR region of PMVK. The nucleotides corresponding to the 
consensus HSE are shown in bold and underlined.
B-C) The activity of the PMVK reporter constructs is dpHSF1 or dnHSF1 sensitive. HEK-cDNA5 
cells were transfected with a mixture of the indicated luciferase reporter, pcDNA5-dpHSF1 or 
an empty vector and a β-actin-β-galactosidase reporter (7:2:1 ratio). Doxycycline was added 24 
hours after transfection and cells were harvested and assayed for reporter gene activities at 48 
hours after transfection. HEK-dnHSF1 cells were seeded with or without doxycycline. After 24 
hours HEK-dnHSF1 cells were transfected with a mixture of the indicated luciferase reporter and 
a β-actin-β-galactosidase reporter (9:1 ratio). At 48 hours after transfection, cells were harvested 
and assayed for reporter gene activities. Luciferase activities shown are relative to the luciferase 
activity in control cells, which was set at one.
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in this particular region. Further dissection of the PMVK 5’UTR sequence led 
us to examine GAAN2TTCN2GGC as a possible HSE. To test whether this 
sequences is a target of dnHSF1 or dpHSF1, we constructed PMVK-HSE-
SV40 in which the sequence of the PMVK-HSE (Fig. 2A) is placed upstream 
of the SV40 promoter. DnHSF1 expression decreased the relative luci-
ferase yield from the PMVK-HSE construct, whereas expression of dpHSF1 
strongly increased the relative luciferase yield from PMVK-HSE-SV40 (Fig. 
2C), suggesting that this particular region of 46 base pairs contains an HSF1 
binding site. Note that the PMVK HSE is relatively weak as the response of 
the Drosophila melanogaster (dm)Hsp70 promoter to dpHSF1 was far higher 
(Fig. S1B).
Expression of HSF1 mutants affects endogenous PMVK mRNA and protein 
levels.
The data presented above show that expression of the PMVK gene is in-
hibited in non-stressed cells by dnHSF1, presumably by binding of dnHSF1 
to the HSE located in the region encoding the 5’UTR, i.e. downstream of 
the promoter. This raises the question whether the expression of the PMVK 
gene in non-stressed cells is regulated by HSF1. To examine this we used 
other HSF1 mutants. We tested HSF448 which lacks the C-terminal trans-
activation domain AD2 but retains the weak transactivation domain AD1 
(dnHSF1 lacks both domains, see Fig. S2). HSF448 acts in a weak dominant 
positive manner under non stress conditions and in a dominant negative way 
during stress [9]. Another mutant of HSF1 we tested has lysine 80 replaced 
by glutamine (HSF1-K80Q); this mutation blocks DNA binding ([17]; data not 
shown). This mutant acts as a dominant negative as it forms heterotrimers 
with the endogenous HSF1 and thereby also prevents endogenous HSF1 
from binding. As control we also overexpressed wild type HSF1. Overexpres-
sion of wild type HSF1 also yields some transcriptionally active HSF1 [18]. 
The effect of overexpression of the HSF1 mutants on the luciferase activity 
obtained from the HSE driven constructs was as expected. Overexpression 
of HSF448 or wild type increased the activity of the SV40 promoter driven 
either by the HSE isolated from the of the Drosophila melanogaster (dm)
Hsp70 promoter or the PMVK-HSE, while expression of the HSF1-K80Q mu-
tant had no or little effect (Fig. 3A). Note that the effects of HSF448 or HSF1 
WT overexpression on the activity of the dmHsp70-HSE driven construct 
were stronger than for the PMVK-HSE containing construct, again suggest-
ing that the PMVK is the weaker HSE.
The constructs used in Figure 3A have the isolated HSE placed upstream of 
the SV40 promoter. In the endogenous situation the PMVK-HSE is located 
downstream of the transcription start site and functions in the context of 
other elements and transcription factors regulating promoter activity. We thus 
also tested the PMVK promoter (-1188 - +142) activity in presence of the 
different HSF1 mutants. We used the human HSPA1A promoter, a known 
HSF1 target, as a positive control. As expected, HSPA1A promoter activity 
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Figure 3   The effect of HSF1 mutants on PMVK levels.
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increased in presence of HSF448 and HSF1 WT, while dnHSF1 overexpres-
sion caused a decrease in activity and HSF1 K80Q had little effect. The 
promoter activity of PMVK was inhibited by dnHSF1 but, surprisingly, also by 
HSF448 overexpression. HSF1-K80Q did not have an effect on the promoter 
activity of PMVK and HSF1 WT very slightly inhibited (Fig. 3B). The results 
from the reporter assays refl ect the endogenous situation as the endog-
enous PMVK mRNA levels also decreased in the presence of the HSF448 
mutant. HSF1 wild type or HSF1-K80Q had no effect on the PMVK mRNA 
level, while expression of the dominant positive HSF1 mutant resulted in an 
increase in PMVK mRNA levels (Fig. 3C). As control, we also looked at the 
changes in HSPA1A mRNA levels. As expected, these levels increased upon 
expression of HSF448, HSF1 wild type and dpHSF1. Note that the HSPA1A 
gene is only poorly active in non-stressed cells (see also below) and that this 
background activity is largely independent of HSF1 as indicated by the lack 
of effect of dnHSF1 or HSF1 K80Q. Similarly, the lack of effect of HSF1-
K80Q on PMVK expression shows that in non-stressed cells HSF1 is not re-
quired for PMVK promoter activity, while the inhibitory effect of both dnHSF1 
and HSF448 imply that if HSF1 is bound to the PMVK HSE, then both HSF1 
activation domains are required to maintain PMVK promoter activity. Finally, 
the stimulatory effect of the dpHSF1 mutant shows that HSF1, when active, 
can activate the PMVK promoter (Fig. 3C).
Figure 3   The effect of HSF1 mutants on PMVK levels.
A) The PMVK-HSE acts like a weak HSE. The effects of HSF448, HSF1 WT or HSF1 K80Q 
overexpresison on the activity of a Drosophila melanogaster Hsp70 HSE containing reporter 
construct or a reporter construct containing the predicted PMVK HSE. HEK-cDNA5, HEK-
HSF448, HEK-HSF1 WT or HEK-HSF1-K80Q cells were seeded in the presence of doxycycline. 
24 hours later the cells were transfected with a mixture of the indicated luciferase reporter and a 
β-actin-β-galactosidase reporter (9:1 ratio). At 48 hours after transfection, cells were harvested 
and assayed for reporter gene activities.
B) The PMVK promoter does not act like a typical HSF1 sensitive promoter. HEK-cDNA5, HEK-
HSF448, HEK-HSF1 WT or HEK-HSF1-K80Q cells were seeded in the presence or absence of 
doxycycline. 24 hours later the cells were transfected with a mixture of the indicated luciferase 
reporter and a β-actin-β-galactosidase reporter (9:1 ratio). At 48 hours after transfection, cells 
were harvested and assayed for reporter gene activities. Luciferase activities shown are relative 
to the luciferase activity in control cells, which was set at one.
C) PMVK and HSPA1A transcript changes in presence of various HSF1 mutants. HEK-cDNA5, 
HEK-HSF448, HEK-HSF1 WT or HEK-HSF1-K80Q cells were seeded in the presence or ab-
sence of doxycycline. 72 hours after seeding, cells were harvested and total RNA was isolated. 
Transcript levels were measured relative to GAPDH mRNA levels by QPCR. The fold induction 
of mRNA levels is plotted relative to the mRNA levels in control cells. 
the indicated time. Cells were exposed to a heat shock (30’, 45°C), harvested at the indicated 
time point after heat shock, and subjected RT-PCR analysis to investigate the effect of HEK-
dnHSF1 on XBP1 splicing after heat stress. C) XBP1s levels in heat stressed cells. HEK-cDNA5 
cells were exposed to a heat shock of 30’ at 45oC or left at 37oC. When heat shocked, cells were 
allowed to recover for the indicated time before harvesting. To induce ER stress, cells were 
treated with 5 μg/ml tunicamycin for 90 minutes. After 5 hours recovery cells were harvested. 
Cell lysates were subjected to SDS-PAGE and levels of XBP1s were determined by western 
blotting with γ-tubulin as a loading control.
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Binding of HSF1 to the endogenous PMVK promoter
We used a ChIP assay to determine whether HSF1 binds in vivo to the 
PMVK HSE identifi ed above either in cells expressing dnHSF1 or in wild 
type cells. As a positive control we assayed HSF1 binding to the human 
DNAJB1 promoter. In wild type cells low but signifi cant binding of HSF1 to 
both the DNAB1 and the PMVK HSEs was detected (compare the signals 
obtained with either no antibody or an antibody against a transcription factor 
that does not bind). When the amount of DNA binding competent HSF1 was 
increased by expression of dnHSF1, an increase in occupancy by HSF1 was 
detected for both the DNAJB1 and PMVK HSEs. These results show that 
both endogenous HSF1 and overexpressed dnHSF1 bind the PMVK 5’UTR 
region in non-stressed cells (Fig. 4). 
PMVK expression is not increased in heat shocked cells
If active HSF1 can activate the PMVK promoter, then one would predict that 
the expression of PMVK is activated when HSF1 is activated, i.e. in cells ex-
periencing cytoplasmic proteotoxic stress. We thus measured PMVK mRNA 
and protein levels in cells that had recovered for either 6 or 24 hrs from a 
heat shock. No signifi cant change in PMVK mRNA levels was detected, 
while the PMVK protein levels decreased. In contrast, HSPA1A mRNA and 
protein levels did increase sharply upon heat shock (Fig. 5A, B). These 
results indicate that PMVK is not an HSF1 target during heat shock. 
HSF1 is not required for the transcriptional activation of PMVK promoter by 
sterol depletion.
It has been demonstrated previously that PMVK mRNA levels increase upon 
depletion of sterol by treatment with the HMG-CoA reductase inhibitor lovas-
tatin [19]. Moreover, HSF1 was shown to be involved in statin induced tran-
scriptional upregulation of endothelial thrombomodulin (TM). Statins were 
shown to cause NO-dependent dissociation of HSF1 from its chaperone 
complex followed by nuclear translocation of HSF1 with subsequent binding 
Figure 4   HSF1 binds the PMVK promoter 
region.
Chromatin immunoprecipitation was per-
formed using an anti-HSF1, or an anti-CEBP 
antibody as a negative control. Bound chro-
matin was analyzed by QPCR using a primer 
set surrounding the HSE of the DNAJB1 
promoter and one surrounding the predicted 
HSE of the PMVK 5’ UTR. As a control the 
ChIP was performed without an antibody. 
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Figure 5   Heat shock response of the PMVK gene.
A) Relative changes in PMVK and HSPA1A transcript levels in heat shocked HEK-cDNA5 cells. 
HEK-cDNA5 cells were exposed to a heat shock of 30’ at 45oC (HS) or left at 37oC (Control). 
When heat shocked, cells were allowed to recover for the indicated time before harvesting. 
Total RNA was isolated and transcript levels relative to GAPDH mRNA levels were measured by 
QPCR. Fold induction of mRNA levels is plotted relative to the transcript level in control cells. 
B) HSPA1A, PMVK and β-actin protein levels in HEK-cDNA5 heat stressed cells. HEK cells 
were exposed to a heat shock of 30’ at 45oC (HS) or left at 37oC (Control), when heat shocked, 
cells were allowed to recover for the indicated time before harvesting. Cell lysates were sub-
jected to SDS-PAGE and levels of HSPA1A and PMVK were determined by western blotting 
using β-actin as a loading control.
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to heat shock elements in the TM promoter [20]. Therefore we tested wheth-
er the lovastatin induced upregulation of PMVK promoter activity is HSF1 
dependent using the luciferase reporter construct driven by the PMVK pro-
moter (-1188, +142). Administration of lovastatin in the presence of charcoal 
stripped fetal bovine serum did not activate the PMVK promoter. The PMVK 
promoter activity did increase by about 50% in cells depleted of serum for 
24 hours and this effect was enhanced by 1 μM, but not by 10 μM, lovastatin 
(Fig. 6A). To determine whether HSF1 was involved in the increased activ-
ity of the PMVK promoter in serum depleted and lovastatin treated cells, we 
also assayed the effect of the various HSF1 mutants. HSF1-K80Q had no 
effect either in control or treated cells. In presence of dnHSF1or HSF448 
there was less PMVK promoter activity in untreated cells as expected from 
the results presented above (Fig. 3B) but the relative increase of the activ-
ity in treated cells remained the same (Fig. 6B). PMVK mRNA levels only 
increased 1.5 fold upon sterol depletion in the presence of lovastatin 
BA
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Figure 6   The effect of sterol depletion 
on PMVK levels.
A) Activation PMVK promoter by sterol 
depletion. HEK-cDNA5 were seeded in 
phenol red free medium supplemented 
10% fetal bovine serum charcoal stripped, 
100 U/ml penicillin, 100 μg/ml streptomy-
cin and GlutaMAX. Cells were transfected 
with a mixture of the indicated luciferase 
reporter and a β-actin-β-galactosidase 
reporter (9:1 ratio). At 24 hours after trans-
fection cells were exposed to lovastatin in 
the presence or absence of fetal bovine 
serum and at different concentrations for 
24 hours, then cells were harvested and 
assayed for reporter gene assay. Luci-
ferase activities shown are relative to that 
of SV40-Luciferase, which was set at one.
B) Effect of HSF1 mutants on the activa-
tion of the PMVK promoter by sterol 
depletion. HEK-cDNA5, HEK- dnHSF1, 
HEK-HSF448 or HEK-HSF1-K80Q cells 
were seeded in the presence or absence 
of doxycycline. Phenol red free medium 
supplemented 10% fetal bovine serum 
charcoal stripped, 100 U/ml penicillin, 
100 μg/ml streptomycin and GlutaMAX 
was used. Cells were transfected with a 
mixture of the indicated luciferase reporter 
and a β-actin-β-galactosidase reporter 
(9:1 ratio). At 24 hours after transfection 
cells were left untreated or exposed to 
1 μM Lovastatin in the absence of fetal 
bovine serum (SF) for 24 hours, then cells 
were harvested and assayed for reporter 
gene assay. Luciferase activities shown 
are relative to the luciferase activity in 
control cells, which was set at one.
C) PMVK trancript changes upon sterol 
depletion. HEK-cDNA5, HEK-dnHSF1 
or HEK-HSF1-K80Q cells were treated 
as described in the legend to Fig. 6B. 
Total RNA was isolated and transcript 
levels relative to GAPDH mRNA levels 
were measured by QPCR. Fold induction 
of mRNA levels is plotted relative to the 
transcript level in control cells.
A
C
B
Fo
ld
ch
an
ge
m
R
N
A
le
ve
ls
Co
ntr
ol
HS
F1-
K8
0Q
dn
HS
F1
0
1
2 Control
SF + 1 uM Lovastatin
PMVK (-1188, +142)
Co
ntr
ol
1 u
M L
ova
sta
tin
Se
rum
fre
e (S
F)
me
diu
m
SF
me
diu
m +
1 u
M L
ova
sta
tin
SF
me
diu
m +
10
uM
Lo
vas
tat
in
0
1
2
3
R
el
at
iv
e
lu
ci
fe
ra
se
ac
tiv
ity
PMVK (-1188, +142)
Co
ntr
ol
dn
HS
F1
HS
F44
8
HS
F1
WT
HS
F1-
K8
0Q
0
1
2
3 Control
SF + 1 uM Lovastatin
R
el
at
iv
e
lu
ci
fe
ra
se
ac
tiv
ity
B
A
The 5’-Untranslated Region of the human PMVK gene contains an HSF1 binding site
143
(Fig. 6C). Overexpression of dnHSF1 strongly reduced PMVK mRNA levels, 
while HSF1-K80Q had no effect on the increase in PMVK mRNA levels 
upon serum depletion in presence of lovastatin. Together these data show 
that HSF1 does not play a role in the upregulation of the PMVK promoter 
upon statin treatment, unlike the TM promoter. It must be noted, however, 
that sterol depletion by lovastatin treatment in the absence of serum did not 
result in HSF1 phosphorylation or translocation to the nucleus in our experi-
mental setup (data not shown). 
Discussion
Expression of a dominant negative transcription factor is a standard way of 
showing that the factor plays a role in the transcriptional regulation of a par-
ticular gene. In the case of HSF1 we identifi ed a number of genes of which 
the transcript level was decreased by dnHSF1 expression and which were 
not otherwise known as HSF1 target genes [9]. Here we have taken a closer 
look at one of these genes, the PMVK gene. We show that the PMVK gene 
has an HSE but that this HSE is not located as usual in the proximal up-
stream promoter region but downstream of the promoter in the region encod-
ing the 5’UTR. Possibly this difference in location explains why the HSF448 
mutant that is a weak dominant positive when tested on canonical HSF1 tar-
get genes such as HSPA1A inhibits the PMVK promoter. Although the PMVK 
promoter can be activated by HSF1 as shown by the increase in expression 
in the presence of exogenous dominant positive HSF1 mutant, we could not 
fi nd conditions under which endogenous HSF1 regulated transcription of the 
PMVK gene. The PMVK mRNA levels do not change in heat shocked cells. 
They do increase somewhat when cells are serum depleted and treated with 
lovastatin but this increase is HSF1 independent. The PMVK gene is also a 
target of the androgen receptor [21] and a possible link between the andro-
gen receptor and HSF1 is their common interaction with CHIP [22]. CHIP 
activates HSF1 and confers protection against apoptosis and cellular stress 
[23]. Unfortunately HEK293 cells lack the androgen receptor. At present time 
the PMVK HSE remains in search of a function.
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Supplemental tables and figures
Figure S1 Changes in PMVK protein 
levels in presence of dnHSF1.
A) HEK-cDNA5 and HEK-dnHSF1 cells were 
cultered in presence of doxycycline for the 
indicated periods of time. Cell lysates were 
subjected to SDS-PAGE and levels of PMVK 
were determined by western blotting with 
β-actin as a loading control.
B) The activity of the dmHsp70 reporter con-
struct is dpHSF1 or dnHSF1 sensitive. HEK-
cDNA5 cells were transfected with a mixture 
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of the dmHsp70 luciferase reporter, pcDNA5-dpHSF1 or an empty vector and a β-actin-β-
galactosidase reporter (7:2:1 ratio). Doxycycline was added 24 hours after transfection and cells 
were harvested and assayed for reporter gene activities at 48 hours after transfection. HEK-
dnHSF1 cells were seeded with or without doxycycline. After 24 hours HEK-dnHSF1 cells were 
transfected with a mixture of the indicated luciferase reporter and a β-actin-β-galactosidase 
reporter (9:1 ratio). At 48 hours after transfection, cells were harvested and assayed for reporter 
gene activities. Luciferase activities shown are relative to the luciferase activity in control cells, 
which was set at one.
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A schematic representation of the HSF1 expression constructs used in this study.
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Abstract
The heat shock response is mainly regulated at the level of transcription by 
heat shock factor 1 (HSF1). In aging cells HSF1 loses its activity and this 
failure of HSF1 would interfere with an organism’s ability to combat pro-
teotoxic stress and increase the susceptibility to protein folding diseases. 
To assess the consequences of inactivation of HSF1 in non-stressed and 
stressed cells, we used Flp-In T-REx-293 cells with tet inducible expression 
of an HSF1 mutant which is unable to bind DNA (HSF1-K80Q). Exogenous 
expression of HSF1-K80Q inhibited binding of endogenous HSF1 to the 
promoter regions of target genes, during non-stress and stress conditions. 
Microarray and QPCR analysis showed, as expected, that the activation of 
the known HSF1 sensitive promoters by heat stress was strongly inhibited 
by HSF1-K80Q expression. These experiments also identifi ed 17 genes of 
which the transcript levels were decreased in non-stressed cells by HSF1-
K80Q, while the transcript levels of 11 genes were higher in the presence 
of HSF1-K80Q. For 308 genes the transcript levels changed more than 2 
fold in heat shocked cells: for 124 genes the transcript levels decreased, 
while for 184 the levels went up. Of these 184, only 30 were 2-fold or more 
inhibited by HSF1-K80Q expression and thus HSF1 dependent. HSF1-K80Q 
inhibited recovery from heat shock and some stress induced transcripts re-
mained high in cells allowed to recover from heat shock for 24 hrs. Surpris-
ingly, HSPA1A and HSPA6 mRNA levels were increased 24 hrs after heat 
shock in cells expressing HSF1-K80Q, while, as expected, the mRNA levels 
were not increased after 6 hrs of recovery. Apparently there is a second 
wave of stress induced transcription, which does not require HSF1.
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Introduction
Cells respond to cytoplasmic proteotoxic stress by producing heat shock 
proteins (HSP). This response is called the heat shock response (HSR) 
and is known as an important mechanism of protection against cytoplasmic 
proteotoxic stress. The heat shock response is mainly regulated at the level 
of transcription by heat shock factor 1 (HSF1). The trimeric and transcription-
ally active form of HSF1 possesses an increased affi nity for the heat shock 
element (HSE) [1]. During aging, the activity of HSF1 declines. The protein is 
still present but can somehow no longer be activated. This aging-related fail-
ure of HSF1 interferes with an organism’s ability to combat proteotoxic stress 
which results in increased susceptibility to protein folding diseases [2-7]. 
Furthermore, with accumulating evidence showing that HSF1 also regulates 
gene expression under non-stress conditions, a decline in HSF1 activity may 
already cause phenotypic defects in the absence of exogenous stress [8]. 
Previously we have used an HSF1 mutant retaining the DNA binding domain 
but lacking the activation domain (dnHSF1) to inhibit HSF1 activity in non-
stressed cells [9]. Expression of dnHSF1 reduced the expression level of 
only 10 genes more than two-fold and did not increase the expression level 
of any gene more than two-fold. In contrast, HeLa cells treated with siRNA 
directed against HSF1 showed changed expression levels of 378 genes in 
the absence of stress [10] where 80% of the affected genes showed in-
creased transcript levels. A comparison of the transcriptome of MEF 
HSF1 -/- with that of MEF WT cells resulted in 49 genes (19 related to 
immune response) that were expressed at reduced levels in MEF HSF1 -/- 
cells [11]. HSF1 thus seems to act as a repressor of transcription in the case 
of HeLa cells and the loss of HSF1 releases repression while expression 
of dnHSF1, which remains bound to the DNA, might maintain it. The differ-
ence between depleting HSF1 and expressing a dominant negative mutant 
may also be partly due to a secondary effect: depletion of HSF1 would free 
the chaperones which are usually complexed with HSF1 while dnHSF1 
might capture more chaperones. Another difference is the involvement of 
HSF2. Recently it has been postulated that HSF2 also plays a role in the 
proteotoxic stress response and is recruited to HSF1 responsive promoters 
as a heteromer with HSF1. HSF1 is the main regulator of the heat shock 
response, but HSF2 binds to the promoters of HSF1 target genes as well. 
HSF2 only binds in the presence of HSF1 and an intact DNA binding domain 
of HSF1 is required [12]. 
The aging cell differs from the HSF1-/- cells in that the cell still contains 
HSF1, although not active, and differs from the dnHSF1 cells in that HSF1 
is no longer bound to its target promoters. We have started to build a model 
system that is a closer mimic of the aging cell, i.e. a cell that still expresses 
HSF1, but in an inactive form. To that end we made an HSF1 mutant in 
which lysine 80 in the DNA binding region is replaced by glutamine (HSF1-
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Materials and Methods
K80Q), thus impairing DNA binding [13]. The HSF1-K80Q expression con-
struct was used to make a stable Flp-In T-REx-293 cell line with tet inducible 
expression of HSF1-K80Q. 
We show here that overexpression of HSF1-K80Q inhibited binding of HSF1 
to its target promoter regions, during non-stress and stress conditions. 
Microarray analysis identifi ed 29 genes of which the transcript level was af-
fected by HSF1-K80Q expression in non-stressed cells; for 17 the transcript 
levels decreased, while for 11 the transcript levels increased. As expected, 
expression of HSF1-K80Q blocked the heat shock induced increase in tran-
script levels of known HSF1 dependent genes. However, most of the stress 
induced changes in the transcriptome were HSF1 independent. 
Surprisingly, we noticed that the HSPA1A and HSPA6 mRNA levels were 
increased after 24 hrs recovery from a heat shock in the HSF1-K80Q 
expressing cells, while, as expected, they were not increased after 6 hrs of 
recovery. Apparently there is a second wave of stress induced transcription, 
which does not require HSF1. 
Cell culture
Flp-In T-REx-293 cells (Invitrogen) were manipulated according to the 
manufacturer’s instructions using the T-REx system (Invitrogen) to generate 
the stable cell lines HEK-dnHSF1, HEK-HSF1-K80Q, HEK-HSF1-WT and 
HEK-cDNA5 that carry a single copy of the tetracycline-inducible plasmids 
pcDNA5-dnHSF1, pcDNA5- HSF1-K80Q, pcDNA5-HSF1 WT and pcDNA5-
FRT/TO, respectively. The cells were cultured at 37oC in the presence of 
humifi ed 5% CO2 in high glucose DMEM medium supplemented with 10% 
fetal calf serum and 100 U/ml penicillin and 100 μg/ml streptomycin. Blasti-
cidin (1.65 μg/ml; Invitrogen) and 100 μg/ml hygromycin were also added to 
the culture medium during maintenance of the cell lines, but were omitted 
during experiments.
Plasmid Construction, transfections and reporter gene assays
The dnHSF1 expression vector and the dmHSP70 and HSP70A1A reporter 
constructs have been described earlier [9]. The pcDNA5-HSF1 silent muta-
tion (HSF1 WT) and the pcDNA5-HSF1-K80Q mutant were made by per-
forming site-directed mutagenesis on pcDNA5-HSF1 with respectively the 
HSF1 sil.mut and the HSF1-K80Q primers, listed in Supplemental Table 1.
Transient transfections were performed using FuGENE-6 (Roche) accord-
ing to the manufacturer’s instructions. Cells were seeded on 24-well plates 
and on the next day transfected with 0.2 μg plasmid per well. 20 ng CMV-β-
galactosidase was used as a transfection effi ciency control. At 24 hours after 
transfection doxycyclin was added. At 48 hours after transfection cells were 
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harvested or exposed to heat shock (30’ 45oC). 
Cells were harvested and lysed in 200 μl reporter lysis mix (25 mM Bicine, 
0.05% Tween 20, 0.05% Tween 80) for 10 min. For the β-galactosidase 
assay, 20 μl cell lysate was mixed with 100 μl Galacton solution (100 mM 
Na-phosphate pH 8.2, 10 mM MgCl2, 1% Galacton-Plus; Tropix). After 30 
minutes incubation at room temperature, 150 μl accelerator II (Tropix) was 
added and luminescence was measured with the Lumat LB 9507 tube lumi-
nometer (Berthold). For the luciferase assay, 20 μl cell lysate was mixed with 
50 μl luciferin solution (Promega) and luminescence was measured with the 
Lumat luminometer. All reporter gene assays were performed in triplicate. 
Relative activities of luciferase reporter genes were determined by dividing 
luciferase values by the corresponding β-galactosidase values to correct for 
varying transfection effi ciencies.
Western blot analysis
Cell pellets were homogenized in buffer containing 50 mM Tris–HCl pH 7.5, 
150 mM NaCl, 1% Triton X-100, 100 mM NaF, 20 mM Na4P2O7, 1 mM PMSF 
and protease inhibitors (Complete Mini; Roche). Then 4x sample buffer 
(200 mM Tris–HCl 6.8, 20% β-mercaptoethanol, 8% SDS, 40% glycerol 
and 0.4% Bromophenolblue) was added and the lysates were incubated 
at 95oC for 5 min. Protein samples were separated in 10% polyacrylamide 
gels and transferred to nitrocellulose transfer membrane (Protran) using a 
Bio-Rad Mini-PROTEAN II Electrophoresis cell according to the manufac-
turer’s instructions. For western blot analysis, polyclonal HSF1 antibody 
(SPA-901; Stressgen) was used at a 1:1,000 dilution, monoclonal HSP90 
antibody (610418, BD Biosciences) at a 1:1,000 dilution, polyclonal HSPB1 
antibody, obtained from Dr. A. Zantema, at a dilution of 1:400, monoclonal 
HSPA1A antibody 4G4 (ab5444; Abcam) was used at a 1:5,000 dilution, and 
monoclonal β-actin antibody (AC-15, Sigma-Aldrich) at a dilution of 1:5,000. 
Blots were incubated with fl uorescent secondary antibodies IRDye® 800 CW 
conjugated goat (polyclonal) Anti-Rabbit IgG and IRDye® 800CW conju-
gated goat (polyclonal) Anti-Mouse IgG. (926-32211 and 926-32210, respec-
tively; LI-COR Biosciences) according to the manufacturer’s instructions and 
scanned using a LI-COR Odyssey infrared scanner. Signals were quantifi ed 
using Odyssey version 2.1 software.
QPCR analysis
Cells were harvested after the treatments and at the times indicated, washed 
twice with ice-cold PBS and after washing the cells, RNA was isolated with 
TRIzol (Invitrogen) according to manufacturer’s recommendation. 1 μg 
of RNA was treated with DNaseI (Amplifi cation grade; RNase-free; Invit-
rogen). Subsequently, 5 mM MgCl2, RT-buffer, 1 mM dNTPs, 18.75 units 
AMV reverse transcriptase, 20 units RNase inhibitors and 1.25 μM oligo(dT) 
were added to a total volume of 20 μl. Reverse transcription was performed 
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for 10 minutes at 25°C, 60 minutes at 42°C and 5 minutes at 95°C. For 
QPCR analysis, cDNA was 10-fold diluted. Quantitative real-time PCR was 
performed using the StepOnePlus™ Real-Time PCR System with Power 
SYBR® Green PCR Master mix (Applied Biosystems) using the following 
amplifi cation protocol: 2 minutes at 50°C followed by 40 cycles of 15 sec-
onds at 95°C and 1 minute at 60°C. Per reaction 3 μl of diluted cDNA was 
used and the DNA was amplifi ed using primers for the sequences of interest, 
listed in Supplemental Table 1. 
Chromatin Immunoprecipitation
HEK-XBP1s or HEK-cDNA5 cells were cultured for 24 h in the presence of 
doxycycline. Chromatin immunoprecipitation was performed as described in 
[14] except that cells were crosslinked for 15 minutes with 1% formaldehyde. 
After quenching with 125 mM glycine, cells were washed twice with ice cold 
PBS and resuspended in ice cold lysis buffer (50 mM HEPES-KOH pH 7.6, 
140 mM NaCl, 1mM EDTA pH 8.0, 1% (v/v) Triton X-100, 0.1% NaDOC and 
1X protease inhibitor complete). Sonicated chromatin was centrifuged for 5 
min at 4°C and then incubated overnight in incubation buffer (fi nal concen-
tration; 12 mM HEPES-KOH pH 7.6, 90 mM NaCl, 0.6 mM EDTA pH. 8.0, 
0.09% SDS, 0.6% Triton X-100, 0.1% BSA) together with purifi ed anti-HSF1 
antibody (SPA-901; Stressgen) and protein A/G beads (Santa Cruz Bio-
technology). Negative control without adding antibody was included. Beads 
were washed six times with different buffers at 4°C: twice with 0.1% SDS, 
0.1% NaDOC, 1% Triton X-100, 150 mM NaCl, HEG (1 mM EDTA, 0.5 mM 
EGTA and 20 mM HEPES-KOH pH 7.6), once with the same buffer but with 
500 mM NaCl, once with 0.25 M LiCl, 0.5% NaDOC, 0.5% NP-40, HEG and 
twice with HEG. Precipitated chromatin was eluted with 400 μl of elution 
buffer (1% SDS, 0.1 M NaHCO3), incubated at 65°C for 4 h in the presence 
of 200 mM NaCl, phenol extracted and precipitated with 20 μg of glycogen 
at -20°C overnight. ChIP experiments were analyzed by qPCR. Effi ciency of 
ChIP was calculated as percentage of input. The primers used are listed in 
Supplemental Table 1.
EMSA
HEK-HSF1-K80Q or HEK-HSF1 WT cells were cultured for 24 h in the 
presence or absence of doxycycline and subsequently heat shocked for 30 
minutes at 45°C. Cells were immediately harvested and nuclear extracts 
were prepared using NE-per nuclear and cytoplasmic reagents (Pierce). 
Extracts were aliquoted and stored at -80°C. Oligonucleotide probes were 
end-labeled with 32P. The sequences of the HSE oligonucleotides used in 
EMSA are listed in Supplemental Table 1. The EMSA protocol was adapted 
from [15, 16]. A mixture containing 5 μg nuclear extract and 3 μg poly dIdC in 
binding buffer (20 mM HEPES pH 7.9, 100 mM KCl, 1 mM EDTA, 1 mM DTT, 
4% (v/v) Ficoll, 1X PhosSTOP (Roche)) was incubated for 20 minutes on ice. 
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Results and Discussion
Characterization HEK- HSF- K80Q cell line
In the HSF1-K80Q mutant lysine 80 in the DNA binding region is replaced 
by glutamine and because of this mutation HSF1 loses its binding activity 
[9, 13]. Exogenously expressed HSF1-K80Q is expected to trimerize with 
endogenous HSF1, resulting in a strong reduction of binding competent 
HSF1 trimers. We tested whether this indeed happens. Only a weak signal 
of HSF1 binding to the HSE was detected using nuclear extracts of either 
unstressed or heat shocked cells expressing HSF1-K80Q. Using nuclear 
extracts from cells overexpressing wild type HSF1 (HSF1 WT) did result, as 
expected, in increased binding of HSF1 to the HSE even when cells were 
unstressed (Fig. 1A). The bandshift shown in fi gure 1A could be supershifted 
by an antibody to HSF1, indicating that it is indeed HSF1 that was bound 
(data not shown). Extracts from heat shocked cells showed a more intense 
bandshift signal and thus an increase in binding competent HSF1. Expres-
sion of HSF1-K80Q blocked this increase. The loss of binding of HSF1 to 
the HSE in the presence of HSF1-K80Q was confi rmed by chromatin immu-
noprecipitation (ChIP) (Fig. 1B). In control cells, i.e. HEK-HSF1-K80Q cells 
cultured in the absence of doxycycline, HSF1 was bound to the HSPA1A or 
HSPA6 promoter region 2 hours after heat shock. The binding of HSF1 is 
transient and as expected we did not observe HSF1 binding 18 hours after 
heat stress. When HSF1-K80Q expression was induced, no bound HSF1 
could be detected either 2 hours or 18 hrs after heat shock. 
0.01 pmol radiolabeled oligonucleotide was added and again the samples 
were incubated for 20 minutes on ice. DNA-protein complexes were sepa-
rated on a pre-run 4% polyacrylamide gel in 0.25x TBE with recirculation of 
the buffer. The gel was dried and signals were visualized using a Phosphor 
Imager.
Microarray analysis
HEK-pcDNA cells and HEK-HSF1-K80Q cells were treated with doxycyclin 
for 48 hours. The transcriptomes of HEK-pcDNA cells and HEK-HSF1-K80Q 
cells, HEK-HSF1-K80Q 6h after heat shock versus unstressed HEK-HSF1-
K80Q cells or HEK-pcDNA5 6h after heat shock versus unstressed HEK-
pcDNA5 cells were compared. Total RNA was isolated using Trizol according 
to the manufacturer’s instructions (Invitrogen) and copied into Cy3-labeled 
or Cy5-labeled cRNA using the Agilent Low RNA Input Linear Amp Kit PLUS, 
and reverse labeled for the repeat array. Labeled cRNA samples were hy-
bridized to an Agilent Whole Human Genome Microarray Kit (4 x 44K). The 
arrays were scanned using an Agilent Microarray Scanner. Image analysis 
and feature extraction were done with Feature Extraction (version 9.5.1, Agi-
lent). We used a cut-off level of 2-fold changed expression and an arbitrarily 
chosen signal cut-off of > 50.
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Figure 1   Characterization of HEK-HSF1-K80Q cells.
A) Nuclear extracts were made of HEK-HSF1 WT cells and HEK-HSF1 K80Q cells either 
non-stressed (-HS) or exposed to heat shock (30’ 45oC, +HS). An electrophoretic mobility shift 
assay (EMSA) was performed with a ds oligo for the HSE sequence. Where indicated (+ Dox), 
doxycyclin was added to induce expression of either HSF1 WT or HSF1-K80Q.
B) Chromatin immunoprecipitation (ChIP) using nuclear extracts from control and HSF1 K80Q 
expressing cells was performed with an HSF1 antibody or no antibody added. Bound chroma-
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To confi rm that expression of HSF1-K80Q inhibits HSF1 driven promoters, 
we used a luciferase reporter constructs driven by the D. melanogaster 
Hsp70 promoter. The heat shock-mediated induction of D. melanogaster 
Hsp70 promoter activity was almost completely abolished by expression of 
HSF1-K80Q (Fig.1C). Similarly, the heat shock-mediated increase of human 
HSPA1A mRNA six hours after heat shock was abolished by HSF1-K80Q 
(Fig. 1D). The increase in endogenous HSPA1A, HSP90AA1 and HSPB1 
protein levels after heat shock was also completely inhibited in the presence 
of HSF1-K80Q (Fig 1E), just as it was by dnHSF1. Together these data show 
that HSF1-K80Q acts as a dominant negative mutant and blocks the HSF1 
directed transcriptional heat shock response.
Transcriptome changes in the presence of HSF1-K80Q
If HSF1 plays a role in the absence of stress, then expression of a non DNA 
binding mutant could change the transcriptome. We used microarrays to 
analyze the effect of expression of HSF1-K80Q on the transcriptome in the 
absence of stress. As overexpression of the HSF1 protein may have second-
ary effects, for example by sequestering chaperones, we also looked at the 
effect of overexpressing wild type HSF1on the transcriptome of non-stressed 
cells. Table 1 shows the list of the 28 genes of which the transcripts level 
changed at least two fold upon expression of HSF1-K80Q in non-stressed 
cells but of which the level was not signifi cantly affected by expression of 
wild type HSF1 (see also Supplemental Table 2). For 17 genes we noted a 
decrease in transcript level, of these, 2, LY6K and VCX2, had an increased 
transcript level in heat shocked cells. None of the 11 genes of which the tran-
tin was analyzed by QPCR using a primer set surrounding the HSE of the HSPA6 or HSPA1A 
promoter. Cells were either non-stressed or harvested 2 hrs or 18 hrs after heat shock, as 
indicated.
C) The effect of HSF1-K80Q overexpresison on basal and heat shock-induced activity of the 
Drosophila melanogaster Hsp70 promoter. HEK293 cells carrying a stably integrated copy 
HSF1-K80Q or an empty vector were cultured in the presence of doxycycline. Cells were trans-
fected with a mixture of the Drosophila melanogaster Hsp70-luciferase reporter and pCMV-β-
galactosidase. At 48 hours after transfection, cells were exposed to a heat shock of 30’ at 45oC 
(HS) or left at 37oC (Control). When heat shocked, cells were allowed to recover for 6 hours and 
harvested. Hsp70 promoter activities were determined by dividing fi refl y luciferase values by 
β-galactosidase values to correct for varying transfection effi ciencies. The results are the aver-
age of four independent transfections (standard deviations are indicated by error bars).
D) HSF1-K80Q blocks the heat shock induced increase in HSPA1A transcript. HEK-HSF1-K80Q 
cells were exposed to a heat shock of 30’ at 45oC (HS) or left at 37oC (Control). When heat 
shocked, cells were allowed to recover for the indicated time before harvesting. Total RNA was 
isolated and transcript levels relative to GAPDH mRNA levels were measured by QPCR. The 
fold induction of mRNA levels is plotted relative to the level in non-stressed control cells.
E) HSF1-K80Q blocks the heat shock induced increase in HSPA1A and HSPB1. HEK-pcDNA, 
HEKdnHSF1 or HEK-HSF1-K80Q cells were cultured in the presence or absence of doxycycline 
and exposed to a heat shock of 30’ at 45oC or left at 37oC (C). When heat shocked, cells were 
allowed to recover for the indicated time before harvesting. Cell lysates were subjected to SDS-
PAGE and levels of HSF1, HSP90, HSPA1A, and HSPB1 were determined by western blotting. 
β-actin was used as a loading control.
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Figure 2   Relative changes in transcript levels of various genes in stressed and non-stressed 
HEK-HSF1-K80Q cells.
(A-C) HEK-HSF1-K80Q cells were cultured in the presence (HSF1-K80Q) or absence of 
doxycycline (Control) and exposed to a heat shock of 30’ at 45oC (HS) or left at 37oC (Control). 
When heat shocked, cells were allowed to recover for the indicated time before harvesting. 
Total RNA was isolated and transcript levels relative to GAPDH mRNA levels were measured by 
QPCR. The fold induction of mRNA levels is plotted relative to the level in non-stressed control 
cells.
script levels increased in non-stressed HSF1-K80Q cells, were heat shock 
responsive. The increase in the level of the transcript of the PCK2 gene, 
which encodes mitochondrial phosphoenolpyruvate carboxykinase 2, was 
confi rmed by QPCR (Fig. 2A). 
Down Up
Gene name Acc. Nr. Gene name Acc. Nr.
BFSP1
C20orf201
CGA
CRLF1
FERMT1
KRT222
LOC100292909
LY6K
NPTX2
PLEKHG4
PPAPDC1A
RAI2
SLC16A5
SYTL5
UBE2C
VCX2
ZNF334
NM_001195
NM_001007125
NM_000735
NM_004750
NM_017671
NM_152349
XM_002345507
NM_017527
NM_002523
NM_015432
NM_001030059
NM_021785
NM_004695
NM_001163335
NM_181803
NM_016378
NM_199441
ASNS
CTH
JUB
NUPR1
PCK2
RNF125
SEPP1
SLC7A11
STC2
TPK1
WDR13
NM_001673
NM_001902
NM_032876
NM_0010424
NM_004563
NM_017831
NM_005410
NM_014331
NM_003714
NM_022445
NM_017883
Table 1  Genes of which the transcript level changes at least 2-fold in non-stressed HSF1-     
  K80Q cells.
The classical role of HSF1 is transcription activation in heat stressed cells. In 
HEK293 cells allowed to recover from a heat shock for 6 hrs, we found in an 
increase of at least two fold in the transcript levels of 184 genes (see below). 
Expression of HSF1-K80Q inhibited the increase in transcript level of 30 of 
these genes by at least two fold (Table 2, Supplemental Table 3). Amongst 
these genes are the canonical HSF1 target genes, such as HSPA1A/B, 
HSPA6, DNAJB1, HSPH1, HSP90AA1, BAG3 but also ATF3 (we also in-
cluded HSPB1 and SERPINH1 in this class even though they failed to meet 
the arbitrary 2-fold cut-off). We confi rmed the inhibitory effect of the expres-
sion of HSF1-K80Q on the increase in transcript levels of these genes (Fig. 
2B). Curiously, according to the QPCR data, but not the microarray data, the 
transcript levels of the ATF3 and HSPB1 genes were higher in non-stressed 
cells expressing HSF1-K80Q.
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Figure 3   Relative changes in transcript levels of various genes in stressed and non-stressed 
HEK-dnHSF1 cells.
(A-B) HEK-dnHSF1 cultured in the presence (dnHSF1) or absence of doxycycline (Control) cells 
were exposed to a heat shock of 30’ at 45oC (HS) or left at 37oC (Control). When heat shocked, 
cells were allowed to recover for the indicated time before harvesting. Total RNA was isolated 
and transcript levels relative to GAPDH mRNA levels were measured by QPCR. The fold induc-
tion of mRNA levels is plotted relative to the level in non-stressed control cells.
Down Up
Gene name Acc. Nr. Gene name Acc. Nr.
ATF3
BAG3
BU532663 (SNORD3D)
C17orf67
C22orf43
CACYBP
CCDC121
CRYAB
DEDD2
DHDH
DNAJB1
DNAJB4
DUSP1
HSP90AA1
HSPA1A
NM_001674 
NM_004281
BU532663
ENST00000397861
NM_016449
NM_014412
NM_024584
NM_001885
NM_133328
NM_014475
NM_006145
NM_007034
NM_004417
NM_005348
NM_005345
HSPA6
HSPB1*
HSPH1
JUN
LOC100130288
LOC100133337
LOC387763
MRPL18
NXT2
SERPINH1*
UBB
UBC
USP51
USPL1
ZFAND2A
NM_002155
NM_001540
NM_006644
NM_002228
BC043212
XM_002343495
NM_001145033
NM_014161
NM_018698
NM_001235
NM_018955
NM_021009
NM_201286
NM_005800
NM_182491
*did not quite meet the 2-fold cut-off
Table 2  Genes of which the increase in transcript level in heat stressed cells was inhibited at  
  least 2-fold by HSF1-K80Q.
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The expression of HSF1 dependent chaperones serves as a feedback 
mechanism to dampen the heat shock response [17]. As in the HSF1-K80Q 
expressing cells the expression of these chaperones is inhibited, we tested 
whether expression of HSF1-K80Q also affects recovery from a heat shock 
as assessed by the level of transcripts of heat shock activated genes in cells 
that were allowed to recover for 24 hrs from the heat shock. Of some HSF1 
target genes (for example HSPA1A, HSPA6, ATF3) the transcript levels 
were higher in HSF1-K80Q cells than in control cells, while for other HSF1 
target genes (for example HSPA1B, DNAJB1) the transcript levels were not 
signifi cantly different between wild type and HSF1-K80Q expressing cells 
(Fig. 2B).  
Most of the transcriptome changes in heat shocked cells were HSF1 inde-
pendent, that is the change was not inhibited but sometimes even enhanced 
by the expression of HSF1-K80Q (Supplemental Table 3). We confi rmed 
the changes in RGS2 (regulator of G-protein signaling 2), GADD34 (PP-
P1R15A), GADD45B, HSPA2 and SGK1 (serum/glucocorticoid regulated 
kinase 1) transcript levels. The transcript levels of the HSPA2 and SGK1 
genes were higher in HSF1-K80Q expressing cells 6 hrs after heat shock, 
that of the GADD34 gene was equal and those of the RGS2 and GADD45B 
genes were lower, but the extent of inhibition by HSF1-K80Q was far less 
than for the canonical HSF1 target genes. In all cases the transcript levels 
were much higher in HSF1-K80Q expressing cell than in control cells 24 hrs 
after heat shock (Fig. 2C). 
 The persistence of stress induced transcripts in HSF1-K80Q cells is 
a sign that HSF1-K80Q, as expected, recuperate more slowly from stress. 
The increase in transcript levels of canonical heat shock genes in HSF1-
K80Q cells 24 hrs after heat shock (Fig. 2B) is rather unexpected, as HSF1-
K80Q should block HSF1 dependent transcriptional activation. We therefore 
tested whether the increase in the level of some of the canonical HSF1 
targets 24 hrs after heat shock is also seen in cells expressing dnHSF1. 
As shown in Fig. 3, this is indeed the case: in the presence of dnHSF1 the 
HSPA1A and BAG3 transcript levels were signifi cantly higher 24 hrs after 
heat shock. The levels of the DNAJB1 and the HSPH1 transcripts did not 
show this 24 hr response in dnHSF1 expressing cells, just as they did not 
in HSF1-K80Q expressing cells. Similarly, the levels of the non-HSF1 target 
genes, GADD34 and GADD45B, did not decrease in dnHSF1 expressing 
cells. Hence, the response of at least these genes is the same in dnHSF1 
and HSF1-K80Q expressing cells.
 These data indicate that the activity of some transcriptions factors, 
which normally decays after heat shock, is maintained when HSF1 activity is 
blocked. One possibility is that the level of endogenous HSF1 is increased in 
cells recovering from heat shock, which would decrease the effi cacy of the 
dnHSF1 and HSF1-K80Q mutants. However, no change in the endogenous 
level of HSF1 in dnHSF1 expressing cells could be detected (Fig. 1E; note 
that the endogenous HSF1 and the HSF1-K80Q cannot be distinguished on 
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Figure 4   ATF4 protein levels do not change in presence of HSF1 mutants.
HEK-cDNA5, HEK-dnHSF1 and HEK-HSF1-K80Q cells were cultured in the presence or ab-
sence of doxycycline and exposed to a heat shock of 30’ at 45oC or left at 37oC (C). When heat 
shocked, cells were allowed to recover for the indicated time before harvesting. Cell lysates 
were subjected to SDS-PAGE and levels of ATF4 were determined by western blotting. β-actin 
was used as a loading control.
SDS PAGE). The GADD34 gene is a target of ATF4 [18] and we thus tested 
whether the level of ATF4 was affected by expression of either dnHSF1 or 
HSF1-K80Q. As shown in Fig. 4, it was not. At this moment we do not know 
which transcription factors are responsible for this second wave of stress 
induced transcription. The activity of the HSPA1A promoter has been report-
ed to rely also on NF-Y which interacts with CCAATTG box [19-21]. We are 
presently testing whether NF-Y is also required for the increased transcript 
levels of HSF1 target genes in HSF1-K80Q or dnHSF1 expressing cells.
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Up Down
Non-stressed, 28 changed
HEK-HSF1-K80Q 11 17
6h heat shock, 308 changed
HEK-pcDNA 184 (30 inhibited by HSF1-K80Q) 124
Table 3A  Transcriptome changes in HSF1-K80Q HEK293 cells.
Comparison of transcriptome changes in the presence of HSF1-K80Q or 
siRNA HSF1
As outlined in the introduction, a lack of HSF1, due to expression of siRNA 
against HSF1, may have a different effect than expression of a non-DNA 
binding HSF1 mutant. We therefore compared our microarray data with 
those in the literature using siRNA against HSF1 in HeLa cells [10] (Table 
3B). For the 17 out of the 28 genes of which the transcripts levels were 
changed in non-stressed HSF1-K80Q expressing cells, we could fi nd data 
in the HSF1 siRNA treated HeLa cells (Supplemental Table 4A). For 16 
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Gene name Up Down No change
non-stressed, out of 28 changed in HEK293, 17 also on HeLa array
Up in HEK293 array & also on HeLa siRNA array 0 0 8
Down in HEK293 array & also on HeLa siRNA array 0 1 (CRLF1) 8
6 h heat shock, out of 308 changed in HEK293, 163 also on HeLa array
Up in HEK293 array & also on HeLa siRNA array 18* 3 98
inhibited both K80Q and siRNA 7
inhibited siRNA only 3
inhibited K80Q only 4
inhibited neither K80Q nor siRNA 4
Down in HEK293 array & also on HeLa siRNA array 0 1 (ZNF264) 43
inhibited neither K80Q nor siRNA 1 (ZNF264)
*The HSF1 target genes HSPA1A, HSPB1 and SERPINH1 were included even though they did not 
meet the cut-off.
In bold and italic: Overlap HeLa and HEK293 array
Table 3B  Comparison of the transcriptome changes in HSF1-K80Q HEK293 and siHSF1  
    HeLa cells.
of these the transcript levels were not signifi cantly affected by the siRNA 
treatment; one (CRLF1, cytokine receptor-like factor 1) was downregulated 
as it was in HEK HSF1 K80Q cells. When we compared the data for heat 
shocked Hela and HEK293 cells we found only 19 genes that were heat 
shock responsive in both HeLa and HEK293 cells (note that the exact heat 
shock conditions do differ). Of these, one gene (ZNF264) had a lower tran-
script level. This regulation appeared to be independent of HSF1 activity. Of 
the 18 genes of which the transcript levels increased in both heat shocked 
HeLa and HEK293 cells, 7 were clearly HSF1 dependent, the activity of 3 
was inhibited signifi cantly only by HSF1 siRNA, that of 4 only by HSF1-K80Q 
and 4 appeared to be not regulated by HSF1 (Table 3B, C and fi gure 5; Sup-
plemental Table 4B). 
There is almost no overlap between the genes of which the transcript level 
changed signifi cantly in non-stressed cells upon siRNA HSF1 treatment or 
upon overexpression of HSF1- K80Q. Either the genes controlled by HSF1 
in the non-stressed state are largely cell specifi c or the effect of deleting 
HSF1 from a cell is signifi cantly different from blocking HSF1 activity by 
overexpression of a non-DNA binding HSF1 mutant. To distinguish between 
these possibilities the comparison must be made using the same cells. The 
HSF1 dependent stress response is much less cell specifi c: most of these 
genes are the traditional HSF1 target genes such as DNAJB1. Curiously, 
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Table 3C  Genes of which the transcripts are heat shock induced in both HEK293 and HeLa  
    cells.
Gene name Acc. Nr. Gene name Acc. Nr.
inhibited both K80Q and siRNA inhibited K80Q only
BAG3
CRYAB
DNAJB1
HSPA6
HSPB1
HSPH1
SERPINH1
NM_004281
NM_001885
NM_006145
NM_002155
NM_001540
NM_006644
NM_001235
ATF3
CYR61
HSPA1A
JUN
NM_001674 
NM_001554
NM_005345
NM_002228
inhibited siRNA only inhibited neither K80Q nor siRNA
ADM
RGS2
TXNIP
NM_001124
NM_002923
NM_006472
DUSP5
GADD45B
PPP1R15A
TUFT1
NM_004419
NM_015675
NM_014330
NM_020127
inhibited by 
siHSF1 Inhibited by 
HSF1-K80Q
73 4
18
Heat shock upregulated in HEK293 and HeLa cells
Figure 5   Schematic view of the 
heat shock induced transcriptome 
changes common to HEK293-
HSF1-K80Q and siHSF1 HeLa 
cells.
and presumably due to the stress conditions used, the best known HSF1 
regulated gene, HSPA1A, is not quite two-fold upregulated in heat shocked 
HeLa cells and its activity is only little affected by HSF1 siRNA treatment 
[10]. The common heat shock response also includes a few genes such as 
GADD34, a target of the stress activated transcription factor ATF4. Most of 
the transcript changes seen during the heat shock response were HSF1 
independent as of the 308 genes of which the transcript levels changed at 
least two fold in HEK293 cells, only 30 are regulated by HSF1. The non-
HSF1 dependent stress response is largely cell specifi c (Table 3B). A marker 
for a failing heat shock response in ageing cells will need to be sought 
among the common HSF1 regulated genes.  
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Supplemental tables
Supplemental table 1  Oligonucleotides that were used to generate recombinant DNA 
constructs.
  Oligo name Oligo sequence (5’        3’)
Cloning
ChIP
EMSA
QPCR
HSF1 sil. mut. (HSF1 WT)
HSF1-K80Q
HSPA6 ChIP fwd
HSPA6 ChIP rev
BAG3 ChIP fwd
BAG3 ChIP rev
HSPH1 ChIP fwd
HSPH1 ChIP rev
HSPA1A ChIP fwd
HSPA1A ChIP rev
HSE_EMSA_up
HSE_EMSA_low
GAPDH_QPCR_fwd
GAPDH_QPCR_rev
HSPA1A_QPCR_fwd
HSPA1A_QPCR_rev
HSPA6_QPCR_fwd
HSPA6_QPCR_rev
HSPA1B_QPCR_fwd
HSPA1B_QPCR_rev
HSPA2_QPCR_fwd
HSPA2_QPCR_rev
DNAJB1_QPCR_fwd
DNAJB1_QPCR_rev
HSP90_QPCR_fwd
HSP90_QPCR_rev
HSPB1_QPCR_fwd
HSPB1_QPCR_rev
PCK2_QPCR_fwd
PCK2_QPCR_rev
SGK_QPCR_fwd
SGK_QPCR_rev
ATF3_QPCR_fwd
ATF3_QPCR_rev
cagaaagtcgtcaacaagcttatccagttcctgatctcactg
catgtatggcttccggcaagtggtccacatcgagc
ggaaggtgcgggaaggttcg
ttcttgtcggatgctgga
gattatagccgatgactcagggcg
agtgtctggaaatagcctcc
gaggcaggtttgagccaatg
cacttcctcagccttatgtatc
ctctggagagttctgagcag 
tataagtcgtcacggagacc
aacgagaatcttcgagaatggct
agccattctcgaagattctcgtt
gcagctgaaagaagcccaagt
tgtcttccatgccaattgca
ccgagaaggacgagtttgag
acaaaaacagcaatcttggaaagg
cagagatgaactttccctcc
gaagcagaagaggatgaacc
cagctctttgctgcttcac
cttacagtatcaacattaaatgc
actcaagtcagcgtaaacct
aatagatctcgtacttggcac
ttccccagacatcaagaacc
accctctcatggtccacaac
gttggtcctgtgcggtcact
tgggcaatttctgcctgaa
cgcgctcagccggcaactc
agccatgctcgtcctgccgc
gcagcagaacacaaagggaag
tagtgcccgaagttgtagcc
cctgggagctgtcttgtatgag
aggtgtcttgcggaatttgtaa
tgccgaaacaagaagaagg
ttagctctgcaatgttccttc
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  Oligo name Oligo sequence (5’        3’)
QPCR RGS2_QPCR_fwd
RGS2_QPCR_rev
GADD45B_QPCR_fwd
GADD45B_QPCR_rev
GADD34_QPCR_fwd
GADD34_QPCR_rev
BAG3_QPCR_fwd
BAG3_QPCR_rev
HSPH1_QPCR_fwd
HSPH1_QCR_rev
aagattggaagacccgtttgag
gcaagaccatatttgctggct
gacctgcattgtctcctggtc
cagcgttcctgaagagagatgta
cgcttctggcagaccgaa
gtagcctgatggggtgcttg
ctccattccggtgatacacga
tggtgggtctggtactccc
aggagttccatatccagaa
cagctcaacattcaccac
Supplemental table 2  transcriptome changes in non-stressed (NS) cells and cells heat 
shocked and allowed to recover for 6 hrs (HS 6).
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increase in transcript level HSF1-K80Q NS relative to HSF1 WT NS
ASNS
CTH
JUB
NUPR1
PCK2
RNF125
SEPP1
SLC7A11
STC2
TPK1
WDR13
NM_001673
NM_001902
NM_032876
NM_001042483
NM_004563
NM_017831
NM_005410
NM_014331
NM_003714
NM_022445
NM_017883
2,24
2,37
2,05
1,40
2,31
1,98
37,02
2,33
2,43
2,94
2,13
0,25
0,14
0,15
0,18
0,28
0,09
6,34
0,10
0,49
0,37
0,00 
1,12
1,16
0,98
0,59
1,07
1,01
13,29
1,11
1,07
1,27
1,19 
0,04
0,11
0,06
0,03
0,11
0,55
1,72
0,09
0,22
0,21
0,08 
1,99
2,04
2,09
2,38
2,18
2,32
2,78
2,10
2,26
2,32
1,79 
0,29
0,07
0,02
0,44
0,44
1,34
0,12
0,07
0,16
0,09
0,12 
0,76
1,38
1,10
1,01
0,85
0,88
0,88
0,72
1,89
1,16
0,99 
0,00
0,08
0,13
0,06
0,09
0,05
0,37
0,04
0,97
0,24
0,03 
0,95
1,38
1,13
1,38
0,97
0,95
0,96
0,62
1,72
0,98
0,93 
0,05
0,16
0,05
0,30
0,13
0,05
0,04
0,01
1,18
0,01
0,06
decrease in transcript level HSF1-K80Q NS relative to HSF1 WT NS
BFSP1
C20orf201
CGA
CRLF1
FERMT1
KRT222
LOC100292909
LY6K
NPTX2
PLEKHG4
PPAPDC1A
RAI2
SLC16A5
SYTL5
UBE2C
VCX2
ZNF334 
NM_001195
NM_001007125
NM_000735
NM_004750
NM_017671
NM_152349
XM_002345507
NM_017527
NM_002523
NM_015432
NM_001030059
NM_021785
NM_004695
NM_001163335
NM_181803
NM_016378
NM_199441
0,36
0,32
0,20
0,48
0,23
0,46
0,50
0,21
0,34
0,50
0,41
0,39
0,11
0,18
0,50
0,28
0,27 
0,01
0,00
0,04
0,04
0,00
0,06
0,03
0,02
0,01
0,02
0,01
0,03
0,00
0,01
0,00
0,12
0,02 
1,48
0,79
0,82
0,83
0,53
0,97
1,13
0,45
0,68
1,03
0,88
1,61
0,24
0,37
1,09
0,65
0,80 
0,16
0,04
0,10
0,12
0,04
0,08
0,19
0,08
0,04
0,11
0,01
0,12
0,02
0,02
0,02
0,29
0,00 
0,24
0,41
0,24
0,58
0,43
0,47
0,45
0,47
0,50
0,49
0,46
0,24
0,44
0,49
0,46
0,43
0,33 
0,02
0,02
0,03
0,12
0,04
0,02
0,05
0,13
0,05
0,04
0,02
0,00
0,03
0,04
0,01
0,01
0,03 
1,06
1,37
1,13
1,10
0,81
0,81
0,48
2,06
1,19
0,79
1,10
0,62
0,64
1,02
1,21
11,14
0,70 
0,05
0,07
0,09
0,01
0,06
0,08
0,14
0,10
0,02
0,02
0,06
0,04
0,00
0,06
0,04
0,71
0,05 
1,10
1,36
1,15
1,18
0,90
0,87
0,51
1,94
2,18
0,80
0,99
0,90
0,81
0,98
1,16
35,82
0,77 
0,08
0,08
0,26
0,07
0,19
0,07
0,02
0,57
0,07
0,08
0,10
0,13
0,23
0,02
0,02
29,77
0,10
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inhibited HSF1-K80Q
HSPA1A
CRYAB
DNAJB1
HSPH1
CCDC121
USPL1
DHDH
DNAJB4
NXT2
ZFAND2A
C17orf67
BAG3
LOC387763
DUSP1
UBB
LOC100130288
LOC100133337
MRPL18
ATF3
USP51
JUN
HSPA6
CACYBP
DEDD2
SNORD3D/BU532663
UBC
C22orf43
HSP90AA1
SERPINH1
HSPB1
NM_005345
NM_001885
NM_006145
NM_006644
NM_024584
NM_005800
NM_014475
NM_007034
NM_018698
NM_182491
ENST00000397861
NM_004281
NM_001145033
NM_004417
NM_018955
BC043212
XM_002343495
NM_014161
NM_001674
NM_201286
NM_002228
NM_002155
NM_014412
NM_133328
BU532663
NM_021009
NM_016449
NM_005348
NM_001235
NM_001540
13,67
24,34
32,62
9,81
4,66
6,77
5,69
5,45
5,48
5,74
2,89
6,68
2,80
11,85
3,29
2,05
2,27
2,45
3,69
2,32
3,99
61,92
2,61
2,78
4,31
2,81
3,20
2,77
1,92
1,94
2,68
1,53
2,54
1,69
0,49
0,70
2,09
0,37
0,76
0,66
0,24
1,05
0,27
0,86
0,68
0,02
0,15
0,24
0,51
0,31
0,66
4,89
1,20
0,33
0,52
0,30
0,31
0,61
0,06
0,16
1,16
2,36
3,41
1,89
1,26
1,85
1,62
1,65
1,67
1,76
0,92
2,24
0,94
4,11
1,23
0,84
0,97
1,06
1,61
1,02
1,76
27,42
1,16
1,32
2,09
1,39
1,59
1,38
1,06
1,19
0,06
1,30
0,73
0,09
0,11
0,17
0,34
0,15
0,10
0,34
0,03
0,04
0,20
0,12
0,18
0,03
0,08
0,04
0,20
0,08
0,05
14,31
0,24
0,02
1,11
0,12
0,07
0,13
0,08
0,06
11,8
10,3
9,6
5,2
3,7
3,7
3,5
3,3
3,3
3,3
3,2
3,0
3,0
2,9
2,7
2,4
2,3
2,3
2,3
2,3
2,3
2,3
2,2
2,1
2,1
2,0
2,0
2,0
1,8
1,6
enhanced HSF1-K80Q
DHRS2
NEFH
PLA2G4C
SGK1
HSPA2
VCX3A
OVGP1
VCX2
VCX
NM_182908
NM_021076
NM_003706
NM_005627
NM_021979
NM_016379
NM_002557
NM_016378
NM_013452
3,71
14,27
3,58
11,68
2,71
10,16
2,74
11,14
9,70
0,31
0,47
1,21
1,15
0,69
0,40
0,15
0,71
1,21
7,68
31,17
8,22
30,22
7,05
27,54
7,48
35,82
34,35
3,20
0,93
0,11
4,99
2,62
20,26
1,42
29,77
23,14
0,5
0,5
0,4
0,4
0,4
0,4
0,4
0,3
0,3
Supplemental table 3  transcriptome changes in cells 6 hours recovered from heat shock  
(HS 6) relative to non stressed (NS).
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ENST00000327934
CYR61
HSP90AB1
EGR1
DNAJB6
CLU
NR4A3
SNHG7
DDIT4
KLF6
NR4A1
EIF2AK3
LOC399851
LOC646626
FOSB
ZNF10
FOS
SNORA24
KCNJ2
LOC100289949
LOC645955
MAFB
HMOX1
JMJD6
DUSP5
EIF1AD
IER2
RGS2
CHORDC1
TXNIP
OTP
FLJ23152
ZNF436
MXD1
KDM2A
CHAC1
CAMTA2
CTGF
ZC3H12A
GEM
C10orf10
SLC6A13 ENST00000436453
HERPUD1
BTN2A3
LOC100293390
ENST00000327934
NM_001554
NM_007355
NM_001964
NM_058246
NM_203339
NM_173198
NR_003672
NM_019058
NM_001300
NM_002135
NM_004836
AY129010
XM_942822
NM_006732
NM_015394
NM_005252
BM926530
NM_000891
XM_002346836
XM_933296
NM_005461
NM_002133
NM_015167
NM_004419
NM_032325
NM_004907
NM_002923
NM_012124
NM_006472
NM_032109
XM_001725362
NM_001077195
NM_002357
NM_012308
NM_024111
NM_015099
NM_001901
NM_025079
NM_005261
NM_007021
ENST00000436453
NM_014685
NR_027795
XM_002346092
2,72
7,82
2,70
232,11
2,19
2,26
6,75
3,80
2,35
2,14
6,30
2,33
3,43
3,50
44,68
3,75
70,19
0,24
2,62
3,18
2,26
4,18
2,58
2,56
4,32
2,32
5,19
19,77
2,08
4,38
2,13
2,91
2,53
2,29
2,60
2,84
2,20
6,20
4,82
5,07
6,20
7,29
4,67
2,91
12,23
0,31
1,08
0,31
72,57
0,82
0,28
0,23
0,23
0,27
0,06
0,95
0,11
0,12
0,80
6,34
0,61
4,29
0,02
0,43
0,30
0,21
0,34
0,11
0,04
0,13
1,86
0,26
1,59
0,39
1,10
0,34
0,12
0,02
0,42
0,18
0,01
0,07
1,87
0,02
0,99
0,48
2,40
0,25
0,19
1,54
1,40
4,02
1,41
121,01
1,16
1,21
3,62
2,07
1,29
1,19
3,50
1,30
1,92
1,97
25,66
2,18
41,08
0,14
1,55
1,90
1,35
2,50
1,57
1,56
2,65
1,44
3,24
12,36
1,33
2,81
1,41
1,97
1,73
1,58
1,79
1,99
1,55
4,45
3,46
3,66
4,48
5,33
3,45
2,17
9,16
0,09
0,70
0,08
24,99
0,09
0,06
0,42
0,23
0,15
0,02
0,35
0,35
0,11
0,26
5,88
0,32
4,19
0,03
0,31
0,34
0,10
0,29
0,48
0,03
0,21
0,87
0,23
0,66
0,01
0,75
0,15
0,06
0,28
0,37
0,21
0,71
0,03
0,11
0,18
0,87
1,09
1,15
0,94
0,17
1,35
1,9
1,9
1,9
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1,9
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1,6
1,6
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1,5
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1,4
1,4
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1,4
1,4
1,4
1,4
1,3
1,3
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ID2
TAC1
KIAA1683
ENST00000342294
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JUNB
ENST00000420072
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ARC
C14orf128
GADD45G
ENST00000454337
ENST00000392994
XM_002345305
CX783461
CRYGS
WEE1
SCARNA17
ING1
PPP1R15A
ETAA1
FLRT3
ENST00000451472
MGC16384
NPPC
TMEM60
FUT10
ENST00000414725
ENST00000440429
IER5L
FLJ44253
MAT2A
DDX47
ZNF17
C19orf30
CLDN5
XIST
LEAP2
ZNF594
GADD45B
ZNF616
LY6K
C20orf111
KIAA1949
NM_002166
NM_003182
NM_025249
ENST00000342294
NM_003597
NM_002229
ENST00000420072
NM_004420
NM_004235
NM_015193
NR_027263
NM_006705
ENST00000454337
ENST00000392994
XM_002345305
CX783461
NM_017541
NM_003390
NR_003003
NM_198219
NM_014330
NM_019002
NM_198391
ENST00000451472
NR_026666
NM_024409
NM_032936
NM_032664
ENST00000414725
ENST00000440429
NM_203434
AK126241
NM_005911
NM_016355
NM_006959
NR_027148
NM_003277
NR_001564
NM_052971
NM_032530
NM_015675
BC032805
NM_017527
NM_016470
NM_133471
2,09
2,56
2,50
2,60
3,17
3,68
0,50
2,72
3,42
8,71
0,38
14,73
0,28
0,34
0,48
0,30
2,37
2,89
0,41
2,14
7,99
0,30
2,33
0,44
0,18
2,05
0,49
0,38
0,24
0,45
5,95
0,44
0,35
0,35
0,43
3,04
2,15
0,47
2,54
0,48
31,97
0,44
2,06
2,05
2,31
0,11
0,11
0,71
0,67
0,15
1,08
0,02
1,43
0,27
0,43
0,04
3,55
0,06
0,06
0,07
0,02
0,40
0,19
0,03
0,50
0,80
0,00
0,12
0,00
0,05
0,49
0,05
0,04
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Supplemental table 4A  comparison of transcriptome changes in non-stressed siHSF1 
treated HeLa cells or HSF1-K80Q HEK293 cells (NS).
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Supplemental table 4B  comparison of transcriptome changes in heat shocked siHSF1 
treated HeLa cells or HSF1-K80Q HEK293 cells (HS 6).
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Accumulation of abnormal proteins is associated with neurodegenerative 
syndromes such as Alzheimer disease, Parkinson disease and Huntington 
disease, all age-related diseases. The existence of these diseases em-
phasizes that defects impairing the body’s ability to remove or repair dam-
aged macromolecules effectively accelerates the aging process. Cells are 
equipped with several different categories of repair and surveillance: DNA 
surveillance and repair systems, RNA surveillance systems, anti-oxidant 
systems and systems like the heat shock response (HSR) and the unfolded 
protein response (UPR) that deal with proteotoxic stress. Defi ciency of any 
of these cellular defence systems might tip the balance from repair to per-
manent damage. Impairment of any of these repair and surveillance systems 
will eventually lead to an increase in proteotoxic stress. Maintaining proteos-
tasis during aging is expected to prevent or at least ameliorate age-related 
protein folding and infl ammatory disease [1, 2]. 
Cells respond to cytoplasmic proteotoxic stress by producing additional 
chaperones. This response is called the heat shock response (HSR) and is 
mainly regulated at the level of transcription by heat shock factor 1 (HSF1). 
The activity of HSF1 declines with age. The protein is still present but can no 
longer be activated. One possible approach to prevent the decline in HSF1 
activity during aging is either by targeting HSF1 directly or by targeting lon-
gevity related factors which control HSF1 activity [3]. One potential drawback 
of maintaining or increasing HSF1 activity is that HSF1 also increases the 
risk of cancer, also often an age-related disease [4]. The other known way to 
upregulate the stress system is to cause cellular stress, which ultimately may 
be deleterious and in aging cells this method will be less effective than in 
normal cells because of the lower activity of HSF1. An alternative is to main-
tain the capacity of the chaperoning network by boosting the expression of a 
single (co-)chaperone. To fi nd ways to boost the defence and repair system 
without the deleterious effects, we need to know more about the system, its 
critical nodes and rate limiting steps.
HSF1 targets in stressed and non-stressed cells. 
To understand the role of HSF1, and the consequences of the loss of activity 
thereof, better, we used cellular model systems based on transformed hu-
man embryonic kidney (HEK293) cells in which the transcriptional activity of 
HSF1 was inhibited by overexpression of HSF1 mutants. Dominant negative 
(dn)HSF1 lacks the transactivation domain but can still bind DNA. DnHSF1 
is predicted to occupy the HSF1 binding sites and to repress transcription di-
rected by those binding sites. HSF1-K80Q has lysine 80 in the DNA binding 
region replaced by glutamine, which inhibits DNA binding [3]. Expression of 
HSF1-K80Q should free the HSF1 binding sites (for an overview see fi gure 
1). The rate of transcription of HSF1 target genes that are activated by HSF1 
will decrease, while that of genes that are repressed by HSF1 will increase. 
The transcriptome changes as a result of exogenous expression of these 
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HSF1 mutants have been measured using microarrays (Chapter 4 and 7). 
Inhibiting HSF1 activity in the absence of stress by overexpressing dnHSF1 
resulted in a downregulation of 10 genes, about half of which are canonical 
HSF1 target genes such as DNAJB1; no genes were upregulated. Inhibiting 
HSF1 activity in the absence of stress by overexpressing HSF1-K80Q result-
ed in a downregulation of 17 genes, while 11 genes were upregulated. There 
was no overlap between the 10 downregulated transcripts by dnHSF1 and 
the down- or upregulated transcripts in the HSF1-K80Q expressing cells. A 
comparison of our HSF1-K80Q microarray results with the published data 
using HeLa cells lacking HSF1 (siRNA) [5] showed only a single gene of 
which the transcript level changed signifi cantly in non-stressed cells express-
ing HSF1-K80Q and in cells treated with siHSF1. The difference between the 
HEK293 and HeLa data could partly be explained by the fact that depletion 
of HSF1 by siRNA would free the chaperones which are usually complexed 
with HSF1 while the HSF1-K80Q mutant could capture more chaperones. 
Alternatively, HSF1 could participate in gene regulatory circuits for which the 
DNA binding activity is not required. To distinguish between these possibili-
ties, the effect of lack of the HSF1 protein or just lack of HSF1 binding activ-
ity needs to be compared in the same cells. Still, the HSF1 dependency in 
the absence of stress of most of the genes found in our microarray analysis 
is probably tissue specifi c.
One of the strongest downregulated transcript in dnHSF1 expressing cells 
was PMVK (see Chapter 6). Further analysis of the PMVK promoter region 
showed the presence of an HSF1 binding site in the region encoding the 
5’UTR. HSF1 is not required to maintain transcription of PMVK in either 
non-stressed or stressed cells as PMVK mRNA levels were not decreased 
in cells overexpressing HSF1-K80Q. These data suggest that HSF1 can 
regulate the PMVK promoter, but under which conditions HSF1 does so is 
still unknown.
Loss of regulation by HSF1 does have consequences for cellular robustness. 
The heat induced expression of several chaperones, like HSPA1A, DNAJB1 
and HSPB1, is completely blocked in presence of dnHSF1 or HSF1-K80Q. A 
non-functional HSR prevents complete recovery from heat stress. Therefore, 
dnHSF1 or HSF1-K80Q expressing cells show a higher stress state 24 hours 
after heat stress than normal cells do. For example, 24 hours after heat 
shock the GADD34 and GADD45B mRNA levels are higher in cells express-
ing dnHSF1 or HSF1-K80Q compared with control cells. Evaluating the tran-
scriptome changes in cells overexpressing the HSF1 mutants 24 hours after 
heat shock by microarray analysis might yield further insight in which stress 
pathways remain activated.
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Transcription
XTranscription 
TranscriptionX
Transcription regulated by HSF1Xx? y?
Endogenous situation
dnHSF1
HSF1-K80Q
Figure 1   Cellular model systems used to inhibit HSF1 activity.
Dominant negative (dn)HSF1 lacks the transactivation domain but can still bind DNA. DnHSF1 
is predicted to occupy the HSF1 binding sites and to repress transcription directed by those 
binding sites. HSF1-K80Q has lysine 80 in the DNA binding region replaced by glutamine, which 
inhibits DNA binding. Expression of HSF1-K80Q should free the HSF1 binding sites. 
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What are the critical nodes of the cytoplasmic chaperoning network?
Expression of dnHSF1 reduces the chaperoning capacity of the cell and 
HEK-dnHSF1 cells provide a good model to pinpoint critical nodes of the 
chaperoning network. A reduced chaperoning capacity results in the loss of 
the basal glucocorticoid response as well as a reduced refolding capacity in 
various organelles. We tested the loss of which chaperone was most critical 
for the inhibition of the glucocorticoid response. Since many gene products 
play a role at various stages of glucocorticoid receptor processing, it was 
very surprising that overexpression of individual proteins could rescue the 
negative effect of dnHSF1 on the glucocorticoid response. Nevertheless, 
the individual co-chaperones DNAJA1, DNAJB1 and ST13/Hip were able to 
rescue the dnHSF-mediated inhibition of the glucocorticoid response fully. 
Together these data show that the limiting node of chaperoning network 
is the Hsp70 folding machine, which is in turn is limited not by the level of 
Hsp70 itself, but rather by its co-chaperones (Chapter 4). These results 
are in apparent contrast with the results obtained when the chaperoning 
capacity of a cell is monitored by measuring refolding of heat-denatured 
luciferase. Exogenous expression of DNAJB1 did not restore refolding of 
luciferase, HSPA1A is required as well (with the exception of peroxisomal 
targeted luciferase) (Chapter 5). PolyQ aggregation inhibiting chaperones 
can still perform their action in cells that express the dominant negative 
HSF-1 construct [6, 7]. The main difference between the approach using the 
glucocorticoid response and the refolding assays is that the refolding assays 
were done in stressed cells, while the experiments using the glucocorticoid 
response or polyQ aggregation as a read out were performed using non 
stressed cells. The need for HSP70 will be higher during stress when more 
unfolded proteins are present. Which node of the chaperoning network is 
critical depends on the substrate tested and the compartment in which the 
substrate is located. Furthermore, the stress state of cells infl uences the 
need for particular chaperones. Increasing expression of (co-)chaperones to 
compensate for the loss of HSF1 regulated chaperones in aging cells thus 
needs to be tailored for specifi c substrates.
 
Does crosstalk between different stress responses exist?
The HSR and the UPR are both activated by proteotoxic stress, although in 
different compartments, and share cellular resources, such as the protea-
some [8] and the eIF2α kinase regulatory pathway. eIF2α phosphorylation 
is a common response to different types of stress [9]. This means that ATF4 
synthesis, which is enhanced by eIF2 α phosphorylation, is also common to 
various types of stress. The pattern of transcriptional activation by ATF4 is 
tailored to fi t the type of stress and ATF4 targets are determined by stress 
specifi c factors [10]. The distinction between the transcriptional programs 
initiated by ATF4 as part of the different stress responses could be caused 
by differences in heteromeric partners. ATF4 produced by the UPR activates 
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some, but not all (see for example [10]), of the promoters also activated 
by the amino acid deprivation response. Although prototypical ATF4 target 
genes such as GADD34 and CHOP are upregulated during heat shock (see 
Chapter 2), ATF4 is not thought to play a signifi cant role in the heat shock 
response. The HSR and the UPR also compete for resources in the, not 
unlikely, case that a stressor causes protein unfolding in both cellular com-
partments. How these resources are allocated when both responses are 
active is not known. Insight in possible crosstalk will help understanding the 
consequences of failure of these systems in (age-related) disease. 
As already demonstrated by others [11], we observed that a heat shock 
evokes phosphorylation of eIF2α and splicing of XBP1 mRNA which are 
typical ER stress markers. Additionally, we show that spliced XBP1 protein 
(XBP1s) is synthesized and that transcription of constructs containing the 
consensus ERSE and UPRE elements is activated. These results together 
suggest that a typical UPR is activated upon heat shock. Nevertheless, iden-
tifying the transcription factors involved in the transcriptional activation of the 
UPR responsive promoters did not result in the expected set of transcription 
factors (See Chapter 2). Heat stressed HEK293 cells show HSF1 independ-
ent activation of the promoters of the genes for the ER resident chaperones 
HSPA5 and DNAJB9. The heat induced activation of the DNAJB9 promoter 
could not be blocked by inhibiting XBP1 splicing, and thus did not require 
spliced XBP1. Although inhibition of eIF2 phosphorylation by overexpress-
ing the C-treminal region of GADD34 inhibited the heat induced activation of 
the DNAJB9 promoter, the activation is not ATF4 dependent. The activation 
was also not ATF6 dependent, so another eIF2 phosphorylation target than 
ATF4 is responsible for the heat stress induced activation of the DNAJB9 
promoter. When the typical UPR promoters, the DNAJB9 and the HSPA5 
promoters, become active in heat stressed cells, the heat shock induced 
UPR (XBP1 splicing and also eIF2 phosphorylation) has already decayed. 
This possibly explains why another set of transcription factors needs to be 
recruited to activate these UPR promoters. 
In heat stressed cells there is an effect on the activation of UPR genes. Does 
the activation of the UPR have an effect on typical heat shock genes? To 
answer this question we focused on XBP1s as we noted that XBP1s inhibits 
the activity of the HSPB1 promoter as well as that of the Drosophila mela-
nogaster Hsp70 promoter after heat stress. Acosta Alvear et.al. [12] identi-
fi ed XBP1 binding sites in skeletal muscle from mice by performing a ChIP-
on-chip assay. A number of the promoter regions binding XBP1 belong to 
HSF1 target genes such as BAG3 and SERPINH1. The heat stress induced 
transcriptional activation directed by either the heat shock element of BAG3 
or the SERPINH1 promoter was also inhibited by spliced XBP1 and spliced 
XBP1 showed binding to the promoter regions of BAG3 and SERPINH1. 
However, spliced XBP1 actually enhanced the heat shock induced increase 
in BAG3 or SERPINH1 mRNA levels, while the HSPB1 mRNA and protein 
levels were reduced by XBP1s (Chapter 3). The responsiveness of canoni-
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cal heat shock promoters to XBP1s and that of a canonical UPR promoter, 
DNAJB9, to heat stress suggest that there is crosstalk between the two 
stress systems. 
Failure to maintain proteostasis is now generally accepted as one of the 
causes of aging. 
Loss of regulation by HSF1 does have consequences for cellular robust-
ness as a non-functional HSR prevents complete recovery from heat stress. 
Individuals differ in the rate and extent in which damage repair decreases 
during aging. Therefore, the likelihood of getting an age-related disease, 
such as the previously mentioned protein folding diseases but also chronic 
infl ammatory diseases like arthritis differs.  Defi ciencies in the HSR change 
the transcriptome even in the absence of stress. In theory this would make 
it possible to select a set of genes which can function as diagnostic markers 
to determine the frailty of cells. Frailty is the inability of a cell to cope with 
stress. However, the HSF1 dependency in the absence of stress of most of 
the genes found in our microarray analysis was found to be tissue specifi c.
More studies are necessary to fi nd ubiquitous biomarkers to determine the 
frailty of cells. In addition to the genomic and proteomic approach one can 
also think of the metabolomic approach. Maybe the combination of the ‘om-
ics’ could provide more answers. We know now that if cells turn out to have a 
defective HSR it is possible to compensate for the loss of HSF1 by increas-
ing the expression of (co-)chaperones. It is important to tailor exactly which 
(co-)chaperones are needed: which (co-)chaperones are needed can differ 
for specifi c substrates, type of stressor and cell type also play a role.
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Ons lichaam bevat heel veel eiwitten met allemaal verschillende taken en 
verantwoordelijkheden. De vorm van ieder eiwit ligt vast in de nucleotide 
volgorde van ons erfelijk materiaal: het DNA. Op dit DNA ligt de informatie 
van meer dan 20.000 genen. De nucleotide volgorde van deze genen wordt 
eerst afgelezen en omgezet naar een boodschapper (boodschapper RNA). 
Dit proces heet transcriptie en vindt plaats in de celkern. De boodschapper 
verhuist dan van de celkern naar het cytoplasma en daar wordt de informatie 
van deze boodschapper vertaald naar een aminozuurketen. Voordat deze 
aminozuurketen een functioneel eiwit kan zijn moet deze eerst gevouwen 
worden. Veel eiwitten worden in het cytoplasma gevouwen, maar membraan 
eiwitten en eiwitten die worden uitgescheiden door de cel worden in het 
endoplasmatisch reticulum (ER) gevouwen. Het vouwen van deze aminozu-
urketens gaat niet altijd goed. Ook kunnen verschillende stressoren (hoge 
temperaturen, UV straling, zware metalen, chemicaliën) eiwitten die een 
juiste vorm hebben zo beschadigen dat deze verkeerd gevouwen of geheel 
ontvouwen raken. Verder kunnen afwijkingen in de DNA volgorde die re-
sulteren in een verandering van de aminozuur volgorde, ervoor zorgen dat 
sommige eiwitten sneller ontvouwen. De verkeerd gevouwen eiwitten zijn 
schadelijk voor de cel, omdat ze heel gevoelig zijn voor samenklontering. 
Deze klonten zijn giftig voor de cel omdat ze essentiële cellulaire proces-
sen verstoren (stress). Ontvouwen of verkeerd gevouwen eiwitten worden 
herkend door speciale (stress) eiwitten, de zogenaamde chaperonnes. Deze 
chaperonnes zorgen ervoor dat eiwitten weer juist gevouwen worden en 
hun functie kunnen blijven vervullen. Chaperonnes zorgen er ook voor dat 
eiwitten met onherstelbare schade worden afgebroken; zo wordt voorkomen 
dat deze eiwitten schade veroorzaken. Cellen zijn in staat om meer chaper-
onnes (waarvan er heel veel verschillende soorten zijn) te maken wanneer 
hier behoefte aan is. Een van de systemen dat hiervoor zorgt is de heat 
shock response (HSR) die wordt aangezet wanneer verkeerd gevouwen 
eiwitten opstapelen in het cytoplasma. De belangrijkste regelaar van de HSR 
is heat shock factor 1 (HSF1). Een ingewikkeld regelsytseem zorgt ervoor 
dat een cel weet wanneer een bepaald eiwit nodig is (bijvoorbeeld meer 
chaperonnes), dit wordt doorgegeven aan het gen en dan wordt er meer 
boodschapper gemaakt. Transcriptie factoren spelen hierbij een belangrijke 
rol. Transcriptie factoren binden aan een bepaalde DNA volgorde en activer-
en (of remmen) zo de transcriptie van een gen, waardoor er meer (of mind-
er) boodschapper RNA van dat gen gemaakt wordt. HSF1 is een transcriptie 
factor, die de activiteit van verschillende genen, waaronder chaperonne 
genen, bepaalt. 
Tijdens veroudering werkt de HSR die voor de aanmaak van chaperonnes 
zorgt steeds minder goed. Hierdoor neemt het herstelvermogen van de cel 
af en wordt de kans op verouderings gerelateerde eiwitstapelings-ziektes 
vergroot (zoals Alzheimer,  Parkinson en de ziekte van Huntington). De HSR 
wordt geremd in een verouderde cel omdat de activiteit van HSF1 afneemt. 
HSF1 is nog steeds aanwezig in de cel, maar heeft problemen met het 
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binden aan DNA. Waarom dit gebeurt, is niet bekend. Een reden zou kunnen 
zijn dat verlaging van de hoeveelheid chaperonnes in een cel de kans op 
kanker verkleint. Chaperonnes kunnen namelijk ongeremde groei stimuleren 
en beschermend werken tegen celdood. Helaas heeft een gebrek aan chap-
eronnes ook nadelige consequenties, namelijk een gebrekkig herstelver-
mogen. Meer kennis over de rol van chaperonnes in het verouderingsproces 
kan het mogelijk maken om aftakeling van organismen te vertragen. Als het 
mogelijk is om de aanmaak van (een aantal) chaperonnes in een verouderde 
cel te herstellen, dan zou het herstelvermogen verbeterd worden. Ons 
onderzoek laat zien dat de aanmaak van enkele chaperonnes inderdaad al 
voldoende is om in sommige omstandigheden de negatieve effecten van een 
verminderde HSR op te heffen.
HSF1 afhankelijke boodschappers in normale cellen en cellen die zijn bloot-
gesteld aan stress.
Wat gebeurt er in cellen die geen extra chaperonne eiwitten meer kunnen 
aanmaken in reactie op stress? Heeft HSF1 een rol wanneer er geen stress 
is? Dit zijn centrale vragen in dit proefschrift. Om de rol van HSF1 en het 
gevolg van minder actieve HSF1 beter te begrijpen, hebben we een cellulair 
model system ontwikkeld, waarvoor weefselkweek cellen (HEK293) ge-
bruikt zijn. Deze cellen hebben extra coderende informatie gekregen zodat 
deze cellen een “fout” HSF1 (dnHSF1) kunnen maken. De “fout” in dnHSF1 
houdt in dat dit eiwit heel erg op gewoon HSF1 lijkt en ook aan DNA kan 
binden, maar het uiteinde mist dat nodig is om de eigenlijke aanmaak van 
boodschappers voor verschillende eiwitten te stimuleren. HSF1-K80Q is 
een andere gemuteerde HSF1 en deze HSF1 heeft een “fout” in het gebied 
dat nodig is voor binding aan het DNA, waardoor deze HSF1 niet meer kan 
binden aan DNA. Aanmaak van HSF1-K80Q zorgt ervoor dat alle bindingsp-
laatsen waar HSF1 kan binden in het genoom geen HSF1 meer gebonden 
hebben, terwijl aanmaak van dnHSF1 als gevolg heeft dat de bindingsp-
laatsen wel bezet zijn maar het afl ezen van de genen geblokkeerd wordt. 
De door HSF1 gestimuleerde aanmaak van boodschappers wordt geremd 
in aanwezigheid van dnHSF1 en HSF1-K80Q. In de literatuur is voorg-
esteld dat HSF1 niet alleen stimulerend maar ook remmend kan werken. Bij 
gebruik van HSF1-K80Q valt deze remming weg, terwijl bij dnHSF1 deze 
remming behouden blijft. 
De hoeveelheid boodschappers van verschillende genen verschilt wanneer 
gewone cellen worden vergeleken met cellen die dnHSF1 of HSF1-K80Q 
hebben (hoofdstuk 4 en 7). Het remmen van HSF1 activiteit in de afwezig-
heid van stress met behulp van dnHSF1 resulteert in de remming van de 
aanmaak van 10 verschillende boodschappers, de aanmaak van de helft 
van deze boodschappers staat bekend als typisch HSF1 afhankelijk. Van 
geen enkele boodschapper wordt meer aangemaakt in cellen met dnHSF1. 
Wanneer HSF1 activiteit wordt geremd door aanwezigheid van HSF1-K80Q 
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wordt de aanmaak van 17 boodschappers geremd, terwijl de aanmaak van 
11 boodschappers verhoogd is. Er is geen overlap tussen de 10 boodschap-
pers waarvan de aanmaak wordt geremd door dnHSF1 en de 17 bood-
schappers waarvan de aan maak wordt geremd door HSF1-K80Q. Wanneer 
de in hoofdstuk 7 beschreven data verkregen met de HSF1-K80Q cellijn 
(zonder stress) wordt vergeleken met gepubliceerde data waarbij HeLa 
cellen zijn gebruikt die HSF1 missen (door gebruik van siRNA), zien we 
slechts één boodschapper waarvan de niveaus in zowel de HSF1-K80Q als 
in siHSF1 behandelde cellen lager zijn. Het verschil tussen HEK293-K80Q 
en HeLa-siHSF1 zou voor een deel verklaard kunnen worden als HSF1 kan 
participeren in de regulatie van boodschapper niveaus zonder dat DNA bind-
ing noodzakelijk is, maar waarschijnlijker is dat de HSF1 afhankelijkheid van 
het niveau van de verschillende boodschappers in de afwezigheid van stress 
sterk cel/weefsel specifi ek is. Om erachter te komen wat hier precies aan 
de hand is moet het gebrek aan HSF1 of alleen het gebrek aan HSF1 DNA 
binding vergeleken worden in hetzelfde cel type. 
In cellen met dnHSF1 zijn 10 verschillende boodschapper niveaus lager 
dan in normale cellen. Het niveau van de boodschapper van het gen PMVK 
wordt het sterkst geremd (zie ook hoofdstuk 6). Analyse van de nucleotide 
volgorde van het PMVK gen laat zien dat een bindingsplaats voor HSF1 is 
te vinden in het begin van het PMVK gen en niet, zoals gebruikelijk, voor het 
gen. Helaas weten we niet onder welke condities deze HSF1 bindingsplaats 
ook daadwerkelijk gebruikt wordt. De aanwezigheid van HSF1-K80Q beïn-
vloedt de hoeveelheid PMVK boodschapper niet en HSF1 is dus niet nodig 
voor de regulatie van de aanmaak van PMVK boodschapper in cellen met of 
zonder stress onder normale kweek condities. Mogelijk reguleert HSF1 de 
aanmaak van de PMVK boodschapper onder speciale omstandigheden of in 
sommige weefsels.
Wanneer HSF1 niet meer goed werkt, heeft dit gevolgen voor het herstelver-
mogen van een cel. De extra aanmaak van verschillende chaperonnes zoals 
HSPA1A, DNAJB1 en HSPB1 als gevolg van schade aangebracht door 
een hitte schok (tijdelijke verhoging van de omgevingstemperatuur) wordt 
volledig geremd door de aanwezigheid van dnHSF1 of HSF1-K80Q. Een niet 
functionele HSR kan volledig herstel na een hitte schok in de weg zitten. Wij 
zien dan ook dat cellen met dnHSF1 of HSF1-K80Q 24 uur na hitte schok 
nog verhoogde niveaus van bepaalde (niet HSF1 afhankelijke) stress bood-
schappers hebben, terwijl deze niveaus alweer gedaald zijn tot de normale 
niveaus in cellen die geen “fout” HSF1 hebben.
 
Wie zijn de belangrijkste spelers in het cytoplasmatische chaperonne 
netwerk?
Een cel heeft een uitgebreid chaperonne netwerk. Is het mogelijk om het 
herstelvermogen van een cel te verbeteren door de aanmaak van slechts 
een paar chaperonnes te verhogen? Ons onderzoek laat zien dat de aan-
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maak van enkele chaperonnes al voldoende zou zijn om de negatieve ef-
fecten van een verminderde HSR op te heffen. Cellen met dnHSF1 hebben 
niet meer de mogelijkheid om cytoplasmatische chaperonnes aan te maken. 
Door deze lagere chaperonne capaciteit zijn de cellen met dnHSF1 minder 
gevoelig voor het corticosteroid hormoon. Wanneer echter extra DNAJA1, 
DNAJB1 of ST13/Hip (allemaal (co-)chaperonnes) wordt gegeven aan 
deze cellen dan herstelt de gevoeligheid voor hormonen weer (hoofdstuk 
4). Ontvouwen eiwitten in cellen met dnHSF1 worden ook minder effi ciënt 
hervouwen dan in normale cellen. Om dit te meten wordt het enzym luci-
ferase, een eiwit, gebruikt, waarvan de activiteit heel makkelijk te meten is. 
Luciferase raakt snel ontvouwen als de omgevingstemperatuur verhoogd 
is en is dan niet meer actief. Wanneer de temperatuur weer normaal is, 
zorgen chaperonnes ervoor dat luciferase weer goed gevouwen wordt en de 
activiteit terug krijgt. Cellen met een gezonde chaperonne capaciteit kun-
nen luciferase weer snel hervouwen en de activiteit herstellen; cellen met 
dnHSF1 hebben een lagere hervouwingscapaciteit. Deze capaciteit kan 
verbeterd worden met extra HSPA1A. HSPA1A met extra DNAJB1 werkt nog 
beter, maar DNAJB1 alleen is niet effectief (hoofdstuk 5). Het grote verschil 
tussen het meten van corticosteroid hormoon gevoeligheid van de cellen en 
het meten van hervouwingscapaciteit zit in het feit dat bij de hervouwings 
assay stress wordt gebruikt en het chaperonne systeem dus belast wordt 
met ontvouwen eiwitten, terwijl dat bij de assay voor corticosteroid hormoon 
gevoeligheid niet het geval is. Welke speler in het chaperonne netwerk 
belangrijk is, is sterk afhankelijk van het substraat waarnaar gekeken wordt. 
Ook is de plaats in de cel waar een eiwit hervouwen moet worden van 
invloed en de hoeveelheid stress waar de cel op dat moment mee te maken 
heeft bepaalt ook welke chaperonnes vooral nodig zijn. Ons onderzoek laat 
zien dat de aanmaak van enkele chaperonnes al voldoende zou zijn om de 
negatieve effecten van een verminderde HSR op te heffen, maar er moet 
dan wel rekening worden gehouden met deze verschillende aspecten.
Communiceren verschillende stress systemen met elkaar?
De HSR, met als belangrijkste speler HSF1, wordt actief wanneer verkeerd 
gevouwen eiwitten opstapelen in het cytoplasma. Het ER heeft zijn eigen 
stress response en deze wordt de unfolded protein response (UPR) ge-
noemd. Stapeling van verkeerd gevouwen eiwitten in het ER zorgt voor 
activering van drie verschillende paden, die ieder leiden tot aanmaak van 
een andere transcriptie factor, namelijk ATF4, ATF6 en XBP1. Deze drie 
transcriptie factoren zijn verantwoordelijk voor de aanmaak van boodschap-
pers voor eiwitten die belangrijk zijn om de ER stress te verlichten (ER 
chaperonnes). De HSR en de UPR maken beide gebruik van verschillende 
hulpmiddelen in de cel, zoals de eiwit aanmaak- en afbraaksystemen. Wan-
neer een stressor ontvouwing van eiwitten in zowel het cytoplasma als in het 
ER veroorzaakt, dan zullen de HSR en de UPR moeten competeren voor de 
hulpbronnen die de cel te bieden heeft. Hoe deze hulpbronnen toegewezen 
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worden wanneer beide stress response systemen actief zijn is niet bekend. 
Inzicht in communicatie tussen de HSR en de UPR kan helpen bij het beter 
begrijpen van de consequenties die een gebrekkige HSR en/of een gebrek-
kige UPR hebben voor de ontwikkeling van (verouderings gerelateerde) 
aandoeningen.
We hebben aangetoond dat een hitte schok de aanmaak van ATF4 gang 
zet. Daarnaast wordt ook XBP1 gemaakt. Verder hebben we gezien dat ook 
het derde pad, dat zorgt voor de activering van ATF6, van de UPR wordt 
geactiveerd met hitte schok, al is deze activering mild in vergelijking met 
activering door specifi eke ER stress. Deze resultaten duiden erop dat de drie 
paden van de UPR actief zijn na hitte schok. De activering van aanmaak van 
de boodschappers voor ER chaperonnes door een hitte schok gaat alleen 
net iets anders dan de activering van aanmaak van dezelfde boodschappers 
via typische ER stress. De aanmaak van DNAJB9 boodschapper, een ER 
chaperonne, wordt geactiveerd na hitte stress, maar de transcriptie factoren 
die nodig zijn om meer DNAJB9 boodschapper te maken zijn niet XBP1 en 
ATF4 zoals bij reguliere ER stress (hoofdstuk 2). Welke transcriptie factor na 
hitte schok wel nodig is, is nog niet bekend.
Wanneer extra XBP1 wordt gemaakt in een cel (wat ook gebeurt tijdens 
hitte schok), wordt de aanmaak van het HSPB1 boodschapper geremd; de 
activiteit van het HSPB1 gen wordt ook door HSF1 gecontroleerd. Hetzelfde 
geldt voor de activiteit van het Drosophila melanogaster Hsp70 gen: ook 
deze activiteit is afhankelijk van HSF1 en wordt geremd door XBP1s (hoofd-
stuk 3). Het feit dat de regulatie van twee genen, welke beide afhankelijk zijn 
van HSF1 voor activiteit, negatief wordt beïnvloed door XBP1s en het feit 
dat de aanmaak van de boodschapper van een ER chaperonne geactiveerd 
kan worden door hitte schok, suggereert dat de twee systemen met elkaar 
communiceren.
Een verouderde cel bevat minder chaperonnes en tijdens stress is deze niet 
in staat om genoeg extra chaperonnes bij te maken. De schade die ontstaat 
aan de eiwitten kan daardoor minder goed hersteld worden en beschadigde 
eiwitten worden minder goed afgebroken waardoor eiwitklontering optreedt. 
Vooral zenuwcellen zijn erg gevoelig doordat hun HSR bij voorbaat al minder 
effi ciënt werkt. Vandaar dat veel verouderings gerelateerde stapelings ziek-
ten neurologisch van aard zijn. Chaperonnes hebben ook het reguleren van 
het immuunsysteem als belangrijke taak. Wanneer de hoeveelheid chaper-
onnes in een cel afneemt neemt de kans op chronische ontstekingsziektes 
zoals reuma toe. Daarnaast heeft ieder mens een andere genetische 
achtergrond en dit wordt benadrukt wanneer de chaperonne capaciteit van 
een cel weg valt. Wanneer een genetisch verschil zorgt voor een iets andere 
eiwit volgorde die wat minder goed vouwt, dan kan dit defect ondervangen 
worden door chaperonnes en ontstaat er toch nog een functioneel eiwit. In 
een oudere cel gaat dat minder goed door een gebrek aan chaperonnes. 
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Doordat iedereen andere genetische variaties heeft zullen de defecten 
door ouderdom ook bij ieder individu anders zijn. Voor de behandeling van 
ouderdoms-gerelateerde ziektes zou het goed zijn om te weten wat de 
kwetsbaarheid van de cellen, i.e. het (on)vermogen tot schade herstel, is. Dit 
kan bepaald worden door te kijken naar de capaciteit van de HSR. Wanneer 
de HSR minder goed werkt heeft dit effect op het boodschapper patroon en 
op het eiwit patroon, zelfs zonder dat er stress aanwezig is. Helaas hebben 
onze data uitgewezen dat de HSF1 afhankelijkheid in de afwezigheid van 
stress sterk cel specifi ek is. Wanneer blijkt dat de HSR minder goed werkt 
dan zou mogelijk de aanmaak van slechts enkele chaperonnes al voldoende 
zijn om de negatieve effecten van een beperkte HSR te verlichten. Daarom 
is het belangrijk dat er (synthetische of natuurlijke) stofjes worden gevonden 
die de aanmaak van bepaalde chaperonnes verhogen (op de plaats waar 
deze nodig zijn). Deze stofjes kunnen ingezet worden om de gevolgen van 
eiwitstapelings- of chronische ontstekingsziektes te verlichten. Uiteraard 
moet daarbij rekening worden gehouden met eventuele verhoogde kans op 
de ontwikkeling van kanker. Wanneer men chaperonnes wilt inzetten om de 
verschijnselen van ouderdoms-gerelateerde ziektes te verminderen moet 
er goed worden nagedacht over welke chaperonnes uit het hele netwerk er 
nodig zijn. Daarnaast is het wenselijk om deze chaperonnes alleen op de 
plaatsen waar zij nodig zijn te introduceren.
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was lang genoeg om uw humor te 
mogen ontdekken.
Beste Ger, je was altijd in positieve 
zin aanwezig. Tijdens de wekelijkse 
werkbesprekingen wist je altijd op 
je eigen rustige manier de vinger op 
de zere plek te leggen en prak-
tische oplossingen voor problemen 
te vinden. Bedankt dat je in mijn 
beoordelingscommissie plaats hebt 
willen nemen. 
 
Wilbert, bedankt voor je enthousi-
aste kijk op dingen. Het is fi jn om 
iemand te kennen die werkelijk 
overal op de wereld is geweest, 
want mocht ik nog een keer te 
weinig inspiratie hebben, dan weet 
ik je te vinden.
Lieve Els, het is heerlijk om te weten 
dat belangrijke zaken altijd in goede 
handen zijn bij jou. Ik vond het heel 
gezellig om eventjes met je te klet-
sen, want niemand op de afdeling 
is beter op de hoogte van de laatste 
nieuwtjes dan jij. En fi jn dat er een 
bewaakster bij de snoepvoorraad 
zit anders had ik waarschijnlijk veel 
meer calorieën verorberd.
Carla (O), het begon heel gezellig 
bij elkaar in het u’tje. Helaas wer-
den we bij de verhuizing naar de 2e 
verdieping bruut gescheiden. Geluk-
kig zaten er maar een paar deuren 
tussen en bestaat er ook nog zoiets 
als de koffi etafel. Je bent een 
fantastische regelaar en dat heeft 
iedereen ook heel snel door.  
Dankwoord
Onderzoek verloopt bijna nooit 
zonder obstakels en toch heb ik 
de afgelopen jaren een hele leuke 
periode gehad. Ontzettend veel 
mensen hebben mij geïnspireerd, 
geholpen en gesteund. Dit alles 
heeft het mogelijk gemaakt dat dit 
proefschrift hier nu ligt. Ik wil graag 
van de gelegenheid gebruik maken
om een aantal mensen in het bij-
zonder te bedanken. 
Als eerste wil ik mijn promotor Lettie 
Lubsen bedanken. Beste Lettie, 
jouw enthousiasme en betrokken-
heid zijn ongeëvenaard. Ik ben erg 
dankbaar dat je mij hebt aangenom-
en op dit project en voor de moge-
lijkheden die je mij hebt geboden 
om mij te ontwikkelen als onder-
zoeker. Je kritische blik, heldere 
kijk, maar ook je snelheid zijn in-
drukwekkend te noemen. Vooral in 
de laatste fase van mijn schrijf 
periode was ik erg blij met de 
enorme snelheid waarmee je mijn 
stukken nakeek. Ik heb het zeer 
gewaardeerd dat de deur altijd open 
stond voor advies en vragen. Ook 
heb ik veel profi jt gehad van de 
wekelijkse bijeenkomsten (samen 
of met de andere Lubsels erbij), 
die vaak nieuwe ideeën oplever-
den. Verder wil ik je mijn allerbeste 
wensen geven voor een gelukkig 
emeritaat, maar dat gaat geloof ik 
wel goed komen!
Beste Wilfried, heel even begonnen 
als mijn promotor, maar inmiddels al 
een tijdje met emeritaat. Ik heb dan 
misschien maar heel even mogen 
profi teren van uw adviezen, het 
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Ron, jij hebt ervoor gezorgd dat ik 
me de eerste week al thuis voelde 
op het lab, ik mocht meteen met 
CHOP aan de slag, zo leuk! Het 
is onbeschrijfl ijk fi jn dat je met de 
“Lubsen Salt Prep” collectie bent 
gestart (je kon het niet langer 
aanzien, de wanorde). Het heeft 
uiteindelijk heel wat zoekacties 
gescheeld. Je was een ontzettend 
leuke collega en je hebt een hele 
belangrijke invloed op dit boekje 
gehad. Ik wens je alle succes toe in 
Leiden.
Siebe, ik had de grote eer een 
u’tje met je te delen. Van overal en 
nergens kwamen mensen om je 
advies vragen, ik hoefde me alleen 
maar om te draaien en te zeggen: 
“Siebe??” Ik heb genoten van onze 
gesprekken, ik kon altijd lekker 
tegen je aankletsen. Maar ik ben je 
natuurlijk ook erg dankbaar voor alle 
lab-hulp. Met jouw jarenlange erva-
ring op het lab heb ik veel trucjes 
van je kunnen leren. Ontzettend 
bedankt hiervoor! Ik ben heel blij 
dat je me ook bij wilt staan tijdens 
het spannendste uurtje van mijn 
promotie. 
Sanne, je bent er wat later bij 
gekomen, maar ik heb veel van je 
geleerd. Je gezelligheid en enthou-
siasme was erg plezierig. En niet 
alleen in het lab, maar ook daar-
buiten (in de lege boogie). Heel veel 
succes met je laatste loodjes.
Carla (S/W), jammer dat je hele-
maal naar Deventer bent ver-
trokken, maar voor jezelf wel heel 
fi jn. Kom snel nog een keertje langs. 
Chantal & Joyce, nu gezellig samen 
in een u en dat met van die ver-
schillende muziekstijlen. Lang leve 
oordopjes. Veel succes met 
schrijven en ik kijk uit naar jullie 
boekjes. Raymond & Remon ik 
moet toch toegeven dat jullie lab 
kant op vrijdag veel gezelliger was 
dan die van ons. En ik weet ook 
heel zeker dat ik nooit meer bij van 
Geel in de auto stap als Staals 
ernaast zit. Succes met jullie eigen 
laatste loodjes. Sander, bij jou kon 
ik stoom afblazen, bedankt voor je 
luisterend oor. Veel geluk in Bonn.
Dear Tamara, it is nice to know 
someone who is not afraid to say 
literally everything what’s on her 
mind. I wish you all the best in 
Croatia.
Ook wil ik alle andere fi jne col-
lega’s die ervoor hebben gezorgd 
dat mijn aio-tijd zo prettig was 
bedanken. Ole, Guido, Erik, John 
mijn oud-labgenoten van de 3e 
verdieping bedankt voor de korte 
maar krachtige tijd. Angelique, 
Helma, Elina, Wilma, Marina, Judith, 
Annemarie (Succes met Joppie en 
Noortje), Sandy, Jeroen en Geurt 
heel hartelijk dank. Bedankt voor 
de leuke borrels, fantastische FeCo 
activiteiten, cake van de week en 
alle gezellige avonden (Jos, fi lm 
avondjes, labstap).
Mijn studenten Martijn, Toine, Lars, 
Rik, Stefan en Tom (chronologische 
volgorde) wil ik bedanken voor hun 
inzet en enthousiasme tijdens hun 
stages. Ik heb veel respect voor de 
creativiteit en originaliteit waarmee 
jullie hebben bijgedragen aan de 
verschillende projecten.
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Beste Wiljan, je was een fi jne 
mentor en bedankt dat je in mijn 
beoordelingscommissie plaats hebt 
willen nemen.
Verder wil ik alle IOP collega’s 
bedanken voor de leuke meetings. 
Bedankt voor alle adviezen en het 
enthousiasme. Bovendien wil ik 
Ineke bedanken voor het beoorde-
len van mijn proefschrift.
Ook al was het soms wat lastig te 
begrijpen wat ik nu allemaal aan 
het doen ben geweest in dat lab in 
Nijmegen, iedereen bleef steevast 
informeren hoe het er nu allemaal 
voorstond. Daarom wil ik al mijn 
vrienden en familie bedanken, voor 
alle steun en de nodige gezelligheid 
tijdens mijn promotietijd. 
Lieve Niros, wij kennen elkaar al 
sinds de middelbare school en zijn 
dan ook al een hele poos vriendin-
nen. Onze vriendschap is mij nog 
steeds heel dierbaar. De tijd dat 
we elkaar elke dag zagen is helaas 
voorbij maar ik hoop dat het, on-
danks de afstand, lukt om nog vaak 
af te blijven spreken. 
Beste Jongmansen, jullie zijn zoveel 
meer dan gewoon schoonfamilie. 
Dank jullie wel voor jullie interesse, 
steun en gezelligheid, jullie zijn een 
stel schatten!
Lieve mama, jammer dat je er niet 
meer bij kan zijn, ik mis je…
Papa, al vanaf jongs af aan heb je 
veel interesse ‘punten?’ getoond. 
Bedankt voor alles wat je mij hebt 
meegegeven en dat je er altijd 
voor me bent geweest met je nooit 
afl atende steun. Zonder jou was het 
allemaal veel moeilijker geweest. 
Fijn dat je Karen hebt ontmoet en 
ik wens jullie al het geluk voor de 
toekomst. Leontien, je bent het 
meest fantastische zusje dat je 
maar kan hebben. Dank je wel voor 
je interesse, je hulp en de gezel-
lige avondjes/telefoontjes. Geniet 
van het leven samen met Bram. En 
Erwin, mijn liefste broertje, ik had 
beloofd dat je in het dankwoord 
van dit boek, werkstuk of whatever 
zou komen. Bedankt dat je nooit 
hebt opgegeven om te vragen hoe 
het ging met mijn vage werk. En ik 
vind het natuurlijk fantastisch dat 
je vandaag naast me wilt staan als 
paranimf.
Lieve Erik, ik kan me een leven 
zonder jou niet meer voorstellen. 
Bedankt voor het vele geduld dat 
je met mij en mijn gestress hebt 
(gehad). Ik kan je voor eindeloos 
veel dingen bedanken. Onder al die 
dingen vallen ook alle grote hoogtes 
die we samen bereikt hebben de 
afgelopen jaren. Geen berg of toren 
laat jij onbeklommen aan je voorbij 
gaan. De Eiffeltoren, Vogel, Oriental 
Pearl Tower, Petronas Twin Towers, 
Arthur’s Seat (en dit is slechts een 
selectie). Laten we deze lijst nog 
veel langer maken!
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Lonneke Heldens werd geboren op 16 januari 1983 te Roosendaal. In 2001 
behaalde zij het VWO diploma aan het Norbertuscollege te Roosendaal. In 
datzelfde jaar werd een begin gemaakt met de studie Gezondheidsweten-
schappen aan de Universiteit van Maastricht. Tijdens haar studie liep zij 
stage bij de Immunotoxicologie groep van de afdeling Gezondheids Risico 
Analyse en Toxicologie (GRAT) te Maastricht. Onder begeleiding van 
Dr. Harald Moonen werkte zij daar aan een project getiteld: De effecten 
van PARP-1 remmers op de activatie van nuclear factor κB (NFκB) door 
immuunstimulerende stoffen. De mogelijke rol van PARP-1 remmers bij de 
preventie van chronische infl ammatoire aandoeningen, zoals de longziekte 
COPD, stond bij deze stage centraal. Tijdens haar tweede stage bij de 
afdeling Moleculair Metabolisme en Endocrinologie (MME)/ Interne Ge-
neeskunde aan de Universiteit Maastricht werkte zij, onder supervisie van 
Dr. Steven Meex en Dr. Carla van der Kallen, aan de identifi catie van nieuwe 
genetische variaties die (mede)verantwoordelijk zijn voor de ontwikkeling 
van familiaire gecombineerde hyperlipidemie en diabetes mellitus type 2. In 
2005 werd het doctoraal diploma behaald met als specialisatie Biologische 
Gezondheidskunde. In 2006 begon ze aan haar promotie-onderzoek aan 
de afdeling Biomoleculaire Chemie aan de Radboud Universiteit Nijmegen. 
Onder begeleiding van Prof. Dr. Lettie Lubsen resulteerde haar onderzoek 
uiteindelijk in dit proefschrift.
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Appendix
Gene 
name
Acc. Nr. Alternative 
name
HSF family
HSF1
HSF2
HSF4
HSF5
HSFX1
HSFY1
NM_005526.
NM_004506.
NM_001538.
NM_001080439
NM_016153
NM_033108
HSFX2, LW-1
HSF2L, HSFY, HSFY2
HSPH family
HSPH1
HSPH2
HSPH3
HSPH4
NM_006644
NM_002154
NM_014278
NM_006389
HSP105
HSPA4, APG-2, HSP110
HSPA4L, APG-1
HSP12A, hypoxia up-
regulated 1
HSP90 family
HSP90AA1
HSP90AB1
HSP90B1
TRAP1
NM_005348
NM_007355
NM_003299
NM_016292
HSPC1, Hsp90α, LAP2, 
HSPCA
HSPC3, Hsp90β, HSPCB
HSPC4, Grp94, TRA1, 
endoplasmin
HSPC5, HSP90L, TNF 
receptor-associated 
protein 1 (mitochondrial 
Hsp90)
HSPA (Hsp70) family
HSPA1A/
B1
HSPA1L
HSPA2
HSPA5
HSPA6
HSPA8
HSPA9
HSPA12A
HSPA12B
HSPA13
HSPA14
NM_005345
NM_005527 
NM_021979
NM_005347
NM_002155
NM_153201
NM_004134
NM_025015
NM_052970
NM_006948
NM_016299
hsp72
heat shock 70kDa protein 
1-like
GRP78, BiP
HSP70B’
HSC70
mortalin-2 (mitochondrial 
protein)
KIAA0417
STCH
Gene 
name
Acc. Nr. Alternative 
name
DNAJ (Hsp40) family
DNAJA1
DNAJA2
DNAJA3
DNAJA4
DNAJB1
DNAJB2
DNAJB3
DNAJB4
DNAJB5
DNAJB6
DNAJB7
DNAJB8
DNAJB9
DNAJB11
DNAJB12
DNAJB13
DNAJB14
DNAJC1
DNAJC2
DNAJC3
DNAJC4
DNAJC5
DNAJC5B
DNAJC5G
DNAJC6
DNAJC7
DNAJC8
DNAJC9
DNAJC10
DNAJC11
DNAJC12
DNAJC13
DNAJC14
DNAJC15
DNAJC16
DNAJC17
DNAJC18
DNAJC19
DNAJC20
DNAJC21
DNAJC22
DNAJC23
DNAJC24
DNAJC25
DNAJC26
DNAJC27
DNAJC28
DNAJC29
DNAJC30
NM_001539
NM_005880
NM_005147
NM_018602
NM_006145
NM_006736
NM_001001394 
NM_007034
NM_012266
NM_005494
NM_145174
NM_153330
NM_012328
NM_016306
NM_001002762
NM_153614
NM_024920
NM_022365
NM_014377
NM_006260
NM_005528
NM_025219 
NM_033105
NM_173650
NM_014787
NM_003315
NM_014280
NM_015190
NM_018981
NM_018198
NM_021800
NM_015268
NM_032364
NM_013238
NM_015291
NM_018163
NM_152686
NM_145261
NM_172002
NM_194283
NM_024902
NM_007214
NM_181706
NM_001015882
NM_005255
NM_016544
NM_017833
NM_014363
NM_032317
DJ-2, HDJ2
HIRIP4, Dnaj3
Tid-1
Dj-4, Hsj-4
hsp40, HDJ1
HSJ1
HSJ3
Hsc40
Hsc40, HSP40-3
Mrj
Dj5
mDj6
ERdj4
ERdj3
Dj10
Tsarg6
FLJ14281
ERdj1
Zuotin related 
factor 1 (ZRF1)
p58
HSPf2
cysteine string protein 
(CSP)
cysteine string protein 
beta (CSP-beta)
MGC107182
Auxilin
Ttc2
spf31
ERdj5
jdp1
J-type co-chaperone 
HSC20 (RP3-366L4.2)
DnaJA5
hypothetical protein 
FLJ13236
SEC63
ZCSL3
DnaJ-like protein 
cyclin G associated kinase 
(GAK), auxilin-2
Ras-associated protein 
Rap1 (RBJ)
C21orf55
sacsin
WBSCR18
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Gene 
name
Acc. Nr. Alternative 
name
HSPB (sHsp) family
HSPB1
HSPB2
HSPB3
HSPB4
HSPB5
HSPB6
HSPB7
HSPB8
HSPB9
HSPB10
NM_001540
NM_001541
NM_006308
NM_000394
NM_001885
NM_144617
NM_014424
NM_014365
NM_033194
NM_024410
Hsp27
MKBP
HSPL27
αA-crystallin (CRYAA)
αB-crystallin (CRYAB)
HSP20
cvHSP
HSP22
FLJ27437
ODF1
Others
HSPD1
HSPE1
SERPINH1
CCT3
NM_002156
NM_002157
NM_001235
NM_005998
HSP60, chaperonin
HSP10, chaperonin 10
HSP47
TCP1, subunit 3 (gamma)
Co-chaperones
AHSA1
AHSA2
BAG1
BAG2
BAG3
BAG4
BAG5
PTGES3
ST13
STIP1
STUB1
AIP
CDC37
FKBP4
FKBP5
PPID
PPP5C
SGTA
TOMM70A
TTC4
UNC45A
NM_012111
NM_152392
NM_004323
NM_004282
NM_004281
NM_004874
NM_001015049
NM_006601
NM_003932
NM_006819
NM_005861
NM_003977
NM_007065
NM_002014
NM_004117
NM_005038
NM_006247
NM_003021
NM_014820
NM_004623
NM_018671
AHA1 homolog 1
AHA1 homolog 2
p23
HIP
HOP
CHIP
cyclophilin D
